Diamandis Laboratory Publications

2017

1. Filippou P, Korbakis D, Farkona S, Soosaipillai A, Karakosta T, Diamandis EP.
   A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9.
   Clin Proteomics. 2017 Jan 17;14:4. PMID: 28115917
2. Di Meo A, Batruch I, Yousef AG, Pasic MD, Diamandis EP, Yousef GM.
   An integrated proteomic and peptidomic assessment of the normal human urinome.
   Clin Chem Lab Med. 2017 Feb 1;55(2):237-247. PMID: 27394047

2016

3. Kulasingam V, Diamandis EP.
   Genomic profiling for copy number changes in plasma of ovarian cancer patients - a new era for cancer diagnostics?
   BMC Med. 2016 Nov 17;14(1):186. PMID: 27852253
4. Konvalinka A, Batruch I, Tokar T, Dimitromanolakis A, Reid S, Song X, Pei Y, Drabovich AP, Diamandis EP, Jurisica I, Scholey JW.
   Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring.
   Clin Proteomics. 2016 Aug 5;13:16. PMID: 27499720
5. Ahmed N, Dorn J, Napieralski R, Drecoll E, Kotzsch M, Goettig P, Zein E, Avril S, Kiechle M, Diamandis EP, Schmitt M, Magdolen V.
   Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
   Biol Chem. 2016 Dec 1;397(12):1265-1276. PMID: 27483364
6. Karakosta TD, Soosaipillai A, Diamandis EP, Batruch I, Drabovich AP.
   Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.
   Mol Cell Proteomics. 2016 Sep;15(9):2863-76. PMID: 27371727
7. Oikonomopoulou K, Yu H, Wang Z, Vasiliou SK, Brinc D, Christofi G, Theodorou M, Pavlou P, Hadjisavvas A, Demetriou CA, Kyriacou K, Diamandis EP.
   Association between Echinococcus granulosus infection and cancer risk - a pilot study in Cyprus.
   Clin Chem Lab Med. 2016 Dec 1;54(12):1955-1961. PMID: 27327131
8. Musrap N, Diamandis EP.
   Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping.
   Clin Chem. 2016 Aug;62(8):1066-74. PMID: 27259815
9. Diamandis EP.
   Theranos phenomenon - part 4: Theranos at an International Conference.
   Clin Chem Lab Med. 2016 Aug 1;54(8):e243-4. PMID: 27259230
10. Begcevic I, Brinc D, Drabovich AP, Batruch I, Diamandis EP.
    Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.
    Clin Proteomics. 2016 May 15;13:11. PMID: 27186164
11. Mangé A, Dimitrakopoulos L, Soosaipillai A, Coopman P, Diamandis EP, Solassol J.
    An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
    J Proteomics. 2016 Jun 16;142:114-21. PMID: 27168011
12. Farkona S, Diamandis EP, Blasutig IM.
    Cancer immunotherapy: the beginning of the end of cancer?
    BMC Med. 2016 May 5;14:73. PMID: 27151159
13. Dorn J, Yassouridis A, Walch A, Diamandis EP, Schmitt M, Kiechle M, Wang P, Drecoll E, Schmalfeldt B, Loessner D, Kotzsch M, Magdolen V.
    Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome.
    Am J Cancer Res. 2015 Dec 15;6(1):61-70. PMID: 27073723
14. Drabovich AP, Pavlou MP, Schiza C, Diamandis EP.
    Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells.
    Mol Cell Proteomics. 2016 Jun;15(6):2093-107. PMID: 27067054
15. Li M, Diamandis EP.
    Theranos phenomenon--part 3.
    Clin Chem Lab Med. 2016 May;54(5):e145-6. PMID: 26966932
16. Diamandis EP.
    Significant increase of serum prostate-specific antigen after exercise.
    Clin Chem Lab Med. 2016 Sep 1;54(9):e245-6. PMID: 26910748
17. Filippou PS, Karagiannis GS, Musrap N, Diamandis EP.
    Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.
    Crit Rev Clin Lab Sci. 2016 Aug;53(4):277-91. PMID: 26886390
18. Li M, Diamandis EP.
    Technology-driven diagnostics: From smart doctor to smartphone.
    Crit Rev Clin Lab Sci. 2016 Aug;53(4):268-76. PMID: 26857116
19. Dimitrakopoulos L, Prassas I, Diamandis EP, Nesvizhskii A, Kislinger T, Jaffe J, Drabovich A.
    Proteogenomics: Opportunities and Caveats.
    Clin Chem. 2016 Apr;62(4):551-7. PMID: 26817480
20. Annesley T, Diamandis E, Bachmann L, Hanash S, Hart B, Javahery R, Singh R, Smith R.
    A Spectrum of Views on Clinical Mass Spectrometry.
    Clin Chem. 2016 Jan;62(1):30-6. PMID: 26553793
21. Dukic L, Simundic AM, Martinic-Popovic I, Kackov S, Diamandis A, Begcevic I, Diamandis EP.
    The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Clin Biochem. 2016 Feb;49(3):213-8. PMID: 26515085
22. Diamandis EP, Li M.
    The side effects of translational omics: overtesting, overdiagnosis, overtreatment.
    Clin Chem Lab Med. 2016 Mar;54(3):389-96. PMID: 26444364
23. Diamandis EP, Plebani M.
    Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker.
    Clin Chem Lab Med. 2016 Jan;54(1):e1-2. PMID: 26389634

2015

24. Li M, Diamandis EP.
    Theranos phenomenon - part 2.
    Clin Chem Lab Med. 2015 Nov;53(12):1911-2. PMID: 26402887
25. Knauer MJ, Diamandis EP, Hulot JS, Kim RB, So DY.
    Clopidogrel and CYP2C19: pharmacogenetic testing ready for clinical prime time?
    Clin Chem. 2015 Oct;61(10):1235-40. PMID: 26272232
26. Drucker KL, Gianinni C, Decker PA, Diamandis EP, Scarisbrick IA.
    Prognostic significance of multiple kallikreins in high-grade astrocytoma.
    BMC Cancer. 2015 Aug 1;15:565. PMID: 26231762
27. Korbakis D, Dimitromanolakis A, Prassas I, Davis GJ, Barber E, Reckamp KL, Blasutig I, Diamandis EP.
    Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.
    Br J Cancer. 2015 Jul 28;113(3):484-91. PMID: 26180921
28. Diamandis EP.
    Getting noticed is half the battle.
    Science. 2015 Jul 10;349(6244):206. PMID: 26160950
29. Raizman JE, Diamandis EP, Holmes D, Stowasser M, Auchus R, Cavalier E.
    A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management.
    Clin Chem. 2015 Aug;61(8):1022-7. PMID: 26106077
30. Yu Y, Prassas I, Dimitromanolakis A, Diamandis EP.
    Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.
    J Biol Chem. 2015 Jul 17;290(29):17762-75. PMID: 26032414
31. Diamandis EP.
    Theranos phenomenon: promises and fallacies.
    Clin Chem Lab Med. 2015 Jun;53(7):989-93. PMID: 26030792
32. Beriault DR, Diamandis EP, Portelius E, Perret-Liaudet A, Salloway S.
    Biomarkers, assays, and therapies for Alzheimer disease.
    Clin Chem. 2015 Jul;61(7):903-8. PMID: 26015517
33. Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP.
    Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).
    J Biol Chem. 2015 Jul 10;290(28):17218-27. PMID: 26004777
34. Grober ED, Garbens A, Božović A, Kulasingam V, Fanipour M, Diamandis EP.
    Accuracy of testosterone concentrations in compounded testosterone products.
    J Sex Med. 2015 Jun;12(6):1381-8. PMID: 25963000
35. Diamandis EP.
    A Day in the Life of Dr. Bean and How the NIH Is Wasting $20 Billion per Year.
    Clin Chem. 2015 May;61(5):783-4. PMID: 25922501
36. Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, Diamandis EP, Bossuyt PM.
    Validation of new cancer biomarkers: a position statement from the European group on tumor markers.
    Clin Chem. 2015 Jun;61(6):809-20. PMID: 25882892
37. Lennox GK, Eiriksson LR, Reade CJ, Leung F, Mojtahedi G, Atenafu EG, Ferguson SE, Murphy J, Diamandis EP, Kulasingam V, Bernardini MQ.
    Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?
    Int J Gynecol Cancer. 2015 Jun;25(5):809-14. PMID: 25855958
38. Korbakis D, Brinc D, Schiza C, Soosaipillai A, Jarvi K, Drabovich AP, Diamandis EP.
    Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids.
    Mol Cell Proteomics. 2015 Jun;14(6):1517-26. PMID: 25813379
39. Diamandis EP.
    Support staff: Build reward system for ace technicians.
    Nature. 2015 Mar 26;519(7544):414. PMID: 25810194
40. Martínez-Morillo E, Childs C, García BP, Álvarez Menéndez FV, Romaschin AD, Cervellin G, Lippi G, Diamandis EP.
    Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury.
    Clin Chem Lab Med. 2015 Sep 1;53(10):1575-84. PMID: 25720124
41. Prassas I, Eissa A, Poda G, Diamandis EP.
    Unleashing the therapeutic potential of human kallikrein-related serine proteases.
    Nat Rev Drug Discov. 2015 Mar;14(3):183-202. PMID: 25698643
42. Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF.
    Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
    J Natl Cancer Inst. 2015 Feb 16;107(4). PMID: 25688116
43. Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V.
    Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers.
    Clin Proteomics. 2015 Jan 13;12(1):1. PMID: 25678896
44. Abou El Hassan M, Diamandis EP, Karumanchi SA, Shennan AH, Taylor RN.
    Preeclampsia: an old disease with new tools for better diagnosis and risk management.
    Clin Chem. 2015 May;61(5):694-8. PMID: 25614469
45. Diamandis EP.
    The Hundred Person Wellness Project and Google's Baseline Study: medical revolution or unnecessary and potentially harmful over-testing?
    BMC Med. 2015 Jan 9;13:5. PMID: 25575898
46. Diamandis EP.
    Publishing costs: Peer review as a business transaction.
    Nature. 2015 Jan 8;517(7533):145. PMID: 25567274
47. Rotondo F, Di Ieva A, Kovacs K, Cusimano MD, Syro LV, Diamandis EP, Yousef GM.
    Human kallikrein 10 in surgically removed human pituitary adenomas.
    Hormones (Athens). 2015 Apr-Jun;14(2):272-9. PMID: 25553760
48. Florentinus-Mefailoski A, Soosaipillai A, Dufresne J, Diamandis EP, Marshall JG.
    An enzyme-linked immuno-mass spectrometric assay with the substrate adenosine monophosphate.
    Anal Bioanal Chem. 2015 Feb;407(4):1119-30. PMID: 25519722
49. Di Meo A, Rotondo F, Kovacs K, Cusimano MD, Syro LV, Di Ieva A, Diamandis EP, Yousef GM.
    Human kallikrein 10 expression in surgically removed human pituitary corticotroph adenomas: an immunohistochemical study.
    Appl Immunohistochem Mol Morphol. 2015 Jul;23(6):433-7. PMID: 25517869
50. Korbakis D, Prassas I, Brinc D, Batruch I, Krastins B, Lopez MF, Diamandis EP.
    Delineating monoclonal antibody specificity by mass spectrometry.
    J Proteomics. 2015 Jan 30;114:115-24. PMID: 25462431
51. Dorn J, Bronger H, Kates R, Slotta-Huspenina J, Schmalfeldt B, Kiechle M, Diamandis EP, Soosaipillai A, Schmitt M, Harbeck N.
    OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.
    Oncol Lett. 2015 Jan;9(1):418-424. PMID: 25436002
52. Taylor DW, Ahmed N, Parreno J, Lunstrum GP, Gross AE, Diamandis EP, Kandel RA.
    Collagen type XII and versican are present in the early stages of cartilage tissue formation by both redifferentating passaged and primary chondrocytes.
    Tissue Eng Part A. 2015 Feb;21(3-4):683-93. PMID: 25315796
53. Drabovich AP, Martínez-Morillo E, Diamandis EP.
    Toward an integrated pipeline for protein biomarker development.
    Biochim Biophys Acta. 2015 Jun;1854(6):677-86. PMID: 25218201
54. Karagiannis GS, Musrap N, Saraon P, Treacy A, Schaeffer DF, Kirsch R, Riddell RH, Diamandis EP.
    Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.
    Biol Chem. 2015 Feb;396(2):163-83. PMID: 25153376

2014

55. Leung F, Diamandis EP, Kulasingam V.
    Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.
    Adv Clin Chem. 2014;66:25-77. PMID: 25344985
56. Satkunasivam R, Zhang W, Trachtenberg J, Toi A, Yu C, Diamandis E, Kattan MW, Narod SA, Nam RK.
    Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.
    Springerplus. 2014 Jun 11;3:295. PMID: 25279276
57. Teodoro-Morrison T, Diamandis EP, Rifai N, Weetjens BJ, Pennazza G, de Boer NK, Bomers MK.
    Animal olfactory detection of disease: promises and pitfalls.
    Clin Chem. 2014 Dec;60(12):1473-9. PMID: 25274554
58. Chan A, Prassas I, Dimitromanolakis A, Brand RE, Serra S, Diamandis EP, Blasutig IM.
    Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.
    Clin Cancer Res. 2014 Nov 15;20(22):5787-95. PMID: 25239611
59. Diamandis EP.
    Towards identification of true cancer biomarkers.
    BMC Med. 2014 Sep 11;12:156. PMID: 25220599
60. Walker F, Nicole P, Jallane A, Soosaipillai A, Mosbach V, Oikonomopoulou K, Diamandis EP, Magdolen V, Darmoul D.
    Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
    Biol Chem. 2014 Sep;395(9):1075-86. PMID: 25153388
61. Sukumar N, Scott E, Dimitromanolakis A, Misiak A, Prassas I, Diamandis EP, Konvalinka A.
    Mining for single nucleotide variants (SNVs) at the kallikrein locus with predicted functional consequences.
    Biol Chem. 2014 Sep;395(9):1037-50. PMID: 25153386
62. Yousef GM, Pasic M, Diamandis EP.
    Highlight: the 5th International Symposium on Kallikreins and Kallikrein-Related Peptidases.
    Biol Chem. 2014 Sep;395(9):913-4. PMID: 25153379
63. Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V.
    Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry.
    Clin Proteomics. 2014 Jul 1;11(1):27. PMID: 25097465
64. Smith CR, Batruch I, Bauça JM, Kosanam H, Ridley J, Bernardini MQ, Leung F, Diamandis EP, Kulasingam V.
    Deciphering the peptidome of urine from ovarian cancer patients and healthy controls.
    Clin Proteomics. 2014 Jun 2;11(1):23. PMID: 24982608
65. Sokratous K, Hadjisavvas A, Diamandis EP, Kyriacou K.
    The role of ubiquitin-binding domains in human pathophysiology.
    Crit Rev Clin Lab Sci. 2014 Oct;51(5):280-90. PMID: 24901807
66. Yu Y, Prassas I, Diamandis EP.
    Putative kallikrein substrates and their (patho)biological functions.
    Biol Chem. 2014 Sep;395(9):931-43. PMID: 24854536
67. Di Meo A, Diamandis EP, Rodriguez H, Hoofnagle AN, Ioannidis J, Lopez M.
    What is wrong with clinical proteomics?
    Clin Chem. 2014 Oct;60(10):1258-66. PMID: 24831563
68. Karagiannis GS, Treacy A, Messenger D, Grin A, Kirsch R, Riddell RH, Diamandis EP.
    Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.
    Mol Oncol. 2014 Oct;8(7):1240-52. PMID: 24812030
69. Diamandis EP.
    Present and future of cancer biomarkers.
    Clin Chem Lab Med. 2014 Jun;52(6):791-4. PMID: 24803613
70. Pavlou MP, Dimitromanolakis A, Martinez-Morillo E, Smid M, Foekens JA, Diamandis EP.
    Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer.
    J Proteome Res. 2014 Jun 6;13(6):2897-909. PMID: 24799281
71. Musrap N, Karagiannis GS, Saraon P, Batruch I, Smith C, Diamandis EP.
    Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.
    J Proteomics. 2014 May 30;103:204-15. PMID: 24726482
72. Drabovich AP, Saraon P, Jarvi K, Diamandis EP.
    Seminal plasma as a diagnostic fluid for male reproductive system disorders.
    Nat Rev Urol. 2014 May;11(5):278-88. PMID: 24709963
73. Lin DC, Diamandis EP, Januzzi JL Jr, Maisel A, Jaffe AS, Clerico A.
    Natriuretic peptides in heart failure.
    Clin Chem. 2014 Aug;60(8):1040-6. PMID: 24700774
74. Bery A, Leung F, Smith CR, Diamandis EP, Kulasingam V.
    Deciphering the ovarian cancer ascites fluid peptidome.
    Clin Proteomics. 2014 Apr 2;11(1):13. PMID: 24694173
75. Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP.
    In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
    J Proteomics. 2014 May 30;103:121-36. PMID: 24681409
76. Kosanam H, Thai K, Zhang Y, Advani A, Connelly KA, Diamandis EP, Gilbert RE.
    Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidney.
    Diabetes. 2014 Jul;63(7):2432-9. PMID: 24677711
77. Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM.
    Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Acta Neuropathol. 2014 May;127(5):633-43. PMID: 24633805
78. Oikonomopoulou K, Brinc D, Hadjisavvas A, Christofi G, Kyriacou K, Diamandis EP.
    The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms.
    Crit Rev Clin Lab Sci. 2014 Jun;51(3):138-48. PMID: 24588712
79. Diamandis EP.
    A repository for "rare" tumor markers?
    Clin Chem Lab Med. 2014 Jun;52(6):795-7. PMID: 24516003
80. Prassas I, Diamandis EP.
    Translational researchers beware! Unreliable commercial immunoassays (ELISAs) can jeopardize your research.
    Clin Chem Lab Med. 2014 Jun;52(6):765-6. PMID: 24497227
81. Dorn J, Beaufort N, Schmitt M, Diamandis EP, Goettig P, Magdolen V.
    Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.
    Crit Rev Clin Lab Sci. 2014 Apr;51(2):63-84. PMID: 24490956
82. Diamandis EP.
    Learning from Siddhartha.
    Clin Chem. 2014 Feb;60(2):429. PMID: 24474734
83. Martínez-Morillo E, Nielsen HM, Batruch I, Drabovich AP, Begcevic I, Lopez MF, Minthon L, Bu G, Mattsson N, Portelius E, Hansson O, Diamandis EP.
    Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms.
    J Proteome Res. 2014 Feb 7;13(2):1077-87. PMID: 24392642
84. Saraon P, Trudel D, Kron K, Dmitromanolakis A, Trachtenberg J, Bapat B, van der Kwast T, Jarvi KA, Diamandis EP.
    Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.
    Prostate. 2014 Apr;74(4):372-80. PMID: 24311408
85. Martínez-Morillo E, García Hernández P, Begcevic I, Kosanam H, Prieto García B, Alvarez Menéndez FV, Diamandis EP.
    Identification of novel biomarkers of brain damage in patients with hemorrhagic stroke by integrating bioinformatics and mass spectrometry-based proteomics.
    J Proteome Res. 2014 Feb 7;13(2):969-81. PMID: 24295473
86. Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, Grin A, Mitrovic B, Kirsch R, Riddell RH, Diamandis EP.
    Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.
    Mol Oncol. 2014 Mar;8(2):178-95. PMID: 24268521
87. Chrystoja CC, Diamandis EP.
    Whole genome sequencing as a diagnostic test: challenges and opportunities.
    Clin Chem. 2014 May;60(5):724-33. PMID: 24227285
88. Bauça JM, Martínez-Morillo E, Diamandis EP.
    Peptidomics of urine and other biofluids for cancer diagnostics.
    Clin Chem. 2014 Aug;60(8):1052-61. PMID: 24212086
89. Rayner K, Dimmeler S, Calin GA, Thum T, Raizman JE, Diamandis EP.
    Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block?
    Clin Chem. 2014 Jun;60(6):812-7. PMID: 24212084
90. Diamandis EP.
    Tumor microenvironment-released peptides: could they form the basis for an early-diagnosis breast cancer test?
    Clin Chem. 2014 Jan;60(1):4-6. PMID: 24198244
91. Karagiannis GS, Saraon P, Jarvi KA, Diamandis EP.
    Proteomic signatures of angiogenesis in androgen-independent prostate cancer.
    Prostate. 2014 Feb;74(3):260-72. PMID: 24166580
92. Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, Brand R, Kulasingam V, Blasutig IM, Diamandis EP.
    False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125.
    Clin Chem. 2014 Feb;60(2):381-8. PMID: 24097894
93. Dorn J, Gkazepis A, Kotzsch M, Kremer M, Propping C, Mayer K, Mengele K, Diamandis EP, Kiechle M, Magdolen V, Schmitt M.
    Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.
    Biol Chem. 2014 Jan;395(1):95-107. PMID: 23999494

2013

94. Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J.
    Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.
    Radiol Oncol. 2013 Oct 8;47(4):319-29. PMID: 24294176
95. Niederkofler EE, Phillips DA, Krastins B, Kulasingam V, Kiernan UA, Tubbs KA, Peterman SM, Prakash A, Diamandis EP, Lopez MF, Nedelkov D.
    Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.
    PLoS One. 2013 Nov 21;8(11):e81125. PMID: 24278387
96. Drabovich AP, Dimitromanolakis A, Saraon P, Soosaipillai A, Batruch I, Mullen B, Jarvi K, Diamandis EP.
    Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma.
    Sci Transl Med. 2013 Nov 20;5(212):212ra160. PMID: 24259048
97. Radulovic M, Yoon H, Larson N, Wu J, Linbo R, Burda JE, Diamandis EP, Blaber SI, Blaber M, Fehlings MG, Scarisbrick IA.
    Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.
    J Neuropathol Exp Neurol. 2013 Nov;72(11):1072-89. PMID: 24128681
98. Oikonomopoulou K, DeAngelis RA, Chen H, Diamandis EP, Hollenberg MD, Ricklin D, Lambris JD.
    Induction of complement C3a receptor responses by kallikrein-related peptidase 14.
    J Immunol. 2013 Oct 1;191(7):3858-66. PMID: 24014879
99. Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP.
    Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
    BMC Cancer. 2013 Sep 3;13:404. PMID: 24007603
100. Stephan C, Diamandis EP, Kristiansen G.
     Research forever - Klaus Jung.
     Clin Chem Lab Med. 2013 Sep;51(9):e221. PMID: 23950575
101. Yuen DA, Connelly KA, Zhang Y, Advani SL, Thai K, Kabir G, Kepecs D, Spring C, Smith C, Batruch I, Kosanam H, Advani A, Diamandis E, Marsden PA, Gilbert RE.
     Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis.
     Stem Cells. 2013 Nov;31(11):2408-19. PMID: 23922321
102. Diamandis EP.
     More discussion on journal impact factor.
     Clin Chem Lab Med. 2013 Dec;51(12):2271. PMID: 23907426
103. Konvalinka A, Zhou J, Dimitromanolakis A, Drabovich AP, Fang F, Gurley S, Coffman T, John R, Zhang SL, Diamandis EP, Scholey JW.
     Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC).
     J Biol Chem. 2013 Aug 23;288(34):24834-47. PMID: 23846697
104. Dorn J, Bayani J, Yousef GM, Yang F, Magdolen V, Kiechle M, Diamandis EP, Schmitt M.
     Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.
     Thromb Haemost. 2013 Jun 13;110(3). PMID: 23765253
105. Kosanam H, Prassas I, Chrystoja CC, Soleas I, Chan A, Dimitromanolakis A, Blasutig IM, Rückert F, Gruetzmann R, Pilarsky C, Maekawa M, Brand R, Diamandis EP.
     Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues.
     Mol Cell Proteomics. 2013 Oct;12(10):2820-32. PMID: 23798558
106. Cretu D, Diamandis EP, Chandran V.
     Delineating the synovial fluid proteome: Recent advancements and ongoing challenges in biomarker research
     Crit Rev Clin Lab Sci. 2013;50(2):51-63.PMID: 23758541
107. Diamandis EP
     Nobelitis: a common disease among Nobel laureates?
     Clin Chem Lab Med. 2013 May 23:1-2PMID: 23729580
108. Bailey D, Diamandis EP, Greub G, Poutanen SM, Christensen JJ, Kostrzew M.
     Use of MALDI-TOF for diagnosis of microbial infections.
     Clin Chem 2013 Oct;59(10):1435-41. PMID: 23695295
109. Misia Landau
     Inspiring Minds: Eleftherios P Diamandis
     Clin Chem 2013; 59(5):850-852.PMID: 23624897
110. Karagiannis GS, Berk A, Dimitromanolakis A, Diamandis EP.
     Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1
     Mol Oncol. 2013 Aug;7(4):826-39. PMID: 23659962
111. Begcevic I, Kosanam H, Martínez-Morillo E, Dimitromanolakis A, Diamandis P, Kuzmanov U, Hazrati LN, Diamandis EP.
     Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains.
     Clin Proteomics. 2013 May 1;10(1):5PMID: 23635041
112. Childs C, Martínez-Morillo E, Wai AP, Zu MM, Diamandis A, Diamandis EP.
     Exploring the relationship between serum biomarkers, acute intracerebral changes and outcome after severe traumatic brain injury (TBI).
     Clin Chem Lab Med. 2013 Apr 11:1-3. PMID: 23612666
113. Chan A, Diamandis EP, Blasutig IM
     Strategies for discovering novel pancreatic cancer biomarkers.
     J Proteomics. 2013;81:126-34PMID: 23026552
114. Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP
     Infection and cancer: revaluation of the hygiene hypothesis.
     Clin Cancer Res. 2013;19(11):2834-41. PMID: 23536438
115. Leung F, Dimitromanolakis A, Kobayashi H, Diamandis EP, Kulasingam V.
     Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.
     Clin Biochem. 2013 Mar 23 [Epub ahead of print]PMID: 23528302
116. Pasic MD, Yousef GM, Diamandis EP.
     The proteomic revolution in laboratory medicine
     Clin Biochem. 2013;46(6):397-8PMID: 23497914
117. Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP.
     Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
     Mol Cell Proteomics. 2013;12(6):1589-601PMID: 23443136
118. Kulasingam V, Diamandis EP
     Fascin-1 is a novel biomarker of aggressiveness in some carcinomas
     BMC Med. 2013 Feb 26;11:53PMID: 23443037
119. Shea JL, Diamandis EP, Hoffman B, Lo YM, Canick J, van den Boom D.
     A new era in prenatal diagnosis: the use of cell-free fetal DNA in maternal circulation for detection of chromosomal aneuploidies.
     Clin Chem. 2013 Aug;59(8):1151-9. PMID: 23426426
120. Eissa A, Cretu D, Soosaipillai A, Thavaneswaran A, Pellett F, Diamandis A, Cevikbas F, Steinhoff M, Diamandis EP, Gladman D, Chandran V.
     Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease.
     Clin Chem Lab Med. 2013 Feb;51(2):317-25PMID: 23096109
121. Cho CK, Drabovich AP, Karagiannis GS, Martínez-Morillo E, Dason S, Dimitromanolakis A, Diamandis EP.
     Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in down syndrome.
     Clin Proteomics. 2013;10(1):2PMID: 23394617
122. Kuzmanov U, Kosanam H, Diamandis EP.
     The sweet and sour of serological glycoprotein tumor biomarker quantification
     BMC Med. 2013;11(1):31PMID: 23390961
123. Pavlou MP, Dimitromanolakis A, Diamandis EP.
     Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer.
     Proteomics. 2013;13(7):1083-95PMID: 23386393
124. Diamandis EP, Bast RC Jr, Lopez-Otín C.
     Conquering cancer in our lifetime: new diagnostic and therapeutic trends.
     Clin Chem. 2013;59(1):1-3PMID: 23204223
125. Diamandis EP, Bast RC Jr, Gold P, Chu TM, Magnani JL.
     Reflection on the Discovery of Carcinoembryonic Antigen, Prostate-Specific Antigen, and Cancer Antigens CA125 and CA19-9.
     Clin Chem. 2013 Jan;59(1):22-31PMID: 23204222
126. Chrystoja CC, Diamandis EP, Brand R, Rückert F, Haun R, Molina R.
     Pancreatic cancer.
     Clin Chem. 2013 Jan;59(1):41-6. PMID: 23136253
127. Bayani J, Kuzmanov U, Saraon P, Fung WA, Soosaipillai A, Squire JA, Diamandis EP.
     Copy Number and Expression Alterations of miRNAs in the Ovarian Cancer Cell Line OVCAR-3: Impact on Kallikrein 6 Protein Expression
     Clin Chem. 2013 Jan;59(1):296-305PMID: 23136250
128. Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP.
     Cobalt and chromium measurement in patients with metal hip prostheses.
     Clin Chem. 2013 Jun;59(6):880-6. PMID: 23115056
129. Sölétormos G, Duffy MJ, Hayes DF, Sturgeon CM, Barak V, Bossuyt PM, Diamandis EP, Gion M, Hyltoft-Petersen P, Lamerz RM, Nielsen DL, Sibley P, Tholander B, Tuxen MK, Bonfrer JM.
     Design of tumor biomarker-monitoring trials: a proposal by the European group on tumor markers.
     Clin Chem. 2013 Jan;59(1):52-9PMID: 23034139
130. Pavlou MP, Diamandis EP, Blasutig IM
     The long journey of cancer biomarkers from the bench to the clinic
     Clin Chem. 2013 Jan;59(1):147-57PMID: 23019307
131. Konforte D, Diamandis EP.
     Is early detection of cancer with circulating biomarkers feasible?
     Clin Chem. 2013 Jan;59(1):35-7PMID: 22522223

2012

132. Darling MR, Hashem NN, Zhang I, Mohamed AB, Fung K, Kwan K, Mara TW, Daley TD, Diamandis EP.
     Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
     Int J Biol Markers. 2012 Dec 27;27(4):e381-8.PMID: 23250777
133. Kuzmanov U, Musrap N, Kosanam H, Smith CR, Batruch I, Dimitromanolakis A, Diamandis EP.
     Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids.
     Clin Chem Lab Med. 2012 Dec 8:1-10PMID: 23241603
134. Leung F, Diamandis EP, Kulasingam V.
     From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade
     Biomark Med. 2012 Oct;6(5):613-25PMID: 23075239
135. Sardana G, Diamandis EP.
     Biomarkers for the diagnosis of new and recurrent prostate cancer.
     Biomark Med. 2012 Oct;6(5):587-96PMID: 23075237
136. Martínez-Morillo E, Diamandis A, Romaschin AD, Diamandis EP.
     Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage.
     PLoS One. 2012;7(9):e45676PMID: 23049835
137. Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP.
     Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.
     Mol Cancer Res. 2012 Nov;10(11):1403-18. PMID: 23024188
138. Leung F, Soosaipillai A, Kulasingam V, Diamandis EP.
     CUB and zona pellucida-like domain-containing protein 1 (CUZD1): a novel serological biomarker for ovarian cancer.
     Clin Biochem. 2012 Dec;45(18):1543-6.PMID: 22985796
139. Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP
     Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
     J Biol Chem. 2012 Oct 5;287(41):34019-31PMID: 22908226
140. Diamandis EP.
     Biomarker validation is still the bottleneck in biomarker research.
     J Intern Med. 2012 Dec;272(6):620PMID: 22905877
141. Musrap N, Diamandis EP
     Revisiting the Complexity of the Ovarian Cancer Microenvironment--Clinical Implications for Treatment Strategies.
     Mol Cancer Res. 2012 Oct;10(10):1254-64PMID: 22896662
142. Diamandis EP.
     The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
     BMC Med. 2012 Aug 9;10:87PMID: 22876833
143. Olkhov-Mitsel E, Van der Kwast T, Kron KJ, Ozcelik H, Briollais L, Massey C, Recker F, Kwiatkowski M, Fleshner NE, Diamandis EP, Zlotta AR, Bapat B.
     Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
     Epigenetics. 2012 Sep 1;7(9):1037-45.PMID: 22874102
144. Konforte D, Diamandis EP, van Venrooij WJ, Lories R, Ward MM.
     Autoimmune diseases: early diagnosis and new treatment strategies.
     Clin Chem. 2012 Nov;58(11):1510-4.PMID: 22761474
145. Chen Y, Kinney L, Božović A, Smith H, Tarr H, Diamandis EP, Leblanc A.
     Performance evaluation of Siemens ADVIA Centaur and Roche MODULAR Analytics E170 Total 25-OH Vitamin D assays.
     Clin Biochem. 2012 Nov;45(16-17):1485-90PMID: 22705028
146. Martínez-Morillo E, Cho CK, Drabovich AP, Shaw JL, Soosaipillai A, Diamandis EP
     Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
     J Proteome Res. 2012 Jul 6;11(7):3880-7PMID: 22681384
147. Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Zhang H, Tian Y, Li Y, Kulasingam V, Drabovich A, Smith CR, Batruch I, Oran PE, Fredolini C, Luchini A, Liotta L, Petricoin E, Diamandis EP, Chan DW, Nelson R, Lopez MF.
     Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.
     J Proteome Res. 2012 Aug 3;11(8):3986-95PMID: 22639787
148. Martínez-Morillo E, Diamandis A, Diamandis EP.
     Reference intervals and biological variation for kallikrein 6: influence of age and renal failure.
     Clin Chem Lab Med. 2012 Mar 24;50(5):931-4. PMID: 22628337
149. Kuzmanov U, Smith CR, Batruch I, Soosaipillai A, Diamandis A, Diamandis EP.
     Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry.
     Proteomics. 2012 Mar;12(6):799-809.PMID: 22539431
150. Drabovich AP, Pavlou MP, Dimitromanolakis A, Diamandis EP
     Quantitative analysis of energy metabolic pathways in mcf-7 breast cancer cells by selected reaction monitoring assay.
     Mol Cell Proteomics. 2012 Aug;11(8):422-34PMID: 22535206
151. Prassas I, Chrystoja CC, Makawita S, Diamandis EP.
     Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery
     BMC Med. 2012 Apr 19;10:39.PMID: 22515324
152. Chung H, Hamza M, Oikonomopoulou K, Gratio V, Saifeddine M, Virca GD, Diamandis EP, Hollenberg MD, Darmoul D.
     Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.
     Biol Chem. 2012 Apr 1;393(5):413-20. PMID: 22505523
153. Seiz L, Dorn J, Kotzsch M, Walch A, Grebenchtchikov NI, Gkazepis A, Schmalfeldt B, Kiechle M, Bayani J, Diamandis EP, Langer R, Sweep FC, Schmitt M, Magdolen V.
     Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients.
     Biol Chem. 2012 Apr 1;393(5):391-401PMID: 22505521
154. Petraki C, Youssef YM, Dubinski W, Lichner Z, Scorilas A, Pasic MD, Komborozos V, Khalil B, Streutker C, Diamandis EP, Yousef GM.
     Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
     Tumour Biol. 2012 Aug;33(4):1209-14PMID: 22437349
155. Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP.
     Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis.
     Oncotarget. 2012 Mar;3(3):267-85PMID: 22408128
156. Diamandis EP
     EPCA-2: a highly specific serum marker for prostate cancer.
     Clin Biochem. 2012 May;45(7-8):600. PMID: 22405900
157. Shaw JL, Diamandis EP, Horne AW, Barnhart K, Bourne T, Messinis IE.
     Ectopic pregnancy.
     Clin Chem. 2012 Sep;58(9):1278-85. PMID: 22389311
158. McDermed JE, Sanders R, Fait S, Klem RE, Sarno MJ, Adams TH, Diamandis EP
     Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
     Clin Chem. 2012 Apr;58(4):732-40. PMID: 22361936
159. Shea J, Diamandis EP, Sharma AM, Després JP, Ezzat S, Greenway F.
     The obesity epidemic.
     Clin Chem. 2012 Jun;58(6):968-73. PMID: 22311921
160. Kagedan D, Lecker I, Batruch I, Smith C, Kaploun I, Lo K, Grober E, Diamandis EP, Jarvi KA.
     Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.
     Clin Proteomics. 2012 Feb 6;9(1):2PMID: 22309592
161. Petraki C, Dubinski W, Scorilas A, Saleh C, Pasic MD, Komborozos V, Khalil B, Gabril MY, Streutker C, Diamandis EP, Yousef GM
     Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
     Pathol Res Pract. 2012 Feb 15;208(2):104-8PMID: 22285222
162. Rifai N, Diamandis EP, Lo YM, Kricka LJ, Wilding P, Ladenson JH, Wittwer CT.
     Advancing laboratory medicine through innovation: a tale of six inventors.
     Clin Chem. 2012 Mar;58(3):502-10.PMID: 22238255
163. Kosanam H, Sato M, Batruch I, Smith C, Keshavjee S, Liu M, Diamandis EP.
     Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction.
     Clin Biochem. 2012 Feb;45(3):223-30PMID: 22206736
164. Batruch I, Smith CR, Mullen BJ, Grober E, Lo KC, Diamandis EP, Jarvi KA.
     Analysis of seminal plasma from patients with non-obstructive azoospermia and identification of candidate biomarkers of male infertility.
     J Proteome Res. 2012 Mar 2;11(3):1503-11PMID: 22188163
165. Florentinus AK, Bowden P, Sardana G, Diamandis EP, Marshall JG.
     Identification and quantification of peptides and proteins secreted from prostate epithelial cells by unbiased liquid chromatography tandem mass spectrometry using goodness of fit and analysis of variance.
     J Proteomics. 2012 Feb 2;75(4):1303-17PMID: 22120120
166. Konvalinka A, Scholey JW, Diamandis EP.
     Searching for new biomarkers of renal diseases through proteomics.
     Clin Chem. 2012 Feb;58(2):353-65.PMID: 21980170

2011

167. Gratio V, Loriot C, Virca GD, Oikonomopoulou K, Walker F, Diamandis EP, Hollenberg MD, Darmoul D.
     Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
     Am J Pathol. 2011 Nov;179(5):2625-36. PMID: 21907696
168. Prassas I, Karagiannis GS, Batruch I, Dimitromanolakis A, Datti A, Diamandis EP.
     Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks.
     Mol Cancer Ther. 2011 Nov;10(11):2083-93PMID: 21859838
169. Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, Loblaw DA, Narod SA.
     Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Room MG-406, Toronto, Ontario,
     Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
     J Clin Oncol. 2011 Aug 1;29(22):2959-64. Epub 2011 Jun 20. PMID: 21690464
170. Pavlou M, Diamandis EP.
     Department of Pathology and Laboratory Medicine
     I Detected My Cancer with My Smart Phone
     Clin Chem. 2011;57:1221-23 PMID: 21690203
171. Rückert F, Aust D, Böhme I, Werner K, Brandt A, Diamandis EP, Krautz C, Hering S, Saeger HD, Grützmann R, Pilarsky C.
     Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.
     J Surg Res. 2012 Jan;172(1):29-39PMID: 21683373
172. Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S, Diamandis EP.
     Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
     Mol Cell Proteomics. 2011 Oct;10(10):M111.008599PMID: 21653254
173. Guillon-Munos A, Oikonomopoulou K, Michel N, Smith CR, Petit-Courty A, Canepa S, Reverdiau P, Heuzé-Vourc'h N, Diamandis EP, Courty Y.
     INSERM U618-Université François Rabelais, Faculté de Médecine, 2 bis bd Tonnellé, 37032 Tours, France
     Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
     J Biol Chem. 2011 Jul 22;286(29):25505-18. Epub 2011 May 31. PMID: 21628462
174. Cho CK, Drabovich AP, Batruch I, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
     Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay.
     J Proteomics. 2011 Sep 6;74(10):2052-9. Epub 2011 May 20. PMID: 21624510
175. Kulasingam V, Smith CR, Batruch I, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
     Immuno-mass spectrometry: quantification of low-abundance proteins in biological fluids
     Methods Mol Biol. 2011;728:207-18. PMID: 21468950
176. Cramer DW, Bast RC Jr, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, Sluss PM, Srivastava S, Ward DC, Zhang Z, Zhu CS, Urban N.
     Brigham and Women's Hospital, Ob/Gyn, Division of Epidemiology, Boston, MA 02115,
     Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
     Cancer Prev Res (Phila). 2011 Mar;4(3):365-74. PMID: 21372036
177. Dorn J, Magdolen V, Gkazepis A, Gerte T, Harlozinska A, Sedlaczek P, Diamandis EP, Schuster T, Harbeck N, Kiechle M, Schmitt M.
     Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany
     Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.
     Ann Oncol. 2011 Aug;22(8):1783-90. Epub 2011 Jan 27. PMID: 21273346
178. Diamandis EP, Goodglick L, Planque C, Thornquist MD.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
     Pentraxin-3 is a novel biomarker of lung carcinoma
     Clin Cancer Res. 2011 Apr 15;17(8):2395-9. Epub 2011 Jan 21. PMID: 21257721
179. Batruch I, Lecker I, Kagedan D, Smith CR, Mullen BJ, Grober E, Lo KC, Diamandis EP, Jarvi KA.
     Samuel Lunenfeld Research Institute, Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
     Proteomic analysis of seminal plasma from normal volunteers and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers of the urogenital system.
     J Proteome Res. 2011 Mar 4;10(3):941-53. Epub 2011 Feb 14. PMID: 21142078
180. Cho CK, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
     Application of proteomics to prenatal screening and diagnosis for aneuploidies
     Clin Chem Lab Med. 2011 Jan;49(1):33-41. Epub 2010 Oct 20 PMID: 20961197
181. Eissa A, Amodeo V, Smith CR, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
     Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.
     J Biol Chem. 2011 Jan 7;286(1):687-706. Epub 2010 Oct 12. PMID: 20940292
182. Dorn J, Harbeck N, Kates R, Gkazepis A, Scorilas A, Soosaipillai A, Diamandis E, Kiechle M, Schmalfeldt B, Schmitt M.
     Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer.
     Ann Oncol. 2011 Apr;22(4):877-83. Epub 2010 Oct 5. PMID: 20924077
183. Bayani J, Diamandis EP.
     The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).
     Clin Chem Lab Med. 2011 Nov 3;50(2):211-33.PMID: 22047144
184. Saraon P, Jarvi K, Diamandis EP
     Molecular alterations during progression of prostate cancer to androgen independence.
     Clin Chem. 2011 Oct;57(10):1366-75PMID: 21956922
185. Drabovich AP, Jarvi K, Diamandis EP.
     Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay.
     Mol Cell Proteomics. 2011 Dec;10(12):M110.004127.PMID: 21933954
186. Kosanam H, Makawita S, Judd B, Newman A, Diamandis EP.
     Mining the malignant ascites proteome for pancreatic cancer biomarkers.
     Proteomics. 2011 Dec;11(23):4551-8.PMID: 21932441
187. Eleftherios P. Diamandis
     Clinical Chemist - Unveiling the Right Side: Playing the Trumpet
     Clin Chem.2011;57:1789PMID: 175828

2010

188. Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Ross MM, Zhang H, Tian Y, Kulasingam V, Drabovich AP, Smith C, Batruch I, Liotta L, Petricoin E, Diamandis EP, Chan DW, Lopez MF.
     Thermo Fisher Scientific, Biomarker research in Mass Spectrometry, Cambridge, Massachusettes, United States
     Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.
     J Proteome Res. 2010 Dec 3;9(12):6678-88. Epub 2010 Nov 2. PMID: 20945832
189. Karagiannis GS, Pavlou MP, Diamandis EP
     Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.
     Mol Oncol. 2010 Dec;4(6):496-510. Epub 2010 Sep 16 PMID: 20934395
190. Bayani J, Marrano P, Graham C, Zheng Y, Li L, Katsaros D, Lassus H, Butzow R, Squire JA, Diamandis EP.
     Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.
     Mol Oncol. 2011 Feb;5(1):48-60. Epub 2010 Aug 11. PMID: 20800559
191. Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 60 Murray St, Rm L6-201, Toronto, ON, Canada M5T 3L9.
     Cancer biomarkers: can we turn recent failures into success?
     J Natl Cancer Inst. 2010 Oct 6;102(19):1462-7. Epub 2010 Aug 12. PMID: 20705936
192. Diamandis EP.
     The time of young scientists.
     Science. 2010 Aug 6;329(5992):626; author reply 626-7. PMID: 20688998
193. Arana CJ, Diamandis EP, Kandel RA.
     Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.
     Cartilage tissue enhances proteoglycan retention by nucleus pulposus cells in vitro.
     Arthritis Rheum. 2010 Nov;62(11):3395-403. doi: 10.1002/art.27651. PMID: 20662071
194. Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
     Can chemoprevention reduce the risk of prostate cancer?
     Clin Chem. 2010 Aug;56(8):1214-5. Epub 2010 Jun 21. PMID: 20567025
195. Rabien A, Fritzsche FR, Jung M, Tölle A, Diamandis EP, Miller K, Jung K, Kristiansen G, Stephan C.
     Department of Urology, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
     KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
     International Journal of Cancer. 2010 Nov 15;127(10):2386-94. PMID: 20473923
196. Cho CK, Smith CR, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
     J Proteome Res. 2010 Jul 2;9(7):3574-82. PMID: 20459121
197. Efthimiou I, Ferentinos G, Tsachouridis G, Sardana G, Diamandis E.
     Department of Urology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
     Determination of the association of urine prostate specific antigen levels with anthropometric variables in children aged 5-14 years.
     Int Braz J Urol. 2010 Mar-Apr;36(2):202-7; discussion 207-8. PMID: 20450506
198. Pavlou MP, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
     The cancer cell secretome: A good source for discovering biomarkers?
     J Proteomics. 2010 Sep 10;73(10):1896-906. Epub 2010 Apr 12. PMID: 20394844
199. Kulasingam V, Pavlou MP, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1X5, Ontario, Canada.
     Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.
     Nat Rev Cancer. 2010 May;10(5):371-8 PMID: 20383179
200. Pavlou MP, Kulasingam V, Sauter ER, Kliethermes B, Diamandis EP.
     Nipple aspirate fluid proteome of healthy females and patients with breast cancer.
     Clin Chem. 2010 May;56(5):848-55. PMID: 20348408
201. Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP.
     National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
     Clin. Chem., Jun 2010; 56: e1 - e48 PMID: 20207771
202. Oikonomopoulou K, Batruch I, Smith CR, Soosaipillai A, Diamandis EP, Hollenberg MD
     Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
     Biol Chem. 2010 Apr;391(4):381-90 PMID: 20180649 (paper not yet available)
203. White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace KT, Sugar L, Diamandis EP, Doré J, Yousef GM.
     Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
     Biol Chem. 2010 Apr;391(4):411-23. PMID: 20180642 (paper not yet available)
204. Oikonomopoulou K, Diamandis EP, Hollenberg MD
     Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
     Biol Chem. 2010 Apr;391(4):299-310 PMID: 20180639
205. Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M.
     Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
     Endocrinology. 2010 Apr;151(4):1520-31 PMID: 20172966
206. Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Early prostate cancer antigen-2: a controversial prostate cancer biomarker?
     Clin Chem. 2010 Apr;56(4):542-4 PMID: 20167690
207. Hashem NN, Mara TW, Mohamed M, Zhang I, Fung K, Kwan KF, Daley TD, Diamandis EP, Darling MR
     Human kallikrein 14 (KLK14) expression in salivary gland tumors.
     Int J Biol Markers. 2010 Jan-Mar;25(1):32-7 PMID: 20155713 (paper not yet available)
208. Diamandis EP.
     Prostate cancer screening with prostate-specific antigen testing: more answers or more confusion?
     Clin Chem. 2010 Mar;56(3):345-51. PMID: 20093554
209. Diamandis EP
     Perspective: Audacity is overrated
     Science 2010;1-3 PMID: Science - Audacity.2010
210. Drabovich AP, Diamandis EP.
     Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
     Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins.
     J Proteome Res. 2010 Mar 5;9(3):1236-45 PMID: 20070123
211. Chen Y, Yazdanpanah M, Wang XY, Hoffman BR, Diamandis EP, Wong PY.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, Dr. Everett Chalmers Regional Hospital / Horizon Health Network, Fredericton, New Brunswick, Canada.
     Direct Measurement of Serum Free Testosterone by Ultrafiltration Followed by Liquid Chromatography Tandem Mass Spectrometry.
     Clin Biochem. 2010 Mar;43(4-5):490-6. Epub 2009 Dec 21; PMID: 20026023 ]
212. Makawita S, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
     The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification.
     Clin Chem. 2010 Feb;56(2):212-22; PMID: 20007861 ]
213. Kuk C, Gunawardana CG, Soosaipillai A, Kobayashi H, Li L, Zheng Y, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
     Nidogen-2: A new serum biomarker for ovarian cancer.
     Clin Biochem. 2010 Mar;43(4-5):355-61; PMID: 19883638 ]
214. Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G.
     Department of Pharmacy, University of Patras, Rion-Patras, 26500, Greece.
     Down-regulation of dicer expression in ovarian cancer tissues.
     Clin Biochem. 2010 Feb;43(3):324-7; PMID: 19782670

     2009

215. Emami N, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, Ontario, Canada.
     Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGFbeta1 in semen.
     Biol Chem. 2009 Nov 17. [Epub ahead of print; PDF unavailable] PMID: 19919178]
216. Diamandis EP, Voelkerding KV, Drmanac R, Agus D, McPherson J.
     Head of Clinical Biochemistry, Mount Sinai Hospital and University Health Network, Toronto, and Professor and Head, Division of Clinical Biochemistry, Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada.
     Next-Generation Sequencing: A New Revolution in Molecular Diagnostics?
     Clin Chem. 2009 Dec;55(12):2088-92. No abstract available. PMID: 19855095 ]
217. Sotiropoulou G, Pampalakis G, Diamandis EP.
     University of Patras, Department of Pharmacy, Greece
     Functional roles of human kallikrein-related peptidases.
     J Biol Chem. 2009 Nov 27;284(48):32989-94. PMID: 19819870
218. Diamandis EP
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
     Journal Impact Factor: it will go away soon.
     Clin Chem Lab Med. 2009;47(11):1317-8; PMID: 19778288
     Comment in:
     Clin Chem Lab Med. 2009;47(12):1585-6.
219. Planque C, Kulasingan V, Smith CR, Reckamp K, Goodglick L, Diamandis EP
     Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5T 3L9.
     Identification of five candidate lung cancer biomarkers by proteomic analysis of conditioned media of four lung cancer cell lines.
     Mol Cell Proteomics. 2009 Dec;8(12):2746-58. PMID: 19776420 ]
220. Yousef GM, Diamandis EP.
     Mount Sinai Hospital, University Health Network and Toronto Medical Laboratories; Division of Clinical Biochemistry, Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada.
     The human kallikrein gene family: new biomarkers for ovarian cancer.
     Cancer Treat Res. 2009;149:165-87. PMID: 19763436
221. Christensen E, Pintilie M, Evans KR, Lenarduzzi M, Ménard C, Catton CN, Diamandis EP, Bristow RG.
     Radiation Medicine Program, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
     Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.
     Clin Cancer Res. 2009 Sep 1;15(17):5576-83. Epub 2009 Aug 25. PMID: 19706801
222. Gunawardana G, Kuk C, Smith CR, Batruch I, Soosaipillai A, Diamandis E.
     Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer
     J Proteome Res. 2009 Oct;8(10):4705-13. [PMID 19663500 625 KB, Related Articles]
223. Strojnik T, Kavalar R, Zajc I, Diamandis EP, Oikonomopoulou K, Lah TT. <T.Strojnik@amis.net>
     Department of Neurosurgery, University Clinical Centre Maribor, Ljubljanska 5, SI-2000 Maribor, Slovenia
     Prognostic impact of CD68 and kallikrein 6 in human glioma
     Anticancer Research 2009 Aug;29(8):3269-79. [PMID 19661345 , Related Articles]
224. Oikonomopoulou K, Soosaipillai A, Diamandis EP
     Samuel Lunenfeld Research Institute and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5T 3L9; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada M5G 1L5; Department of Clinical Biochemistry, University Health Network and Toronto Medical Laboratories, Toronto, Ontario, Canada M5G 2C4
     Evaluation of prostate-specific antigen as a novel biomarker of Hsp90 inhibition
     Clin Biochem. 2009 Nov;42(16-17):1705-12. [PMID 19632215 426 KB, Related Articles]
225. Pavlou M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada
     The search for new prostate cancer biomarkers continues
     Clinical Chemistry 2009 Jul;55(7):1277-9. [PMID 19478024 50 KB, Related Articles] [ISI 000267460200006]
226. Diamandis EP, Hanash S, Lopez M, Carr S, Petricoin EF 3rd.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada
     Protein quantification by mass spectrometry: is it ready for prime time?
     Clinical Chemistry 2009 Jul;55(7):1427-30. [PMID 19443560 326 KB, Related Articles] [ISI 000267460200028cited once]
227. Diamandis EP.
     Unveiling the Right Side How to Win Wimbledon Championships: Creating Beklof and Vamos [editorial]
     Clinical Chemistry 2009 Jun;55(6):1253-1254 [ISI 000266687200039 45 KB]
228. Kulasingam V, Zheng Y, Soosaipillai A, Leon AE, Gion M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer
     International Journal of Cancer 2009 Jul 1;125(1):9-14. [PMID 19322904 174 KB, Related Articles] [ISI 000266569200002]
229. Emami N, Scorilas A, Soosaipillai A, Earle T, Mullen B, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility
     Biol Chem 2009 Jun 27. [PMID 19558318, Related Articles]
230. Sardana G, Diamandis EP.
     Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
     The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer
     Clin Biochem 2009 Jun 25. [PMID 19560453 193 KB, Related Articles]
231. Talieri M, Li L, Zheng Y, Alexopoulou DK, Soosaipillai A, Scorilas A, Xynopoulos D, Diamandis EP. <talieri@agsavvas-hosp.gr>
     Department of Cellular Physiology, G Papanicolaou Research Center of Oncology, Saint Savvas Hospital, Athens, Greece
     The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
     British Journal of Cancer 2009 May 19;100(10):1659-65. [PMID 19367279 166 KB, Related Articles] [ISI 000266025100018]
232. Chen Y, Yazdanpanah M, Hoffman BR, Diamandis EP, Wong PY.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Rapid determination of serum testosterone by liquid chromatography-isotope dilution tandem mass spectrometry and a split sample comparison with three automated immunoassays
     Clinical Biochemistry 2009 Apr;42(6):484-90. [PMID 19109939 572 KB, Related Articles] [ISI 000264538300008]
233. Kuzmanov U, Jiang N, Smith CR, Soosaipillai A, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1X5, Ontario, Canada
     Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system
     Molecular & Cellular Proteomics 2009 Apr;8(4):791-8. [PMID 19088065 237 KB, Related Articles] [ISI 000265098200017]
234. Kuk C, Kulasingam V, Gunawardana CG, Smith CR, Batruch I, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
     Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers
     Molecular & Cellular Proteomics 2009 Apr;8(4):661-9. [PMID 19047685 299 KB, Related Articles] [ISI 000265098200007]
235. Talieri M, Mathioudaki K, Prezas P, Alexopoulou DK, Diamandis EP, Xynopoulos D, Ardavanis A, Arnogiannaki N, Scorilas A. <talieri@agsavvas-hosp.gr.>
     Department of Cellular Physiology, "G. Papanicolaou" Research Center of Oncology, "Saint Savas" Hospital, 171, Alexandras Avenue, Athens 11522, Greece
     Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer
     Thrombosis and Haemostasis 2009 Apr;101(4):741-7. [PMID 19350120, Related Articles] [ISI 000265333600022]
236. Gunawardana CG, Memari N, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 6th Floor, Room m6-201, 60 Murray Street, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, The University of Toronto, Toronto, ON, Canada
     Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays
     Clinical Biochemistry 2009 Mar;42(4-5):426-9. [PMID 19094976 182 KB, Related Articles] [ISI 000264309400106]
237. Kountourakis P, Psyrri A, Scorilas A, Markakis S, Kowalski D, Camp RL, Diamandis EP, Dimopoulos MA.
     Yale Cancer Center, PO Box 208032, New Haven, CT 06520, USA
     Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis
     Thrombosis and Haemostasis 2009 Mar;101(3):541-6. PMID 19277417 , Related Articles]
238. Cherney DZ, Konvalinka A, Zinman B, Diamandis EP, Soosaipillai A, Reich H, Lorraine J, Lai V, Scholey JW, Miller JA. <David.Cherney@utoronto.ca>
     Division of Medicine, University Health Network, Toronto, Canada
     Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study
     Diabetes Care 2009 Jan;32(1):91-3. [PMID 18945921 67 KB, Related Articles] [ISI 000262188000019]

2008

239. Shaw JL, Petraki C, Watson C, Bocking A, Diamandis EP.
     Department of Pathology and Laboratory Medicine and Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M5T 3L9, ON, Canada and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     Role of tissue kallikrein-related peptidases in cervical mucus remodeling and host defense
     Biological Chemistry 2008 Dec;389(12):1513-22. [PMID 18844451 457 KB, Related Articles] [ISI 000262137600008]
240. Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brünner N, Chan DW, Babaian R, Bast RC Jr, Dowell B, Esteva FJ, Haglund C, Harbeck N, Hayes DF, Holten-Andersen M, Klee GG, Lamerz R, Looijenga LH, Molina R, Nielsen HJ, Rittenhouse H, Semjonow A, Shih IeM, Sibley P, Sölétormos G, Stephan C, Sokoll L, Hoffman BR, Diamandis EP. <C.Sturgeon@ed.ac.uk>
     Department of Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh, UK
     National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
     Clin Chem 2008 Dec;54(12):e11-79. [PMID 19042984 444 KB, Related Articles]
241. Sardana G, Dowell B, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Emerging biomarkers for the diagnosis and prognosis of prostate cancer [review, 82 refs]
     Clinical Chemistry 2008 Dec;54(12):1951-60. [PMID 18927246 107 KB, Related Articles] [ISI 000261248800005cited 5 times ]
242. Rückert F, Hennig M, Petraki CD, Wehrum D, Distler M, Denz A, Schröder M, Dawelbait G, Kalthoff H, Saeger HD, Diamandis EP, Pilarsky C, Grützmann R. <Felix.Rueckert@uniklinikum-dresden.de>
     Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, Dresden 01307, Germany
     Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
     British Journal of Cancer 2008 Nov 4;99(9):1484-92. [PMID 18854834 370 KB, Related Articles] [ISI 000260502900017]
243. Shaw JL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Toronto, ON, Canada
     Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines
     Biological Chemistry 2008 Nov;389(11):1409-19. [PMID 19031603 184 KB, Related Articles] [ISI 000262137400008]
244. Kountourakis P, Psyrri A, Scorilas A, Camp R, Markakis S, Kowalski D, Diamandis EP, Dimopoulos MA.
     Departments of Medical Oncology, Yale Cancer Centre, New Haven, Connecticut 06520-8023, USA
     Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)
     Cancer Science 2008 Nov;99(11):2224-9. [PMID 18957059 152 KB, Related Articles] [ISI 000260730700016]
245. Diamandis EP, Hoffman BR, Sturgeon CM.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers
     Clin Chem 2008 Nov;54(11):1935-9. [PMID 18801938 67 KB, Related Articles]
246. Kulasingam V, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Tissue culture-based breast cancer biomarker discovery platform [review, 59 refs]
     International Journal of Cancer 2008 Nov 1;123(9):2007-12. [PMID 18712711 93 KB, Related Articles] [ISI 000259836100004cited twice ]
247. Prassas I, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Banting Institute, 100 College Street, Room 110, Toronto, Ontario M5G1L5, Canada
     Novel therapeutic applications of cardiac glycosides [review, 132 refs]
     Nature Reviews Drug Discovery 2008 Nov;7(11):926-35. [PMID 18948999 553 KB, Related Articles] [ISI 000260532400023cited 3 times ]
248. Oikonomopoulou K, Li L, Zheng Y, Simon I, Wolfert RL, Valik D, Nekulova M, Simickova M, Frgala T, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1L5, Canada
     Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
     British Journal of Cancer 2008 Oct 7;99(7):1103-13. [PMID 18766180 217 KB, Related Articles] [ISI 000259681600018cited twice]
249. Emami N, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers [review, 43 refs]
     Clinical Chemistry 2008 Oct;54(10):1600-7. [PMID 18687738 265 KB, Related Articles] [ISI 000259939900005cited 5 times ]
250. Bayani J, Paliouras M, Planque C, Shan SJ, Graham C, Squire JA, Diamandis EP.
     Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2M9, Canada
     Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer
     Molecular Oncology 2008 Oct;2(3):250-60. [PMID 19383346 3.9 MB, Related Articles] [ISI 000264062200009]
251. Kulasingam V, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Strategies for discovering novel cancer biomarkers through utilization of emerging technologies [review, 93 refs]
     Nature Clinical Practice Oncology 2008 Oct;5(10):588-99. [PMID 18695711 666 KB, Related Articles] [ISI 000259505100007cited 3 times ]
252. Prassas I, Paliouras M, Datti A, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies
     Clinical Cancer Research 2008 Sep 15;14(18):5778-84. [PMID 18794087 328 KB, Related Articles] [ISI 000259347600020]
253. Sharma N, Oikonomopoulou K, Ito K, Renaux B, Diamandis EP, Hollenberg MD, Rancourt DE.
     Department of Biochemistry and Molecular Biology, University of Calgary, Calgary T2N 4N1, Canada
     Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display
     Biological Chemistry 2008 Aug;389(8):1097-105. [PMID 18979633 314 KB, Related Articles] [ISI 000258262300014]
254. Hansen KK, Oikonomopoulou K, Baruch A, Ramachandran R, Beck P, Diamandis EP, Hollenberg MD.
     Proteinases and Inflammation Network, University of Calgary Faculty of Medicine, Calgary T2N 4N1, AB, Canada
     Proteinases as hormones: targets and mechanisms for proteolytic signaling [review, 103 refs]
     Biological Chemistry 2008 Aug;389(8):971-82. [PMID 18979623, Related Articles] [ISI 000258262300002cited once]
255. Sturgeon CM, Hoffman BR, Chan DW, Ch'ng SL, Hammond E, Hayes DF, Liotta LA, Petricoin EF, Schmitt M, Semmes OJ, Söletormos G, van der Merwe E, Diamandis EP. <C.Sturgeon@ed.ac.uk>
     Department of Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh, UK
     National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements
     Clin Chem 2008 Aug;54(8):e1-e10. [PMID 18606634 162 KB, Related Articles]
256. Sardana G, Jung K, Stephan C, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
     Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers
     Journal of Proteome Research 2008 Aug;7(8):3329-38. [PMID 18578523 1.8 MB, Related Articles] [ISI 000258200400024cited 5 times ]
257. Emami N, Deperthes D, Malm J, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
     Major role of human KLK14 in seminal clot liquefaction
     Journal of Biological Chemistry 2008 Jul 11;283(28):19561-9. [PMID 18482984 568 KB, Related Articles] [ISI 000257387600042cited twice]
258. Psyrri A, Kountourakis P, Scorilas A, Markakis S, Camp R, Kowalski D, Diamandis EP, Dimopoulos MA. <Diamando.Psyrri@yale.edu>
     Department of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520, USA
     Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
     Annals of Oncology 2008 Jul;19(7):1271-7. [PMID 18325919 345 KB, Related Articles] [ISI 000257169300011cited twice]
259. Paliouras M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines
     Biological Chemistry 2008 Jun;389(6):773-80. [PMID 18627304 273 KB, Related Articles] [ISI 000257671500021cited twice]
260. Planque C, Bléchet C, Ayadi-Kaddour A, Heuzé-Vourc'h N, Dumont P, Guyétant S, Diamandis EP, El Mezni F, Courty Y.
     INSERM U618 Protéases et Vectorisation Pulmonaires, Faculté de Médecine, F-37000 Tours, France
     Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung
     Biological Chemistry 2008 Jun;389(6):781-6. [PMID 18627302 177 KB, Related Articles] [ISI 000257671500022]
261. Scarisbrick IA, Linbo R, Vandell AG, Keegan M, Blaber SI, Blaber M, Sneve D, Lucchinetti CF, Rodriguez M, Diamandis EP. <Scarisbrick.Isobel@mayo.edu>
     Program for Molecular Neuroscience, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
     Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration
     Biological Chemistry 2008 Jun;389(6):739-45. [PMID 18627300 139 KB, Related Articles] [ISI 000257671500017cited 5 times ]
262. Eissa A, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions [review, 74 refs]
     Biological Chemistry 2008 Jun;389(6):669-80. [PMID 18627299 229 KB, Related Articles] [ISI 000257671500007]
263. Shaw JL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, and Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Toronto M5T 3L9, ON, Canada
     A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology [review, 77 refs]
     Biological Chemistry 2008 Jun;389(6):681-8. [PMID 18627298 128 KB, Related Articles] [ISI 000257671500008cited 3 times ]
264. Hollenberg MD, Oikonomopoulou K, Hansen KK, Saifeddine M, Ramachandran R, Diamandis EP. <mhollenb@ucalgary.ca>
     Proteinases and Inflammation Network, Department of Pharmacology and Therapeutics, University of Calgary Faculty of Medicine, Calgary T2N 4N1, AB, Canada
     Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer [review, 81 refs]
     Biological Chemistry 2008 Jun;389(6):643-51. [PMID 18627296 144 KB, Related Articles] [ISI 000257671500005cited twice]
265. Oikonomopoulou K, Hansen KK, Baruch A, Hollenberg MD, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto M5T 3L9, Ontario, Canada
     Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids
     Biological Chemistry 2008 Jun;389(6):747-56. [PMID 18627291 271 KB, Related Articles] [ISI 000257671500018cited once]
266. Chow TF, Crow M, Earle T, El-Said H, Diamandis EP, Yousef GM.
     Department of Laboratory Medicine, and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto M5B 1W8, Canada
     Kallikreins as microRNA targets: an in silico and experimental-based analysis
     Biological Chemistry 2008 Jun;389(6):731-8. [PMID 18627289 180 KB, Related Articles] [ISI 000257671500016cited twice]
267. Komatsu N, Saijoh K, Jayakumar A, Clayman GL, Tohyama M, Suga Y, Mizuno Y, Tsukamoto K, Taniuchi K, Takehara K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients
     Journal of Investigative Dermatology 2008 May;128(5):1148-59. [PMID 17989726 4.8 MB, Related Articles] [ISI 000255250400013cited 4 times ]
268. Paliouras M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
     Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor
     Molecular Oncology 2008 Apr;1(4):413-24. [PMID 19383315 829 KB, Related Articles] [ISI 000264061600008]
269. Planque C, Li L, Zheng Y, Soosaipillai A, Reckamp K, Chia D, Diamandis EP, Goodglick L.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma
     Clinical Cancer Research 2008 Mar 1;14(5):1355-62. [PMID 18316555 523 KB, Related Articles] [ISI 000253565000013cited 5 times ]
270. Heshmat SM, Mullen JB, Jarvi KA, Soosaipillai A, Diamandis EP, Hamilton RJ, Lo KC.
     Department of Surgery (Division of Urology), Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
     Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia
     Journal of Urology 2008 Mar;179(3):1077-80. [PMID 18206953 89 KB, Related Articles] [ISI 000253176000075cited once ]
271. Emami N, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G-1L5, Canada
     Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin
     Journal of Biological Chemistry 2008 Feb 8;283(6):3031-41. [PMID 18056261 669 KB, Related Articles] [ISI 000253083000006cited 8 times ]
272. Kulasingam V, Smith CR, Batruch I, Buckler A, Jeffery DA, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     ''Product ion monitoring'' assay for prostate-specific antigen in serum using a linear ion-trap
     Journal of Proteome Research 2008 Feb;7(2):640-7. [PMID 18186600 829 KB, Related Articles] [ISI 000252864400017cited 9 times ]
273. Maki J, Robinson K, Reguly B, Alexander J, Wittock R, Aguirre A, Diamandis EP, Escott N, Skehan A, Prowse O, Thayer RE, Froberg MK, Wilson MJ, Maragh S, Jakupciak JP, Wagner PD, Srivastava S, Dakubo GD, Parr RL.
     Genesis Genomics, Thunder Bay, Canada
     Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens
     American Journal of Clinical Pathology 2008 Jan;129(1):57-66. [PMID 18089489 981 KB, Related Articles] [ISI 000251824700005cited 4 times ]
274. Paliouras M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont., Canada
     Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression
     Tumor Biology 2008;29(2):63-75. [PMID 18515984 875 KB, Related Articles] [ISI 000257903500001cited 3 times ]
275. Rabien A, Fritzsche F, Jung M, Diamandis EP, Loening SA, Dietel M, Jung K, Stephan C, Kristiansen G. <Anja.Rabien@charite.de>
     Department of Urology, Charité-Universitatsmedizin Berlin, CCM, Berlin, Germany
     High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse
     Tumor Biology 2008;29(1):1-8. [PMID 18497543 397 KB, Related Articles] [ISI 000256571400001cited twice]

2007

276. Diamandis EP.
     POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma? [letter]
     Clinical Biochemistry 2007 Dec;40(18):1437-9. [PMID 17945209 107 KB, Related Articles] [ISI 000251763400017cited 5 times ]
277. Zheng Y, Katsaros D, Shan SJ, de la Longrais IR, Porpiglia M, Scorilas A, Kim NW, Wolfert RL, Simon I, Li L, Feng Z, Diamandis EP.
     The Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
     A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy
     Clinical Cancer Research 2007 Dec 1;13(23):6984-92. [PMID 18056174 330 KB, Related Articles] [ISI 000251529000010cited 4 times ]
278. Yousef GM, Denic N, Wadhwa J, Chandracanth SA, Smith T, Elms F, Diamandis EP. <yousefg@smh.toronto.on.ca>
     Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada
     Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature [review, 10 refs]
     J Otolaryngol 2007 Dec;36(6):E93-5. [PMID 18076837 251 KB, Related Articles]
279. Goard CA, Bromberg IL, Elliott MB, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus
     Molecular Oncology 2007 Dec;1(3):303-12. [PMID 19383304 484 KB, Related Articles] [ISI 000206299900011]
280. Emami N, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family [review, 190 refs]
     Molecular Oncology 2007 Dec;1(3):269-87. [PMID 19383303 1.2 MB, Related Articles] [ISI 000206299900009cited twice]
281. Borgoño CA, Gavigan JA, Alves J, Bowles B, Harris JL, Sotiropoulou G, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Defining the extended substrate specificity of kallikrein 1-related peptidases
     Biological Chemistry 2007 Nov;388(11):1215-25. [PMID 17976015 336 KB, Related Articles] [ISI 000250905900013cited 6 times ]
282. Kulasingam V, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada
     Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets
     Molecular & Cellular Proteomics 2007 Nov;6(11):1997-2011. [PMID 17656355 1.7 MB, Related Articles] [ISI 000251552900014cited 22 times ]
283. Kulasingam V, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto M5G 1X5, ON, Canada
     Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines
     Biological Chemistry 2007 Oct;388(10):1113-9. [PMID 17937626 213 KB, Related Articles] [ISI 000249947900016cited twice]
284. Memari N, Diamandis EP, Earle T, Campbell A, Van Dekken H, Van der Kwast TH.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues
     Prostate 2007 Sep 15;67(13):1465-74. [PMID 17654496 349 KB, Related Articles] [ISI 000249355300010cited once]
285. Stephan C, Jung K, Lein M, Diamandis EP.
     Department of Urology, Charité - Universitätsmedizin Berlin, Berlin, Germany
     PSA and other tissue kallikreins for prostate cancer detection [review, 139 refs]
     European Journal of Cancer 2007 Sep;43(13):1918-26. [PMID 17689069 204 KB, Related Articles] [ISI 000250128300016cited 11 times ]
286. Rabien A, Kristiansen G, Diamandis EP, Jung K, Stephan C. <Anja.Rabien@charite.de>
     Klinik für Urologie, Charité--Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin
     [Human kallikreins as tumor markers. Validation of potential marker of prostate cancer in serum and tissue] (German)
     Urologe 2007 Sep;46(9):1070-1. [PMID 17605120 5.7 MB, Related Articles] [ISI 000250342100021]
287. McIntosh MW, Liu Y, Drescher C, Urban N, Diamandis EP.
     Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
     Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma
     Clinical Cancer Research 2007 Aug 1;13(15 Pt 1):4422-8. [PMID 17671125 125 KB, Related Articles] [ISI 000248525100018cited 7 times ]
288. Shaw JL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Distribution of 15 human kallikreins in tissues and biological fluids
     Clinical Chemistry 2007 Aug;53(8):1423-32. [PMID 17573418 937 KB, Related Articles] [ISI 000248360000005, cited 49 times]
289. Simon I, Katsaros D, Rigault de la Longrais I, Massobrio M, Scorilas A, Kim NW, Sarno MJ, Wolfert RL, Diamandis EP. <irissimon@yahoo.com>
     diaDexus, Inc., 343 Oyster Point Blvd., South San Francisco, CA, USA
     B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression
     Gynecologic Oncology 2007 Aug;106(2):334-41. [PMID 17498784 364 KB, Related Articles] [ISI 000248585700009cited 4 times ]
290. Cho CK, Shan SJ, Winsor EJ, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
     Proteomics analysis of human amniotic fluid
     Molecular & Cellular Proteomics 2007 Aug;6(8):1406-15. [PMID 17495049 461 KB, Related Articles] [ISI 000248810100010, cited 14 times]
291. Shaw JL, Smith CR, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Proteomic analysis of human cervico-vaginal fluid
     Journal of Proteome Research 2007 Jul;6(7):2859-65. [PMID 17567164 381 KB, Related Articles] [ISI 000247792300045cited 19 times ]
292. Diamandis EP.
     Oncopeptidomics: a useful approach for cancer diagnosis? [editorial]
     Clinical Chemistry 2007 Jun;53(6):1004-6. [PMID 17517585 55 KB, Related Articles] [ISI 000246830300003, cited 5 times]
     Comment on -- Clin Chem. 2007 Jun;53(6):1067-74. [PMID 17463175, Related Articles]
293. Komatsu N, Saijoh K, Kuk C, Liu AC, Khan S, Shirasaki F, Takehara K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
     Experimental Dermatology 2007 Jun;16(6):513-9. [PMID 17518992 654 KB, Related Articles] [ISI 000246683100008cited 9 times ]
294. Oikonomopoulou K, Hansen KK, Chapman K, Vergnolle N, Diamandis EP, Hollenberg MD.
     Kallikrein-mediated activation of PARs in inflammation and nociception
     Inflammation Research 2007 Jun;56:S499-S502 [ISI 000247517900340 69 KBcited once]
295. Evans KR, Hoffman BR, Diamandis EP.
     Cancer biomarkers [editorial]
     Cancer Letters 2007 Apr 28;249(1):1-2 [ISI 000246129800001 76 KBcited once]
296. Evans KR, Hoffman BR, Diamandis EP.
     Featuring the special issue editors Dr. Kenneth R. Evans, Dr. Barry R. Hoffman and Dr. Eleftherios P. Diamandis [biographical-item]
     Cancer Letters 2007 Apr 28;249(1):3-4 [ISI 000246129800002 135 KB]
297. Komatsu N, Saijoh K, Kuk C, Shirasaki F, Takehara K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
     British Journal of Dermatology 2007 May;156(5):875-83. [PMID 17459012 883 KB, Related Articles] [ISI 000245938700011cited 7 times ]
298. Emami N, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Human tissue kallikreins: a road under construction [review, 64 refs]
     Clinica Chimica Acta 2007 May;381(1):78-84. [PMID 17382920 183 KB, Related Articles] [ISI 000247513400013cited 13 times ]
299. Shih IeM, Salani R, Fiegl M, Wang TL, Soosaipillai A, Marth C, Müller-Holzner E, Gastl G, Zhang Z, Diamandis EP. <ishi@jhmi.edu>
     Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
     Ovarian cancer specific kallikrein profile in effusions
     Gynecologic Oncology 2007 May;105(2):501-7. [PMID 17303231 540 KB, Related Articles] [ISI 000246216800035]
300. Gunawardana CG, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont., Canada
     High throughput proteomic strategies for identifying tumour-associated antigens [review, 34 refs]
     Cancer Letters 2007 Apr 28;249(1):110-9. [PMID 17306453 571 KB, Related Articles] [ISI 000246129800013, cited 10 times]
301. Paliouras M, Borgono C, Diamandis EP.
     Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
     Human tissue kallikreins: the cancer biomarker family [review, 161 refs]
     Cancer Letters 2007 Apr 28;249(1):61-79. [PMID 17275179 203 KB, Related Articles] [ISI 000246129800009, cited 34 times]
302. Memari N, Jiang W, Diamandis EP, Luo LY.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto M5G 1X5, ON, Canada
     Enzymatic properties of human kallikrein-related peptidase 12 (KLK12)
     Biological Chemistry 2007 Apr;388(4):427-35. [PMID 17391064 224 KB, Related Articles] [ISI 000245407000009, cited 6 times]
303. Dorn J, Schmitt M, Kates R, Schmalfeldt B, Kiechle M, Scorilas A, Diamandis EP, Harbeck N.
     Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
     Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients
     Clinical Cancer Research 2007 Mar 15;13(6):1742-8. [PMID 17363527 130 KB, Related Articles] [ISI 000245031800019, cited 7 times]
304. Paliouras M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave., M5G 1X5 Toronto, ON, Canada
     Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines
     Breast Cancer Research and Treatment 2007 Mar;102(1):7-18. [PMID 16897430 442 KB, Related Articles] [ISI 000244302800002, cited 11 times]
305. Sardana G, Marshall J, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
     Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium
     Clinical Chemistry 2007 Mar;53(3):429-37. [PMID 17259234 346 KB, Related Articles] [ISI 000244550300009, cited 11 times]
306. Stephan C, Xu C, Cammann H, Graefen M, Haese A, Huland H, Semjonow A, Diamandis EP, Remzi M, Djavan B, Wildhagen MF, Blijenberg BG, Finne P, Stenman UH, Jung K, Meyer HA. <Carsten.Stephan@charite.de>
     Department of Urology, Charité-Universitätsmedizin Berlin, CCM, Berlin, Germany
     Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men
     World Journal of Urology 2007 Mar;25(1):95-103. [PMID 17333205 385 KB, Related Articles] [ISI 000246842700013, cited 10 times]
307. Borgoño CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada
     A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation
     Journal of Biological Chemistry 2007 Feb 9;282(6):3640-52. [PMID 17158887 889 KB, Related Articles] [ISI 000244481900026, cited 20 times]
308. Komatsu N, Saijoh K, Otsuki N, Kishi T, Micheal IP, Obiezu CV, Borgono CA, Takehara K, Jayakumar A, Wu HK, Clayman GL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada M5G 1L5
     Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein
     Clinica Chimica Acta 2007 Feb;377(1-2):228-36. [PMID 17140555 1.6 MB, Related Articles] [ISI 000243675000033, cited 6 times]
309. Shan SJ, Scorilas A, Katsaros D, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
     British Journal of Cancer 2007 Jan 29;96(2):362-72. [PMID 17242704 304 KB, Related Articles] [ISI 000243790300028cited 4 times ]
310. Borgoño CA, Michael IP, Shaw JL, Luo LY, Ghosh MC, Soosaipillai A, Grass L, Katsaros D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14
     Journal of Biological Chemistry 2007 Jan 26;282(4):2405-22. [PMID 17110383 1 MB, Related Articles] [ISI 000243593200032, cited 18 times]
311. van der Merwe DE, Oikonomopoulou K, Marshall J, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G1X5, Canada
     Mass spectrometry: uncovering the cancer proteome for diagnostics [review, 120 refs]
     Advances in Cancer Research: Advances in Cancer Research, Vol 96 2007;96:23-50. [PMID 17161675 1.3 MB, Related Articles] [ISI 000243406600002cited 23 times ]
312. Shaw JL, Grass L, Sotiropoulou G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada, M5G 1X5
     Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids
     Clinical Biochemistry 2007 Jan;40(1-2):104-10. [PMID 17045982 361 KB, Related Articles] [ISI 000243631100018, cited 6 times]

2006

313. Prezas P, Scorilas A, Yfanti C, Viktorov P, Agnanti N, Diamandis E, Talieri M.
     G. Papanicolaou Research Center of Oncology, Saint Savas Hospital, 171 Alexandras Avenue, GR-11522 Athens, Greece
     The role of human tissue kallikreins 7 and 8 in intracranial malignancies
     Biological Chemistry 2006 Dec;387(12):1607-12. [PMID 17132107 83 KB, Related Articles] [ISI 000242534900011cited 6 times ]
314. Diamandis EP.
     Quality of the scientific literature: all that glitters is not gold [editorial]
     Clinical Biochemistry 2006 Dec;39(12):1109-11. [PMID 17052701 106 KB, Related Articles] [ISI 000243163900001, cited 4 times]
315. Elliott MB, Irwin DM, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada M5G 1L5
     In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families
     Genomics 2006 Nov;88(5):591-9. [PMID 16829021 1.5 MB, Related Articles] [ISI 000241563400008cited 5 times ]
316. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI, Scarisbrick I, Andrade-Gordon P, Cottrell GS, Bunnett NW, Diamandis EP, Hollenberg MD.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
     Proteinase-activated receptors, targets for kallikrein signaling
     Journal of Biological Chemistry 2006 Oct 27;281(43):32095-112. [PMID 16885167 907 KB, Related Articles] [ISI 000241414500007, cited 52 times]
317. Shan SJ, Scorilas A, Katsaros D, Rigault de la Longrais I, Massobrio M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols
     Clinical Chemistry 2006 Oct;52(10):1879-86. [PMID 16916986 264 KB, Related Articles] [ISI 000240858000008, cited 11 times]
318. Darling MR, Tsai S, Jackson-Boeters L, Daley TD, Diamandis EP. <Mark.Darling@schulich.uwo.ca>
     Division of Oral Pathology, Department of Pathology, University of Western Ontario, London, Ontario N6A 5C1, Canada
     Human kallikrein 3 (prostate specific antigen) and human kallikrein 5 expression in salivary gland tumors
     International Journal of Biological Markers 2006 Oct-Dec;21(4):201-5. [PMID 17177156 156 KB, Related Articles] [ISI 000244123400001cited once]
319. Komatsu N, Suga Y, Saijoh K, Liu AC, Khan S, Mizuno Y, Ikeda S, Wu HK, Jayakumar A, Clayman GL, Shirasaki F, Takehara K, Diamandis EP.
     Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes [letter]
     Journal of Investigative Dermatology 2006 Oct;126(10):2338-42. [PMID 16778802 2 MB, Related Articles] [ISI 000241359400029, cited 11 times]
320. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Peptidomics for cancer diagnosis: present and future [editorial]
     Journal of Proteome Research 2006 Sep;5(9):2079-82. [PMID 16944917 203 KB, Related Articles] [ISI 000240200700002, cited 37 times]
321. Dorn J, Harbeck N, Kates R, Magdolen V, Grass L, Soosaipillai A, Schmalfeldt B, Diamandis EP, Schmitt M.
     Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
     Biological Chemistry 2006 Aug;387(8):1121-8. [PMID 16895483 108 KB, Related Articles] [ISI 000240351400015cited twice]
322. Slagter MH, Scorilas A, Gooren LJ, de Ronde W, Soosaipillai A, Giltay EJ, Paliouras M, Diamandis EP.
     Department of Endocrinology, Vrije Universiteit University Medical Centre, Amsterdam, The Netherlands, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals
     Clinical Chemistry 2006 Aug;52(8):1546-51. [PMID 16777918 83 KB, Related Articles] [ISI 000239480300013, cited twice]
323. Slagter MH, Gooren LJ, Scorilas A, Petraki CD, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada
     Effects of long-term androgen administration on breast tissue of female-to-male transsexuals
     Journal of Histochemistry & Cytochemistry 2006 Aug;54(8):905-10. [PMID 16618941 277 KB, Related Articles] [ISI 000239138100007, cited 5 times]
324. Slagter MH, Gooren LJ, de Ronde W, Soosaipillai A, Scorilas A, Giltay EJ, Paliouras M, Diamandis EP.
     Department of Endocrinology, VU University Medical Centre, Amsterdam, The Netherlands
     Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens
     Clinical Chemistry 2006 Jul;52(7):1356-65. [PMID 16644872 99 KB, Related Articles] [ISI 000238725800020cited once]
325. Parr RL, Dakubo GD, Crandall KA, Maki J, Reguly B, Aguirre A, Wittock R, Robinson K, Alexander JS, Birch-Machin MA, Abdel-Malak M, Froberg MK, Diamandis EP, Thayer RE. <Ryan.Parr@genesisgenomics.com>
     Genesis Genomics Inc., 1294 Balmoral St., Thunder Bay, Ontario, Canada, P7B 5Z5
     Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology
     Journal of Molecular Diagnostics 2006 Jul;8(3):312-9. [PMID 16825503 4 MB, Related Articles] [ISI 000239106800004, cited 11 times]
326. Diamandis EP, Deperthes D, Lundwall A.
     The First International Symposium on Kallikreins [editorial]
     Biological Chemistry 2006 Jun;387(6):635-636 [ISI 000238758800001 29 KBcited once]
327. Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Blaber M, Blaber SI, Scarisbrick I, Diamandis EP, Hollenberg MD.
     Department of Laboratory Medicine and Pathobiology, University of Toronto and Mount Sinai Hospital, Toronto M5G 1X5, ON, Canada
     Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
     Biological Chemistry 2006 Jun;387(6):817-24. [PMID 16800746 113 KB, Related Articles] [ISI 000238758800024, cited 22 times]
328. Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M, Talieri M, Diamandis EP, Krüger A, Magdolen V.
     Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, D-81675 Munich, Germany, and G. Papanicolaou Research Center of Oncology, Saint Savas Hospital, GR-11522 Athens, Greece
     Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
     Biological Chemistry 2006 Jun;387(6):807-11. [PMID 16800744 96 KB, Related Articles] [ISI 000238758800022, cited 17 times]
329. Stephan C, Meyer HA, Cammann H, Nakamura T, Diamandis EP, Jung K. <Carsten.Stephan@charite.de>
     Department of Urology, University Hospital Charité, D-10098 Berlin, Germany
     Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
     Biological Chemistry 2006 Jun;387(6):801-5. [PMID 16800743 66 KB, Related Articles] [ISI 000238758800021, cited 13 times]
330. Pampalakis G, Diamandis EP, Sotiropoulou G. <geopamp@upatras.gr>
     Department of Pharmacy, School of Health Sciences, University of Patras, GR-26500 Rion-Patras, Greece, and Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     The epigenetic basis for the aberrant expression of kallikreins in human cancers
     Biological Chemistry 2006 Jun;387(6):795-9. [PMID 16800742 142 KB, Related Articles] [ISI 000238758800020, cited 5 times]
331. Obiezu CV, Michael IP, Levesque MA, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, and Department of Laboratory Medicine and Pathobiology, University of Toronto, 100 College Street, Toronto M5G 1L5, ON, Canada
     Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins
     Biological Chemistry 2006 Jun;387(6):749-59. [PMID 16800736 221 KB, Related Articles] [ISI 000238758800014, cited 13 times]
332. Memari N, Grass L, Nakamura T, Karakucuk I, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     Human tissue kallikrein 9: production of recombinant proteins and specific antibodies
     Biological Chemistry 2006 Jun;387(6):733-40. [PMID 16800734 118 KB, Related Articles] [ISI 000238758800012, cited 5 times]
333. Kishi T, Cloutier SM, Kündig C, Deperthes D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     Activation and enzymatic characterization of recombinant human kallikrein 8
     Biological Chemistry 2006 Jun;387(6):723-31. [PMID 16800733 129 KB, Related Articles] [ISI 000238758800011, cited 9 times]
334. Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Diamandis EP, Hollenberg MD.
     Department of Laboratory Medicine and Pathobiology, University of Toronto and Mount Sinai Hospital, Toronto M5G 1X5, ON, Canada
     Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more [review, 66 refs]
     Biological Chemistry 2006 Jun;387(6):677-85. [PMID 16800728 121 KB, Related Articles] [ISI 000238758800006, cited 16 times]
335. Petraki CD, Papanastasiou PA, Karavana VN, Diamandis EP.
     Department of Pathology, Evangelismos Hospital, GR-10676 Athens, Greece, and Depament of Laboratory Medicine and Pathobiology, University of Toronto, Canada
     Cellular distribution of human tissue kallikreins: immunohistochemical localization [review, 107 refs]
     Biological Chemistry 2006 Jun;387(6):653-63. [PMID 16800726 371 KB, Related Articles] [ISI 000238758800004, cited 19 times]
336. Paliouras M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, ON, Canada
     The kallikrein world: an update on the human tissue kallikreins [review, 91 refs]
     Biological Chemistry 2006 Jun;387(6):643-52. [PMID 16800725 149 KB, Related Articles] [ISI 000238758800003, cited 27 times]
337. Lundwall A, Band V, Blaber M, Clements JA, Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, Olsson AY, Petraki C, Scorilas A, Sotiropoulou G, Stenman UH, Stephan C, Talieri M, Yousef GM. <Ake.Lundwall@med.lu.se>
     Lund University, Clinical Chemistry, Department of Laboratory Medicine, University Hospital MAS, S-205 02 Malmö, Sweden
     A comprehensive nomenclature for serine proteases with homology to tissue kallikreins [review]
     Biological Chemistry 2006 Jun;387(6):637-41. [PMID 16800724 68 KB, Related Articles] [ISI 000238758800002, cited 43 times]
338. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
     Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps
     Cancer Research 2006 Jun 1;66(11):5540-1. [PMID 16740686 60 KB, Related Articles] [ISI 000238003100003, cited 30 times]
339. Felber LM, Kündig C, Borgoño CA, Chagas JR, Tasinato A, Jichlinski P, Gygi CM, Leisinger HJ, Diamandis EP, Deperthes D, Cloutier SM.
     Urology Research Unit, Department of Urology, CHUV, Epalinges, Switzerland
     Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
     Febs Journal 2006 Jun;273(11):2505-14. [PMID 16704423 236 KB, Related Articles] [ISI 000238389900014, cited 6 times]
340. Soleas GJ, Grass L, Josephy PD, Goldberg DM, Diamandis EP.
     A comparison of the anticarcinogenic properties of four red wine polyphenols (reprinted from Clinical Biochemistry, 2002, vol. 35, pg. 119-124) [reprint]
     Clinical Biochemistry 2006 May;39(5):492-497 [ISI 000237902300017 129 KB, cited 18 times]
341. Michael IP, Pampalakis G, Mikolajczyk SD, Malm J, Sotiropoulou G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression
     Journal of Biological Chemistry 2006 May 5;281(18):12743-50. [PMID 16517595 495 KB, Related Articles] [ISI 000237134700067, cited 26 times]
342. Santin AD, Diamandis EP, Bellone S, Marizzoni M, Bandiera E, Palmieri M, Papasakelariou C, Katsaros D, Burnett A, Pecorelli S. <SantinAlessandroD@uams.edu>
     Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
     Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas
     American Journal of Obstetrics and Gynecology 2006 May;194(5):1296-302. [PMID 16647913 176 KB, Related Articles] [ISI 000237331900017, cited 3 times]
343. Stephan C, Xu C, Brown DA, Breit SN, Michael A, Nakamura T, Diamandis EP, Meyer H, Cammann H, Jung K. <Carsten.Stephan@charite.de>
     Department of Urology, University Hospital Charité Berlin, Berlin, Germany
     Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network
     Prostate 2006 May 1;66(6):651-9. [PMID 16388506 149 KB, Related Articles] [ISI 000236721800008, cited 14 times]
344. Diamandis EP.
     Validation of breast cancer biomarkers identified by mass spectrometry [comment]
     Clin Chem 2006 Apr;52(4):771-2; author reply 772. [PMID 16595832 68 KB, Related Articles]
     Comment on -- Clin Chem. 2005 Dec;51(12):2229-35. [PMID 16223889 351 KB, Related Articles]
345. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP. <Mark.Darling@schulich.uwo.ca>
     Division of Oral Pathology, Department of Pathology, University of Western Ontario, London, Canada
     Human kallikrein 13 expression in salivary gland tumors
     International Journal of Biological Markers 2006 Apr-Jun;21(2):106-10. [PMID 16847813 203 KB, Related Articles] [ISI 000239074900006, cited 3 times]
346. Komatsu N, Tsai B, Sidiropoulos M, Saijoh K, Levesque MA, Takehara K, Diamandis EP.
     Quantification of eight tissue kallikreins in the stratum corneum and sweat [letter]
     Journal of Investigative Dermatology 2006 Apr;126(4):925-9. [PMID 16456535 96 KB, Related Articles] [ISI 000238968600036, cited 9 times]
347. Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada
     Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer
     Clinical Cancer Research 2006 Mar 1;12(5):1487-93. [PMID 16533772 191 KB, Related Articles] [ISI 000235988000013, cited 15 times]
348. Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP. <Carsten.Stephan@charite.de>
     Department of Urology, University Hospital Charité Berlin, Berlin, Germany
     Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer
     International Journal of Urology 2006 Mar;13(3):238-43. [PMID 16643616 80 KB, Related Articles] [ISI 000236456100009, cited 7 times]
349. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP. <Mark.Darling@fmd.uwo.ca>
     Department of Pathology, University of Western Ontario, London, Ontario, Canada N6A 5C1
     Human kallikrein 6 expression in salivary gland tumors
     Journal of Histochemistry & Cytochemistry 2006 Mar;54(3):337-42. [PMID 16286664 283 KB, Related Articles] [ISI 000235563200008, cited 3 times]
350. Fritzsche F, Gansukh T, Borgoño CA, Burkhardt M, Pahl S, Mayordomo E, Winzer KJ, Weichert W, Denkert C, Jung K, Stephan C, Dietel M, Diamandis EP, Dahl E, Kristiansen G.
     Institute of Pathology, Department of Urology, Charité Universitätsmedizin, Berlin, Germany
     Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
     British Journal of Cancer 2006 Feb 27;94(4):540-7. [PMID 16434994 208 KB, Related Articles] [ISI 000235475300014, cited 7 times]
351. Simon I, Zhuo S, Corral L, Diamandis EP, Sarno MJ, Wolfert RL, Kim NW. <isimon@diadexus.com>
     diaDexus Inc., 343 Oyster Point Boulevard, South San Francisco, CA 94080, USA
     B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer
     Cancer Research 2006 Feb 1;66(3):1570-5. [PMID 16452214 360 KB, Related Articles] [ISI 000235095900041, cited 29 times]
352. Luo LY, Shan SJ, Elliott MB, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma
     Clinical Cancer Research 2006 Feb 1;12(3 Pt 1):742-50. [PMID 16467084 716 KB, Related Articles] [ISI 000235201900009, cited 16 times]
353. Diamandis EP.
     Lost in (the business of) translation: invest in the youth [comment]
     Clinical Cancer Research 2006 Jan 15;12(2):669; author reply 669-70. [PMID 16428514 125 KB, Related Articles] [ISI 000234791300048]
     Comment on -- Clin Cancer Res. 2005 Jul 1;11(13):4644-5. [PMID 16000555 38 KB, Related Articles]
354. Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, Amin J, Jung K, Diamandis EP, Hampton GM, Russell PJ, Giles GG, Breit SN.
     Centre for Immunology at St. Vincent's Hospital, Sydney, Australia
     Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis
     Clinical Cancer Research 2006 Jan 1;12(1):89-96. [PMID 16397029 182 KB, Related Articles] [ISI 000234503700015, cited 13 times]
355. Luo LY, Soosaipillai A, Grass L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients
     Tumor Biology 2006;27(5):227-34. [PMID 16864975 239 KB, Related Articles] [ISI 000240090400001cited twice]
356. Oikonomopoulou K, Scorilas A, Michael IP, Grass L, Soosaipillai A, Rosen B, Murphy J, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
     Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study
     Tumor Biology 2006;27(2):104-14. [PMID 16557045 311 KB, Related Articles] [ISI 000237199300005, cited 7 times]
357. Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP.
     Department of Pathology, Evangelismos Hospital, Athens, Greece
     Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma
     Tumor Biology 2006;27(1):1-7. [PMID 16340244 335 KB, Related Articles] [ISI 000233955000001, cited 8 times]

2005

358. Komatsu N, Saijoh K, Sidiropoulos M, Tsai B, Levesque MA, Elliott MB, Takehara K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender
     Journal of Investigative Dermatology 2005 Dec;125(6):1182-9. [PMID 16354188 149 KB, Related Articles] [ISI 000233823900018cited 24 times ]
359. Rosen DG, Wang L, Atkinson JN, Yu Y, Lu KH, Diamandis EP, Hellstrom I, Mok SC, Liu J, Bast RC Jr.
     Department of Pathology, University of Texas M.D. Anderson Cancer Center, Box 355, 1515 Holcombe Boulevard, Houston, TX 77030, USA
     Potential markers that complement expression of CA125 in epithelial ovarian cancer
     Gynecologic Oncology 2005 Nov;99(2):267-77. [PMID 16061277 544 KB, Related Articles] [ISI 000233124100004, cited 59 times]
360. Sidiropoulos M, Pampalakis G, Sotiropoulou G, Katsaros D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers
     Tumor Biology 2005 Nov-Dec;26(6):324-36. [PMID 16254462 299 KB, Related Articles] [ISI 000233364700006, cited 19 times]
361. Stephan C, Jung K, Soosaipillai A, Yousef GM, Cammann H, Meyer H, Xu C, Diamandis EP. <Carsten.Stephan@charite.de>
     Department of Urology, Univeristy Hospital Charité, Berlin, Germany
     Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection
     Bju International 2005 Sep;96(4):521-7. [PMID 16104903 95 KB, Related Articles] [ISI 000231387900014, cited 15 times]
362. Yousef GM, Ejeckam GC, Best LM, Diamandis EP. <GYousef@hotmail.com>
     Memorial University, St. John's, Canada
     Collecting duct carcinoma associated with oncocytoma
     Int Braz J Urol 2005 Sep-Oct;31(5):465-7; discussion 467-9. [PMID 16255793 291 KB, Related Articles]
363. Yousef GM, White NM, Michael IP, Cho JC, Robb JD, Kurlender L, Khan S, Diamandis EP.
     Discipline of Laboratory Medicine, Memorial University, St. John's, Canada
     Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker
     Tumor Biology 2005 Sep-Oct;26(5):227-35. [PMID 16103744 178 KB, Related Articles] [ISI 000231756600002, cited 7 times]
364. Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, Takehara K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada, M5G 1X5
     Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases
     British Journal of Dermatology 2005 Aug;153(2):274-81. [PMID 16086736 629 KB, Related Articles] [ISI 000230842300003, cited 30 times]
365. Obiezu CV, Shan SJ, Soosaipillai A, Luo LY, Grass L, Sotiropoulou G, Petraki CD, Papanastasiou PA, Levesque MA, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids
     Clinical Chemistry 2005 Aug;51(8):1432-42. [PMID 15961548 316 KB, Related Articles] [ISI 000230766000016, cited 24 times]
366. Obiezu CV, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ont., Canada M5G 1X5
     Human tissue kallikrein gene family: applications in cancer [review, 207 refs]
     Cancer Letters 2005 Jun 16;224(1):1-22. [PMID 15911097 254 KB, Related Articles] [ISI 000229734800001, cited 44 times]
367. Kurlender L, Borgono C, Michael IP, Obiezu C, Elliott MB, Yousef GM, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, 600 University Avenue, Toronto, Ontario, Canada M5G 1L5
     A survey of alternative transcripts of human tissue kallikrein genes [review, 93 refs]
     Biochimica et Biophysica Acta-Reviews on Cancer 2005 May 25;1755(1):1-14. [PMID 15878240 828 KB, Related Articles] [ISI 000229528000001, cited 25 times]
368. Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S. <SantinAlessandroD@uams.edu>
     Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199, USA
     Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer
     Clinical Cancer Research 2005 May 1;11(9):3320-5. [PMID 15867230 181 KB, Related Articles] [ISI 000228848000025, cited 12 times]
369. Michael IP, Sotiropoulou G, Pampalakis G, Magklara A, Ghosh M, Wasney G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression
     Journal of Biological Chemistry 2005 Apr 15;280(15):14628-35. [PMID 15713679 372 KB, Related Articles] [ISI 000228236800037, cited 49 times]
370. Felber LM, Borgoño CA, Cloutier SM, Kündig C, Kishi T, Ribeiro Chagas J, Jichlinski P, Gygi CM, Leisinger HJ, Diamandis EP, Deperthes D.
     Urology Research Unit, Department of Urology, CHUV, CH-1066 Epalinges, Switzerland
     Enzymatic profiling of human kallikrein 14 using phage-display substrate technology
     Biological Chemistry 2005 Mar;386(3):291-8. [PMID 15843175 95 KB, Related Articles] [ISI 000228131400012, cited 28 times]
371. Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L, Stephan C, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Intron retention: a common splicing event within the human kallikrein gene family
     (GenBank: AF148532, AJ310938, AY373373, AY429508, AY429509, AY461805)
     Clinical Chemistry 2005 Mar;51(3):506-15. [PMID 15650036 420 KB, Related Articles] [ISI 000227230600006, cited 12 times]
372. Diamandis EP, van der Merwe DE.
     Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations [editorial]
     Clinical Cancer Research 2005 Feb 1;11(3):963-5. [PMID 15709159 55 KB, Related Articles] [ISI 000226740400001, cited 55 times]
     Comment on -- Clin Cancer Res. 2005 Feb 1;11(3):1110-8. [PMID 15709178 554 KB, Related Articles]
373. Yousef GM, Obiezu CV, Luo LY, Magklara A, Borgoño CA, Kishi T, Memari N, Michael P, Sidiropoulos M, Kurlender L, Economopolou K, Kapadia C, Komatsu N, Petraki C, Elliott M, Scorilas A, Katsaros D, Levesque MA, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Human tissue kallikreins: from gene structure to function and clinical applications [review, 273 refs]
     Advances in Clinical Chemistry: Advances in Clinical Chemistry, Vol 39 2005;39:11-79. [PMID 16013667 14.1 MB, Related Articles] [ISI 000231115200002, cited 19 times]

2004

374. Tran N, Bharaj BS, Diamandis EP, Smith M, Li BD, Yu H.
     Department of Epidemiology and Public Health, Yale University School of Medicine, P.O. Box 208034 New Haven, CT 06520-8034, USA
     Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings
     Cancer Epidemiology Biomarkers & Prevention 2004 Dec;13(12):2133-40. [PMID 15598771 436 KB, Related Articles] [ISI 000226077100022, cited 12 times]
     Comment in -- Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1581; author reply 1581-2. [PMID 15941980, Related Articles]
375. Yousef GM, Borgono CA, Michael IP, Diamandis EP.
     Discipline of Pathology, Health Care Corporation of St. John's, St. John's, Newfoundland, Canada
     Cloning of a kallikrein pseudogene
     Clinical Biochemistry 2004 Nov;37(11):961-7. [PMID 15498522 810 KB, Related Articles] [ISI 000225389900003, cited 9 times]
376. Borgoño CA, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G1X5, Canada
     The emerging roles of human tissue kallikreins in cancer
     Nature Reviews Cancer 2004 Nov;4(11):876-90. [PMID 15516960 320 KB, Related Articles] [ISI 000224815700014, cited 180 times]
377. Kapadia C, Ghosh MC, Grass L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
     Human kallikrein 13 involvement in extracellular matrix degradation
     Biochemical and Biophysical Research Communications 2004 Oct 22;323(3):1084-90. [PMID 15381110 4.9 MB, Related Articles] [ISI 000224232100052, cited 20 times]
378. Diamandis EP, Borgoño CA, Scorilas A, Harbeck N, Dorn J, Schmitt M. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada
     Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients
     Clinical Biochemistry 2004 Sep;37(9):823-9. [PMID 15329323 263 KB, Related Articles] [ISI 000223841800014, cited 16 times]
379. Diamandis EP.
     Proteomic patterns to identify ovarian cancer: 3 years on [editorial]
     Expert Review of Molecular Diagnostics 2004 Sep;4(5):575-7. [PMID 15347249 515 KB, Related Articles] [ISI 000223825500001, cited 22 times]
380. Yousef GM, Borgoño CA, White NM, Robb JD, Michael IP, Oikonomopoulou K, Khan S, Diamandis EP.
     Discipline of Pathology, Memorial University, St. John's, Toronto, Canada
     In silico analysis of the human kallikrein gene 6
     Tumor Biology 2004 Sep-Dec;25(5-6):282-9. [PMID 15627893 191 KB, Related Articles] [ISI 000226047200010, cited 11 times]
381. Yousef GM, White NM, Kurlender L, Michael I, Memari N, Robb JD, Katsaros D, Stephan C, Jung K, Diamandis EP.
     Discipline of Laboratory Medicine, Memorial University, St. John's, Toronto, Canada
     The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer
     Tumor Biology 2004 Sep-Dec;25(5-6):221-7. [PMID 15627884 194 KB, Related Articles] [ISI 000226047200001, cited 5 times]
     Comment in -- Tumour Biol. 2004 Sep-Dec;25(5-6):327-8. [PMID 15627899 48 KB, Related Articles]
382. Diamandis EP.
     OvaCheck: doubts voiced soon after publication [comment]
     Nature 2004 Aug 5;430(7000):611. [PMID 15295572 80 KB, Related Articles] [ISI 000223085400020, cited 9 times]
     Comment on -- Nature. 2004 Jun 3;429(6991):496-7. [PMID 15175721 465 KB, Related Articles]
383. Diamandis EP.
     Identification of serum amyloid a protein as a potentially useful biomarker for nasopharyngeal carcinoma [comment]
     Clinical Cancer Research 2004 Aug 1;10(15):5293; author reply 5293-4. [PMID 15297433 15 KB, Related Articles] [ISI 000223257200045, cited 6 times]
     Comment on -- Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):43-52. [PMID 14734450 309 KB, Related Articles]
384. Pampalakis G, Kurlender L, Diamandis EP, Sotiropoulou G.
     Department of Pharmacy, School of Health Sciences, University of Patras, Rion, Greece
     Cloning and characterization of novel isoforms of the human kallikrein 6 gene
     (GenBank: AY318867, AY318868, AY318869, AY318870)
     Biochemical and Biophysical Research Communications 2004 Jul 16;320(1):54-61. [PMID 15207701 389 KB, Related Articles] [ISI 000222494500009, cited 17 times]
385. Hoffman BR, Diamandis EP.
     Recent advances in cancer biomarkers [editorial]
     Clinical Biochemistry 2004 Jul;37(7):503-4. [PMID 15234230 54 KB, Related Articles] [ISI 000222746800001, cited once]
386. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells
     Tumor Biology 2004 Jul-Aug;25(4):193-9. [PMID 15557757 165 KB, Related Articles] [ISI 000225260000006, cited 33 times]
387. Diamandis EP.
     Immunoassay interference: a relatively rare but still important problem [editorial]
     Clinical Biochemistry 2004 May;37(5):331-2. [PMID 15087246 69 KB, Related Articles] [ISI 000221030500001, cited 6 times]
     Comment on -- Clin Biochem. 2004 May;37(5):344-9. [PMID 15087248 116 KB, Related Articles]
388. Diamandis EP.
     How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer [editorial]
     Clinical Chemistry 2004 May;50(5):793-5. [PMID 15105344 56 KB, Related Articles] [ISI 000221118800001, cited 13 times]
     Comment on -- Clin Chem. 2004 May;50(5):857-66. [PMID 14764641 450 KB, Related Articles]
389. Borgoño CA, Michael IP, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5 Canada
     Human tissue kallikreins: physiologic roles and applications in cancer [review, 403 refs]
     Molecular Cancer Research 2004 May;2(5):257-80. [PMID 15192120 639 KB, Related Articles] [ISI 000221944600001, cited 129 times]
390. Kurlender L, Yousef GM, Memari N, Robb JD, Michael IP, Borgoño C, Katsaros D, Stephan C, Jung K, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
     Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer
     Tumor Biology 2004 May-Jun;25(3):149-56. [PMID 15361712 427 KB, Related Articles] [ISI 000223981700008, cited 11 times]
391. Yousef GM, Borgoño CA, Michael IP, Davidian C, Stephan C, Jung K, Diamandis EP.
     Department of Laboratory Medicine, Memorial University, St. John's, Newfoundland, Canada
     Molecular cloning of a new gene which is differentially expressed in breast and prostate cancers
     Tumor Biology 2004 May-Jun;25(3):122-33. [PMID 15361709 1.7 MB, Related Articles] [ISI 000223981700005, cited 6 times]
392. Yousef GM, Elliott MB, Kopolovic AD, Serry E, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Division of Clinical Biochemistry, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, Canada M5G 1X5
     Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases
     Biochimica et Biophysica Acta-Proteins and Proteomics 2004 Apr 8;1698(1):77-86. [PMID 15063317 3.2 MB, Related Articles] [ISI 000220757100007, cited 9 times]
393. Antoniou A, Papanastasiou P, Stephanidis A, Diamandis E, Androulakakis PA. <drantoniou@evangelismos-hospital.com>
     Department of Paediatric Urology, Aghia Sophia Children's Hospital, Athens, Greece
     Assessment of serum prostate specific antigen in childhood
     Bju International 2004 Apr;93(6):838-40. [PMID 15050001 59 KB, Related Articles] [ISI 000220463300033cited once]
394. Diamandis EP, Yousef GM, Olsson AY. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
     An update on human and mouse glandular kallikreins [review, 15 refs]
     Clinical Biochemistry 2004 Apr;37(4):258-60. [PMID 15003726 165 KB, Related Articles] [ISI 000220342400002, cited 17 times]
395. Kishi T, Soosaipillai A, Grass L, Little SP, Johnstone EM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids
     Clinical Chemistry 2004 Apr;50(4):709-16. [PMID 14764643 205 KB, Related Articles] [ISI 000220524400004, cited 25 times]
396. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital,and Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
     Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations [review, 68 refs]
     Molecular & Cellular Proteomics 2004 Apr;3(4):367-78. [PMID 14990683 96 KB, Related Articles] [ISI 000220426900007, cited 239 times]
397. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems [editorial]
     Journal of the National Cancer Institute 2004 Mar 3;96(5):353-6. [PMID 14996856 28 KB, Related Articles] [ISI 000220090500007, cited 189 times]
398. Papageorgiou PC, Pourdjabbar A, Amfilochiadis AA, Diamandis EP, Boomsma F, Osmond DH.
     Dept. of Physiology and Medicine, Faculty of Medicine, Univ. of Toronto, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8
     Are cardiovascular and sympathoadrenal effects of human ''new pressor protein'' preparations attributable to human coagulation beta-FXIIa?
     American Journal of Physiology-Heart and Circulatory Physiology 2004 Mar;286(3):H837-46. [PMID 14576079 436 KB, Related Articles] [ISI 000188783200004, cited twice]
399. Diamandis EP, Scorilas A, Kishi T, Blennow K, Luo LY, Soosaipillai A, Rademaker AW, Sjogren M. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
     Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
     Clinical Biochemistry 2004 Mar;37(3):230-7. [PMID 14972646 236 KB, Related Articles] [ISI 000220037900010, cited 10 times]
400. Diamandis EP.
     Re: diagnostic potential of serum proteomic patterns in prostate cancer [comment]
     Journal of Urology 2004 Mar;171(3):1244-5; author reply 124-5-64. [PMID 14767317 104 KB, Related Articles] [ISI 000188965100061, cited 8 times]
     Comment on -- J Urol. 2003 Aug;170(2 Pt 1):442-6. [PMID 12853795 584 KB, Related Articles]
401. Scorilas A, Borgoño CA, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
     Department of Biochemistry and Molecular Biology, University of Athens, Greece
     Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker
     Journal of Clinical Oncology 2004 Feb 15;22(4):678-85. [PMID 14966091 139 KB, Related Articles] [ISI 000189018800017, cited 28 times]
402. Sauter ER, Lininger J, Magklara A, Hewett JE, Diamandis EP. <SauterE@health.missouri.edu>
     Department of Surgery, University of Missouri, Columbia, MO 65212, USA
     Association of kallikrein expression in nipple aspirate fluid with breast cancer risk
     International Journal of Cancer 2004 Feb 10;108(4):588-91. [PMID 14696124 72 KB, Related Articles] [ISI 000187734600015, cited 17 times]
403. Yousef GM, Yacoub GM, Polymeris ME, Popalis C, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Kallikrein gene downregulation in breast cancer
     British Journal of Cancer 2004 Jan 12;90(1):167-72. [PMID 14710225 125 KB, Related Articles] [ISI 000188096500029, cited 24 times]
404. Yousef GM, Borgoño CA, Popalis C, Yacoub GM, Polymeris ME, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     In-silico analysis of kallikrein gene expression in pancreatic and colon cancers
     Anticancer Research 2004 Jan-Feb;24(1):43-51. [PMID 15015574 116 KB, Related Articles] [ISI 000189271900006, cited 20 times]
405. Sauter ER, Klein G, Wagner-Mann C, Diamandis EP. <SauterE@health.missouri.edu>
     Department of Surgery, University of Missouri-Columbia, M588 Health Sciences Center, One Hospital Drive, Columbia, MO 65212, USA
     Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer
     Cancer Detection and Prevention 2004;28(1):27-31. [PMID 15041074 68 KB, Related Articles] [ISI 000220805500004, cited 10 times]
406. Kapadia C, Yousef GM, Mellati AA, Magklara A, Wasney GA, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
     Complex formation between human kallikrein 13 and serum protease inhibitors
     Clinica Chimica Acta 2004 Jan;339(1-2):157-67. [PMID 14687906 656 KB, Related Articles] [ISI 000188214900019, cited 15 times]
407. Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Kishi T, Nakamura T, Loening SA, Diamandis EP.
     Department of Urology, University Hospital Charité, Humboldt University, Berlin, Germany
     Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer
     Journal of Urology 2004 Jan;171(1):187-91. [PMID 14665873 132 KB, Related Articles] [ISI 000187390800043, cited 36 times]
408. Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A.
     G. Papanicolaou Research Center of Oncology, Saint Savas Hospital, Athens Greece
     Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma
     Thrombosis and Haemostasis 2004 Jan;91(1):180-6. [PMID 14691584 258 KB, Related Articles] [ISI 000188420200023, cited 26 times]

2003

409. Borgoño CA, Grass L, Soosaipillai A, Yousef GM, Petraki CD, Howarth DH, Fracchioli S, Katsaros D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Human kallikrein 14: a new potential biomarker for ovarian and breast cancer
     Cancer Research 2003 Dec 15;63(24):9032-41. [PMID 14695222 399 KB, Related Articles] [ISI 000187580300060, cited 52 times]
410. Luo LY, Grass L, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
     Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter
     Clinica Chimica Acta 2003 Nov;337(1-2):115-26. [PMID 14568187 315 KB, Related Articles] [ISI 000186363300013, cited 12 times]
411. Diamandis EP, Borgoño CA, Scorilas A, Yousef GM, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M. <E.Diamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis
     Tumor Biology 2003 Nov-Dec;24(6):299-309. [PMID 15004490 175 KB, Related Articles] [ISI 000220001300005, cited 20 times]
412. Nakamura T, Scorilas A, Stephan C, Jung K, Soosaipillai AR, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
     The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia
     Cancer Research 2003 Oct 1;63(19):6543-6. [PMID 14559849 76 KB, Related Articles] [ISI 000185967700064, cited 35 times]
413. Borgoño CA, Fracchioli S, Yousef GM, Rigault de la Longrais IA, Luo LY, Soosaipillai A, Puopolo M, Grass L, Scorilas A, Diamandis EP, Katsaros D.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma
     International Journal of Cancer 2003 Sep 10;106(4):605-10. [PMID 12845660 106 KB, Related Articles] [ISI 000184672300023, cited 30 times]
414. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers [review, 119 refs]
     Clinical Biochemistry 2003 Sep;36(6):443-52. [PMID 12951170 118 KB, Related Articles] [ISI 000185346100005, cited 38 times]
415. Yousef GM, Stephan C, Scorilas A, Ellatif MA, Jung K, Kristiansen G, Jung M, Polymeris ME, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues
     Prostate 2003 Sep 1;56(4):287-92. [PMID 12858357 89 KB, Related Articles] [ISI 000184741800007, cited 28 times]
416. Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
     Prognostic value of the human kallikrein gene 15 expression in ovarian cancer
     Journal of Clinical Oncology 2003 Aug 15;21(16):3119-26. [PMID 12915603 124 KB, Related Articles] [ISI 000184780300019, cited 22 times]
417. Magklara A, Mellati AA, Wasney GA, Little SP, Sotiropoulou G, Becker GW, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ont., Canada M5G 1X5
     Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors
     Biochemical and Biophysical Research Communications 2003 Aug 8;307(4):948-55. [PMID 12878203 225 KB, Related Articles] [ISI 000184510100030, cited 59 times]
418. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5 Canada
     Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? [editorial]
     Clinical Chemistry 2003 Aug;49(8):1272-5. [PMID 12881441 71 KB, Related Articles] [ISI 000184378900006, cited 159 times]
     Comment in -- Clin Chem. 2003 Aug;49(8):1276-8. [PMID 12881442 54 KB, Related Articles]
     Comment in -- Clin Chem. 2004 Aug;50(8):1475-6; author reply 1476-7. [PMID 15277364 57 KB, Related Articles]
419. Yousef GM, Kapadia C, Polymeris ME, Borgono C, Hutchinson S, Wasney GA, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Division of Clinical Biochemistry, Mount Sinai Hospital, 600 University Avenue, M5G 1X5, Toronto, ON, Canada
     The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids
     Biochimica et Biophysica Acta-Gene Structure and Expression 2003 Jul 28;1628(2):88-96. [PMID 12890555 571 KB, Related Articles] [ISI 000184560600002, cited 14 times]
420. Yousef GM, Polymeris ME, Grass L, Soosaipillai A, Chan PC, Scorilas A, Borgoño C, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer
     Cancer Research 2003 Jul 15;63(14):3958-65. [PMID 12873991 209 KB, Related Articles] [ISI 000184379800021, cited 66 times]
     Erratum in -- Cancer Res. 2003 Sep 1;63(17):5647. [PMID 12873991 erratum 58 KB]
421. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Tissue kallikreins: new players in normal and abnormal cell growth? [review, 88 refs]
     Thrombosis and Haemostasis 2003 Jul;90(1):7-16. [PMID 12876620 572 KB, Related Articles] [ISI 000184683100003, cited 16 times]
422. Nam RK, Zhang WW, Trachtenberg J, Diamandis E, Toi A, Emami M, Ho M, Sweet J, Evans A, Jewett MA, Narod SA. <Robert.Nam@utoronto.ca>
     Division of Urology, 2075 Bayview Ave, MG-406, Toronto, Ontario, Canada, M4N 3M5
     Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection
     Journal of Clinical Oncology 2003 Jun 15;21(12):2312-9. [PMID 12805332 79 KB, Related Articles] [ISI 000183564800016, cited 17 times]
423. Kishi T, Grass L, Soosaipillai A, Scorilas A, Harbeck N, Schmalfeldt B, Dorn J, Mysliwiec M, Schmitt M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Human kallikrein 8, a novel biomarker for ovarian carcinoma
     Cancer Research 2003 Jun 1;63(11):2771-4. [PMID 12782581 70 KB, Related Articles] [ISI 000183343200011, cited 41 times]
424. Talieri M, Diamandis EP, Katsaros N, Gourgiotis D, Scorilas A.
     G Papanicolaou Research Center of Oncology, Saint Savas Hospital Athens, Greece
     Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors
     Thrombosis and Haemostasis 2003 Jun;89(6):1081-8. [PMID 12783122 592 KB, Related Articles] [ISI 000184683000018, cited 14 times]
425. Yousef GM, Kopolovic AD, Elliott MB, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont, Canada, M5G 1X5
     Genomic overview of serine proteases
     Biochemical and Biophysical Research Communications 2003 May 23;305(1):28-36. [PMID 12732192 586 KB, Related Articles] [ISI 000182937500006, cited 24 times]
426. Scorilas A, Chiang PM, Katsaros D, Yousef GM, Diamandis EP. <scorilas@netscape.net>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, M5G 1X5, Toronto, ON, Canada
     Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors
     (GenBank: AF406955)
     Gene 2003 May 22;310:79-89. [PMID 12801635 1.6 MB, Related Articles] [ISI 000183677900008, cited 7 times]
427. Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A, Popalis C, Fracchioli S, Katsaros D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Parallel overexpression of seven kallikrein genes in ovarian cancer
     Cancer Research 2003 May 1;63(9):2223-7. [PMID 12727843 59 KB, Related Articles] [ISI 000182640400036, cited 56 times]
428. Hutchinson S, Luo LY, Yousef GM, Soosaipillai A, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin
     Clinical Chemistry 2003 May;49(5):746-51. [PMID 12709365 125 KB, Related Articles] [ISI 000182541900006, cited 14 times]
429. Nakamura T, Stephan C, Scorilas A, Yousef GM, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues
     Urology 2003 May;61(5):1042-6. [PMID 12736044 108 KB, Related Articles] [ISI 000183040400049, cited 15 times]
430. Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues
     British Journal of Cancer 2003 Apr 7;88(7):1101-4. [PMID 12671711 97 KB, Related Articles] [ISI 000182663700021, cited 20 times]
431. Petraki CD, Karavana VN, Diamandis EP.
     Department of Pathology, Evangelismos Hospital, Athens, Greece
     Human kallikrein 13 expression in normal tissues: an immunohistochemical study
     Journal of Histochemistry & Cytochemistry 2003 Apr;51(4):493-501. [PMID 12642628 721 KB, Related Articles] [ISI 00018600011, cited 19 times]
432. Kollara A, Diamandis EP, Brown TJ.
     Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Suite 876, 600 University Avenue, Toronto, Ont., Canada M5G 1X5
     Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells
     Journal of Steroid Biochemistry and Molecular Biology 2003 Apr;84(5):493-502. [PMID 12767274 361 KB, Related Articles] [ISI 000183376100001, cited 9 times]
433. Diamandis EP.
     Re: Serum proteomic patterns for detection of prostate cancer [comment]
     Journal of the National Cancer Institute 2003 Mar 19;95(6):489-90; author reply 490-1. [PMID 12644546 34 KB, Related Articles] [ISI 000181559700017, cited 20 times]
     Comment on -- J Natl Cancer Inst. 2002 Oct 16;94(20):1576-8. [PMID 12381711 68 KB, Related Articles]
434. Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Katsaros D. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma
     Journal of Clinical Oncology 2003 Mar 15;21(6):1035-43. [PMID 12637468 169 KB, Related Articles] [ISI 000181678300013, cited 89 times]
435. Yousef GM, Fracchioli S, Scorilas A, Borgoño CA, Iskander L, Puopolo M, Massobrio M, Diamandis EP, Katsaros D.
     Dept of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
     Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer
     American Journal of Clinical Pathology 2003 Mar;119(3):346-55. [PMID 12645335 104 KB, Related Articles] [ISI 000181138400004, cited 31 times]
436. Yousef GM, Scorilas A, Nakamura T, Ellatif MA, Ponzone R, Biglia N, Maggiorotto F, Roagna R, Sismondi P, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer
     Breast Cancer Research and Treatment 2003 Mar;78(2):149-58. [PMID 12725415 112 KB, Related Articles] [ISI 000181765400002, cited 20 times]
437. Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1X5 Canada
     Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
     Clinical Biochemistry 2003 Mar;36(2):135-43. [PMID 12633763 155 KB, Related Articles] [ISI 000182151500008, cited 25 times]
438. Yousef GM, Kishi T, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Role of kallikrein enzymes in the central nervous system [review, 75 refs]
     Clinica Chimica Acta 2003 Mar;329(1-2):1-8. [PMID 12589961 124 KB, Related Articles] [ISI 000181662500001, cited 30 times]
439. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Bellino R, van Gramberen M, de Bruijn H, Henrik A, Stenman UH, Massobrio M, van der Zee AG, Vergote I, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis
     Cancer Research 2003 Feb 15;63(4):807-11. [PMID 12591730 90 KB, Related Articles] [ISI 000181006500014, cited 78 times]
440. Scorilas A, Plebani M, Mazza S, Basso D, Soosaipillai AR, Katsaros N, Pagano F, Diamandis EP.
     National Center for Scientific Research Demokritos, IPC, Athens, Greece
     Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA
     Prostate 2003 Feb 15;54(3):220-9. [PMID 12518327 150 KB, Related Articles] [ISI 000180542300007, cited 26 times]
     Comment in -- J Urol. 2003 Jul;170(1):343. [PMID 14567353 50 KB, Related Articles]
441. Luo LY, Yousef G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada
     Human tissue kallikreins and testicular cancer [review, 60 refs]
     Apmis 2003 Jan;111(1):225-32; discussion 232-3. [PMID 12752266 183 KB, Related Articles] [ISI 000182540800025, cited 17 times]
442. Kishi T, Grass L, Soosaipillai A, Shimizu-Okabe C, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids
     Clinical Chemistry 2003 Jan;49(1):87-96. [PMID 12507964 208 KB, Related Articles] [ISI 000180195700012, cited 33 times]
443. Kapadia C, Chang A, Sotiropoulou G, Yousef GM, Grass L, Soosaipillai A, Xing X, Howarth DH, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay
     Clinical Chemistry 2003 Jan;49(1):77-86. [PMID 12507963 492 KB, Related Articles] [ISI 000180195700011, cited 31 times]
444. Stephan C, Yousef GM, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Bharaj BS, Nakamura T, Loening SA, Diamandis EP.
     Department of Urology, University Hospital Charité, Humboldt University, Berlin, Germany
     Quantitative analysis of kallikrein 15 gene expression in prostate tissue
     Journal of Urology 2003 Jan;169(1):361-4. [PMID 12478190 113 KB, Related Articles] [ISI 000179921200118, cited 29 times]
445. Sotiropoulou G, Rogakos V, Tsetsenis T, Pampalakis G, Zafiropoulos N, Simillides G, Yiotakis A, Diamandis EP. <sotiro@upatras.gr>
     Department of Pharmacy, School of Health Sciences, University of Patras, Rion, 26500 Patras, Greece. G
     Emerging interest in the kallikrein gene family for understanding and diagnosing cancer [review]
     Oncology Research 2003;13(6-10):381-91. [PMID 12725528 3 MB, Related Articles] [ISI 000182358200013, cited 19 times]
446. Petraki CD, Gregorakis AK, Papanastasiou PA, Karavana VN, Luo LY, Diamandis EP.
     Departments of Pathology and Urology, Evangelismos Hospital, Athens, Greece
     Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues
     Prostate Cancer and Prostatic Diseases 2003;6(3):223-7. [PMID 12970725 220 KB, Related Articles] [ISI 000185506100008, cited 13 times]

2002

447. Yousef GM, Scorilas A, Magklara A, Memari N, Ponzone R, Sismondi P, Biglia N, Abd Ellatif M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
     British Journal of Cancer 2002 Nov 18;87(11):1294-300. [PMID 12439720 155 KB, Related Articles] [ISI 000179819900017, cited 20 times]
448. Yousef GM, Borgoño CA, Scorilas A, Ponzone R, Biglia N, Iskander L, Polymeris ME, Roagna R, Sismondi P, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
     British Journal of Cancer 2002 Nov 18;87(11):1287-93. [PMID 12439719 111 KB, Related Articles] [ISI 000179819900016, cited 24 times]
449. Katsaros D, Fracchioli S, Stenman UH, Van Der Zee AGJ, Vergote I, Diamandis EP.
     The diagnostic and prognostic value of two novel serum biomarkers, human kallikrein 6 (hK6) and 10 (hK10), in epithelial ovarian cancer [proceedings paper]
     9th Biennial Meeting of the Internationl Gynecologic Cancer Society 2002;103-111 [ISI 000179395500023]
450. Brauer PM, McKeown-Eyssen GE, Jazmaji V, Logan AG, Andrews DF, Jenkins D, Marcon N, Saibil F, Cohen L, Stern H, Baron D, Greenberg G, Diamandis E, Kakis G, Singer W, Steiner G. <pbrauer@uoguelph.ca>
     Department of Public Health Sciences, University of Toronto, Ontario, Canada
     Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia
     American Journal of Epidemiology 2002 Oct 15;156(8):702-13. [PMID 12370158 176 KB, Related Articles] [ISI 000178652900003, cited 4 times]
451. Yousef GM, Obiezu CV, Jung K, Stephan C, Scorilas A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues
     Urology 2002 Oct;60(4):714-8. [PMID 12385949 117 KB, Related Articles] [ISI 000178578700035, cited 31 times]
452. Rosenberg Zand RS, Jenkins DJ, Diamandis EP. <rzand@hnrc.tufts.edu>
     Department of Nutritional Sciences, University of Toronto, Toronto, Canada
     Flavonoids and steroid hormone-dependent cancers [review, 151 refs]
     Journal of Chromatography B-Analytical Technologies in the Biomedical And Life Sciences 2002 Sep 25;777(1-2):219-32. [PMID 12270215 380 KB, Related Articles] [ISI 000178936300020, cited 12 times]
453. Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada
     Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
     British Journal of Cancer 2002 Sep 23;87(7):763-71. [PMID 12232761 317 KB, Related Articles] [ISI 000178583900015, cited 37 times]
454. Petraki CD, Karavana VN, Luo LY, Diamandis EP.
     Department of Pathology, Evangelismos Hospital, Athens, Greece
     Human kallikrein 10 expression in normal tissues by immunohistochemistry
     Journal of Histochemistry & Cytochemistry 2002 Sep;50(9):1247-61. [PMID 12185203 1.2 MB, Related Articles] [ISI 000177967500012, cited 21 times]
455. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital Toronto, Ontario, Canada
     Kallikreins, steroid hormones and ovarian cancer: is there a link? [review, 101 refs]
     Minerva Endocrinol 2002 Sep;27(3):157-66. [PMID 12091791 1.6 MB, Related Articles]
456. Sauter ER, Welch T, Magklara A, Klein G, Diamandis EP. <SauterE@health.missouri.edu>
     Department of Surgery, Thomas Jefferson University, 1025 Walnut Street, Suite 605, Philadelphia, PA 19107, USA
     Ethnic variation in kallikrein expression in nipple aspirate fluid
     International Journal of Cancer 2002 Aug 20;100(6):678-82. [PMID 12209605 295 KB, Related Articles] [ISI 000177211900008, cited 6 times]
457. Magklara A, Brown TJ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3
     International Journal of Cancer 2002 Aug 10;100(5):507-14. [PMID 12124798 298 KB, Related Articles] [ISI 000177086700002, cited 20 times]
458. Diamandis EP, Bruns DE.
     Cancer diagnostics: Discovery and clinical applications - Introduction [editorial]
     Clinical Chemistry 2002 Aug;48(8):1145-1146 [ISI 000176996500001 35 KB, cited 3 times]
459. Stephan C, Cammann H, Semjonow A, Diamandis EP, Wymenga LF, Lein M, Sinha P, Loening SA, Jung K. <Carsten.Stephan@charite.de>
     Department of Urology, University Hospital Charité, Humboldt University, D-10098 Berlin, Germany
     Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies
     Clinical Chemistry 2002 Aug;48(8):1279-87. [PMID 12142385 214 KB, Related Articles] [ISI 000176996500021, cited 57 times]
460. Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave., Toronto, Ontario, M5G 1X5 Canada
     Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer
     Clinical Chemistry 2002 Aug;48(8):1241-50. [PMID 12142380 287 KB, Related Articles] [ISI 000176996500016, cited 47 times]
461. Obiezu CV, Soosaipillai A, Jung K, Stephan C, Scorilas A, Howarth DH, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave., Toronto, Ontario, M5G 1X5 Canada
     Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry
     Clinical Chemistry 2002 Aug;48(8):1232-40. [PMID 12142379 270 KB, Related Articles] [ISI 000176996500015, cited 43 times]
462. Diamandis EP, Yousef GM. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Human tissue kallikreins: a family of new cancer biomarkers [review, 84 refs]
     Clinical Chemistry 2002 Aug;48(8):1198-205. [PMID 12142373 138 KB, Related Articles] [ISI 000176996500009, cited 114 times]
463. Luo LY, Herrera I, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada
     Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library
     British Journal of Cancer 2002 Jul 29;87(3):339-43. [PMID 12177805 107 KB, Related Articles] [ISI 000177435600016, cited 31 times]
464. Mahmoud AA, Yousef GM, Al-Hifzi I, Diamandis EP. <AMahmoud2000@hotmail.com>
     Division of Neurology, Hospital For Sick Children, Toronto, Ontario, Canada
     Cockayne syndrome in three sisters with varying clinical presentation
     American Journal of Medical Genetics 2002 Jul 22;111(1):81-5. [PMID 12124741 151 KB, Related Articles] [ISI 000176822200016, cited 6 times]
465. Diamandis EP.
     Proteomic patterns in serum and identification of ovarian cancer [comment]
     Lancet 2002 Jul 13;360(9327):170; author reply 170-1. [PMID 12126845 52 KB, Related Articles] [ISI 000176839100033, cited 46 times]
     Comment on -- Lancet. 2002 Feb 16;359(9306):572-7. [PMID 11867112 184 KB, Related Articles]
466. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Human tissue kallikreins: a new enzymatic cascade pathway? [review, 144 refs]
     Biological Chemistry 2002 Jul-Aug;383(7-8):1045-57. [PMID 12437087 106 KB, Related Articles] [ISI 000177737800004, cited 65 times]
467. Luo LY, Diamandis EP, Look MP, Soosaipillai AP, Foekens JA.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada
     Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
     British Journal of Cancer 2002 Jun 5;86(11):1790-6. [PMID 12087468 104 KB, Related Articles] [ISI 000176522200022, cited 25 times]
468. Petraki CD, Karavana VN, Revelos KI, Luo LY, Diamandis EP.
     Department of Pathology, Evangelismos Hospital, Athens, Greece
     Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets
     Histochemical Journal 2002 Jun-Jul;34(6-7):313-22. [PMID 12769263 779 KB, Related Articles] [ISI 000182132300007, cited 11 times]
469. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, Sotiropoulou G, Diamandis EP, Hudson TJ, White JH.
     Department of Physiology, McGill University, Montréal, Québec H3G 1Y6, Canada
     Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation
     Molecular Endocrinology 2002 Jun;16(6):1243-56. [PMID 12040012 827 KB, Related Articles] [ISI 000175897500011, cited 62 times]
470. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Duties and responsibilities of laboratory scientists [review]
     Clinica Chimica Acta 2002 May 21;319(2):111-5. [PMID 11955487 76 KB, Related Articles] [ISI 000175627200005]
471. Chang A, Yousef GM, Scorilas A, Grass L, Sismondi P, Ponzone R, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
     Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer
     British Journal of Cancer 2002 May 6;86(9):1457-64. [PMID 11986781 148 KB, Related Articles] [ISI 000176032500017, cited 30 times]
472. Zarghooni M, Soosaipillai A, Grass L, Scorilas A, Mirazimi N, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients
     Clinical Biochemistry 2002 May;35(3):225-31. [PMID 12074831 83 KB, Related Articles] [ISI 000176492200010, cited 18 times]
473. Scorilas A, Levesque MA, Ashworth LK, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ont. M5G 1X5, Canada
     Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene
     (GenBank: AF289221)
     Gene 2002 May 1;289(1-2):191-9. [PMID 12036598 835 KB, Related Articles] [ISI 000177867000022, cited twice]
474. Yousef GM, Scorilas A, Chang A, Rendl L, Diamandis M, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
     Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
     Prostate 2002 May 1;51(2):126-32. [PMID 11948967 142 KB, Related Articles] [ISI 000175357100006, cited 31 times]
475. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont, Canada
     Expanded human tissue kallikrein family--a novel panel of cancer biomarkers [review, 56 refs]
     Tumor Biology 2002 May-Jun;23(3):185-92. [PMID 12218299 75 KB, Related Articles] [ISI 000178175700009, cited 51 times]
476. Bharaj BB, Luo LY, Jung K, Stephan C, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers
     Prostate 2002 Apr 1;51(1):35-41. [PMID 11920956 207 KB, Related Articles] [ISI 000174829700005, cited 20 times]
477. Yousef GM, Ordon MH, Foussias G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, Canada M5G 1X5
     Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes
     (GenBank: AY040541, AY040542, AY040543, AY040544, AY040545)
     Gene 2002 Mar 20;286(2):259-70. [PMID 11943481 860 KB, Related Articles] [ISI 000175231600010, cited 17 times]
478. Soleas GJ, Grass L, Josephy PD, Goldberg DM, Diamandis EP.
     Quality Assurance Department, Liquor Control Board of Ontario, 55 Lakeshore Blvd. E., Toronto, Ontario M5E 1A4, Canada
     A comparison of the anticarcinogenic properties of four red wine polyphenols
     Clinical Biochemistry 2002 Mar;35(2):119-24. [PMID 11983346 108 KB, Related Articles] [ISI 000175495600006, cited 65 times]
     Reprint in -- Clin Biochem. 2006 May;39(5):492-7. [PMID 16783880 129 KB, Related Articles]
479. Rosenberg Zand RS, Jenkins DJ, Brown TJ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Flavonoids can block PSA production by breast and prostate cancer cell lines
     Clinica Chimica Acta 2002 Mar;317(1-2):17-26. [PMID 11814454 239 KB, Related Articles] [ISI 000173895900002, cited 18 times]
480. Sauter ER, Tichansky DS, Chervoneva I, Diamandis EP. <SauterE@health.missouri.edu>
     Department of Surgery, Thomas Jefferson University Hospital, 1025 Walnut Street, Suite 605, Philadelphia, PA 19107, USA
     Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer
     Environmental Health Perspectives 2002 Mar;110(3):241-6. [PMID 11882474 1.5 MB, Related Articles] [ISI 000174311300022, cited 15 times]
481. Sauter ER, Chervoneva I, Diamandis A, Khosravi JM, Litwin S, Diamandis EP. <SauterE@health.missouri.edu>
     Department of Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA
     Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer
     Cancer Detection and Prevention 2002;26(2):149-57. [PMID 12102150 122 KB, Related Articles] [ISI 000177139200008, cited 17 times]
482. Diamandis EP, Okui A, Mitsui S, Luo LY, Soosaipillai A, Grass L, Nakamura T, Howarth DJ, Yamaguchi N. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma
     Cancer Research 2002 Jan 1;62(1):295-300. [PMID 11782391 264 KB, Related Articles] [ISI 000173382600045, cited 111 times]
483. Stephan C, Jung K, Diamandis EP, Rittenhouse HG, Lein M, Loening SA.
     Department of Urology, University Hospital Charité, Humboldt University Berlin, Berlin, Germany
     Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer [review, 60 refs]
     Urology 2002 Jan;59(1):2-8. [PMID 11796270 129 KB, Related Articles] [ISI 000173362900002, cited 46 times]

2001

484. Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker
     Cancer Research 2001 Nov 1;61(21):7811-8. [PMID 11691797 551 KB, Related Articles] [ISI 000172013500018, cited 64 times]
485. Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJ, Yousef GM, Diamandis EP.
     Department of Pathology, Evangelismos Hospital, Athens, Greece
     The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry
     Journal of Histochemistry & Cytochemistry 2001 Nov;49(11):1431-41. [PMID 11668196 826 KB, Related Articles] [ISI 000171788400011, cited 45 times]
486. Rosenberg Zand RS, Jenkins DJ, Diamandis EP.
     Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
     Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression
     Clinica Chimica Acta 2001 Oct;312(1-2):213-9. [PMID 11580929 100 KB, Related Articles] [ISI 000171781700026, cited 3 times]
487. Becker C, Noldus J, Diamandis E, Lilja H. <Charlotte.Becker@klkemi.mas.lu.se>
     Dept. of Clinical Chemistry, Lund University, Malmö University Hospital, Malmö, Sweden
     The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease [review, 277 refs]
     Critical Reviews in Clinical Laboratory Sciences 2001 Oct;38(5):357-99. [PMID 11720279 5.8 MB, Related Articles] [ISI 000171985500001, cited 11 times]
488. Chang A, Yousef GM, Jung K, Rajpert-De Meyts E, Diamandis EP.
     Department of Pathology and Laboratoty Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer
     Anticancer Research 2001 Sep-Oct;21(5):3147-52. [PMID 11848466 1.8 MB, Related Articles] [ISI 000173740400002, cited 27 times]
489. Shimizu-Okabe C, Yousef GM, Diamandis EP, Yoshida S, Shiosaka S, Fahnestock M.
     Department of Psychiatry and Behavioral Neurosciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada
     Expression of the kallikrein gene family in normal and Alzheimer's disease brain
     Neuroreport 2001 Aug 28;12(12):2747-51. [PMID 11522960 381 KB, Related Articles] [ISI 000170600500031, cited 23 times]
490. Yousef GM, Bharaj BS, Yu H, Poulopoulos J, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element
     Biochemical and Biophysical Research Communications 2001 Aug 3;285(5):1321-9. [PMID 11478802 429 KB, Related Articles] [ISI 000170300900040, cited 8 times]
491. Sidiropoulos M, Chang A, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer
     British Journal of Cancer 2001 Aug 3;85(3):393-7. [PMID 11487271 95 KB, Related Articles] [ISI 000170368700015, cited 9 times]
492. Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients
     Clinical Cancer Research 2001 Aug;7(8):2380-6. [PMID 11489816 97 KB, Related Articles] [ISI 000170328300029, cited 68 times]
493. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Piccinno R, Rigault de la Longrais IA, Howarth DJ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma
     Clinical Cancer Research 2001 Aug;7(8):2372-9. [PMID 11489815 406 KB, Related Articles] [ISI 000170328300028, cited 67 times]
494. Luo LY, Rajpert-De Meyts ER, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada
     Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
     British Journal of Cancer 2001 Jul 20;85(2):220-4. [PMID 11461080 157 KB, Related Articles] [ISI 000170152500014, cited 46 times]
495. Scorilas A, Kyriakopoulou L, Katsaros D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer
     British Journal of Cancer 2001 Jul 20;85(2):190-8. [PMID 11461075 301 KB, Related Articles] [ISI 000170152500009, cited 12 times]
496. Scorilas A, Yousef GM, Jung K, Rajpert-De Meyts E, Carsten S, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors
     (GenBank: AF200923)
     Biochemical and Biophysical Research Communications 2001 Jul 13;285(2):400-8. [PMID 11444856 292 KB, Related Articles] [ISI 000170020900037, cited 7 times]
497. Soleas GJ, Goldberg DM, Grass L, Levesque M, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Do wine polyphenols modulate p53 gene expression in human cancer cell lines?
     Clinical Biochemistry 2001 Jul;34(5):415-20. [PMID 11522280 163 KB, Related Articles] [ISI 000170931000012, cited 18 times]
498. Diamandis EP, Yousef GM. <EDiamandis@mtsinai.on.ca>
     Dept. of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
     Human tissue kallikrein gene family: a rich source of novel disease biomarkers [review, 59 refs]
     Expert Rev Mol Diagn 2001 Jul;1(2):182-90. [PMID 11901813 1.3 MB, Related Articles]
499. Yousef GM, Ordon MH, Foussias G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants
     (GenBank: AY029277)
     Biochemical and Biophysical Research Communications 2001 Jun 22;284(4):900-10. [PMID 11409878 357 KB, Related Articles] [ISI 000169568200006, cited 11 times]
500. Foussias G, Taylor SM, Yousef GM, Tropak MB, Ordon MH, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs
     (GenBank: AF277806)
     Biochemical and Biophysical Research Communications 2001 Jun 22;284(4):887-99. [PMID 11409877 376 KB, Related Articles] [ISI 000169568200005, cited 7 times]
501. Yousef GM, Diamandis M, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis
     (GenBank: AF321918)
     Genomics 2001 Jun 15;74(3):385-95. [PMID 11414767 303 KB, Related Articles] [ISI 000169671100015, cited 17 times]

2000

502. Katsaros D, Obiezu CV, Fracchioli S, Yousef GM, Diamandis EP, Massobrio M.
     First evidence of kallikrein-like gene 1 (KLK-L1/prostase KLK4) presence in ovarian cancer: Biological and clinical implications [proceedings paper]
     Gynecologic Oncology Issues in the 8th Igcs Meeting of Buenos Aires 2000;73-81 [ISI 000171689500011]

2001

503. Sauter ER, Diamandis EP.
     Prostate-specific antigen levels in nipple aspirate fluid [comment]
     Journal of Clinical Oncology 2001 Jun 15;19(12):3160. [PMID 11408517 71 KB, Related Articles] [ISI 000169303900031, cited twice]
     Comment on -- J Clin Oncol. 2001 Mar 1;19(5):1462-7. [PMID 11230492 140 KB, Related Articles]
504. Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies
     Cancer Research 2001 Apr 15;61(8):3425-31. [PMID 11309303 433 KB, Related Articles] [ISI 000168215000034, cited 59 times]
505. Magklara A, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Danese S, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, M5G 1X5 Canada
     The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer
     Clinical Cancer Research 2001 Apr;7(4):806-11. [PMID 11309326 91 KB, Related Articles] [ISI 000168297800008, cited 80 times]
506. Luo LY, Bunting P, Scorilas A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5
     Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
     Clinica Chimica Acta 2001 Apr;306(1-2):111-8. [PMID 11282101 271 KB, Related Articles] [ISI 000168137600013, cited 73 times]
507. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5
     The new human tissue kallikrein gene family: structure, function, and association to disease [review, 251 refs]
     Endocrine Reviews 2001 Apr;22(2):184-204. [PMID 11294823 839 KB, Related Articles] [ISI 000168099300002, cited 300 times]
508. Obiezu CV, Scorilas A, Magklara A, Thornton MH, Wang CY, Stanczyk FZ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada M5G 1X5
     Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome
     Journal of Clinical Endocrinology and Metabolism 2001 Apr;86(4):1558-61. [PMID 11297583 135 KB, Related Articles] [ISI 000168243000020, cited 12 times]
509. Scorilas A, Bharaj B, Giai M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer
     British Journal of Cancer 2001 Mar 23;84(6):760-7. [PMID 11259089 212 KB, Related Articles] [ISI 000167784400005, cited 14 times]
510. Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, Toronto, M5G 1X5, Canada
     Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
     British Journal of Cancer 2001 Mar 2;84(5):643-50. [PMID 11237385 91 KB, Related Articles] [ISI 000167490900010, cited 83 times]
511. Bulmer B, Ward G, Diamandis E, Nicol D, Clements J.
     Prostaglandin D synthase does not produce prostate-specific antigen cross-reactivity in renal cell carcinoma [letter]
     Clinical Chemistry 2001 Mar;47(3):607-8. [PMID 11238325 129 KB, Related Articles] [ISI 000167347700041, cited once]
512. Diamandis EP.
     Signal amplification in time-resolved fluorometry [editorial]
     Clinical Chemistry 2001 Mar;47(3):380-1. [PMID 11238286 106 KB, Related Articles] [ISI 000167347700002, cited twice]
     Comment on -- Clin Chem. 2001 Mar;47(3):561-8. [PMID 11238312 737 KB, Related Articles]
513. Katsaros D, Yu H, Levesque MA, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi MJ, Diamandi A, Gordini G, Diamandis EP, Massobrio M.
     Department of Obstetrics and Gynecology, Gynecologic Oncology and Breast Cancer Unit, University of Turin, Turin, Italy
     IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival
     European Journal of Cancer 2001 Mar;37(4):478-85. [PMID 11267857 128 KB, Related Articles] [ISI 000167739600017, cited 23 times]
514. Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family
     (GenBank: AF289220)
     Genomics 2001 Mar 1;72(2):217-21. [PMID 11401436 177 KB, Related Articles] [ISI 000167850100013, cited 29 times]
515. Yu H, Nicar MR, Shi R, Berkel HJ, Nam R, Trachtenberg J, Diamandis EP.
     Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71104, USA
     Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence
     Urology 2001 Mar;57(3):471-5. [PMID 11248622 130 KB, Related Articles] [ISI 000167553200018, cited 20 times]
516. Luo LY, Grass L, Howarth DJ, Thibault P, Ong H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues
     Clinical Chemistry 2001 Feb;47(2):237-46. [PMID 11159772 491 KB, Related Articles] [ISI 000166805700011, cited 64 times]
517. Luo LY, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Molecular cloning of a novel human gene on chromosome 4p11 by immunoscreening of an ovarian carcinoma cDNA library
     Biochemical and Biophysical Research Communications 2001 Jan 12;280(1):401-6. [PMID 11162530 201 KB, Related Articles] [ISI 000166404700064, cited 4 times]
518. Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer
     (GenBank: AF242195)
     Journal of Biological Chemistry 2001 Jan 5;276(1):53-61. [PMID 11010966 646 KB, Related Articles] [ISI 000166280700009, cited 73 times]
519. Soleas GJ, Diamandis EP, Goldberg DM.
     Quality Assurance, Liquor Control Board of Ontario, Toronto, Canada
     The world of resveratrol [review, 91 refs]
     Advances in Experimental Medicine and Biology: Nutrition and Cancer Prevention - New Insights Into t 2001;492:159-82. [PMID 11480664 3.6 MB, Related Articles] [ISI 000171156300013, cited 35 times]
520. Soleas GJ, Angelini M, Grass L, Diamandis EP, Goldberg DM.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
     Absorption of trans-resveratrol in rats
     Methods in Enzymology: Flavonoids and Other Polyphenols 2001;335:145-54. [PMID 11400363 1 MB, Related Articles] [ISI 000170554800013, cited 40 times]

2000

521. Bjartell A, Paju A, Stenman UH, Väisänen V, Aumüller G, Diamandis E, Becker C, Lilja H.
     Department of Urology, Malmö University Hospital, Sweden
     Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues
     Prostate Cancer Prostatic Dis 2000 Dec;3(S1):S7. [PMID 12497117 40 KB, Related Articles]
522. Foussias G, Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene
     Biochemical and Biophysical Research Communications 2000 Nov 30;278(3):775-81. [PMID 11095983 175 KB, Related Articles] [ISI 000165701900044, cited 19 times]
523. Scorilas A, Black MH, Talieri M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene
     (GenBank: AF222689)
     Biochemical and Biophysical Research Communications 2000 Nov 19;278(2):349-59. [PMID 11097842 360 KB, Related Articles] [ISI 000165610700014, cited 23 times]
524. Diamandis EP, Yousef GM, Petraki C, Soosaipillai AR. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
     Human kallikrein 6 as a biomarker of alzheimer's disease
     Clinical Biochemistry 2000 Nov;33(8):663-7. [PMID 11166014 176 KB, Related Articles] [ISI 000166882400009, cited 42 times]
525. Diamandis EP, Yousef GM, Clements J, Ashworth LK, Yoshida S, Egelrud T, Nelson PS, Shiosaka S, Little S, Lilja H, Stenman UH, Rittenhouse HG, Wain H. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     New nomenclature for the human tissue kallikrein gene family
     Clinical Chemistry 2000 Nov;46(11):1855-8. [PMID 11067830 144 KB, Related Articles] [ISI 000165228700026, cited 122 times]
526. Yousef GM, Magklara A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer
     (GenBank: AF135025)
     Genomics 2000 Nov 1;69(3):331-41. [PMID 11056051 366 KB, Related Articles] [ISI 000165169500007, cited 44 times]
527. Luo LY, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
     Preliminary examination of time-resolved fluorometry for protein array applications
     Luminescence 2000 Nov-Dec;15(6):409-13. [PMID 11114118 171 KB, Related Articles] [ISI 000166269100012, cited 16 times]
528. Obiezu CV, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
     An alternatively spliced variant of KLK4 expressed in prostatic tissue
     (GenBank: AF135023; RefSeq: NM_004917)
     Clinical Biochemistry 2000 Oct;33(7):599-600. [PMID 11124349 103 KB, Related Articles] [ISI 000166009300014, cited 11 times]
529. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma
     Clinical Biochemistry 2000 Oct;33(7):579-83. [PMID 11124344 216 KB, Related Articles] [ISI 000166009300009, cited 98 times]
530. Diamandis EP.
     Sequencing with microarray technology--a powerful new tool for molecular diagnostics [editorial]
     Clinical Chemistry 2000 Oct;46(10):1523-5. [PMID 11017926 118 KB, Related Articles] [ISI 000089844100001, cited 13 times]
     Comment on -- Clin Chem. 2000 Oct;46(10):1555-61. [PMID 11017932 371 KB, Related Articles]
531. Magklara A, Cheung CC, Asa SL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Ontario, M5G 1X5, Toronto, Canada
     Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland
     Clinica Chimica Acta 2000 Oct;300(1-2):171-80. [PMID 10958873 254 KB, Related Articles] [ISI 000089169800016, cited 11 times]
532. Comay D, Cauch-Dudek K, Hemphill D, Diamandis E, Wanless I, Heathcote EJ.
     Department of Medicine, University of Toronto, Ontario, Canada
     Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?
     Digestive Diseases and Sciences 2000 Oct;45(10):2018-21. [PMID 11117577 51 KB, Related Articles] [ISI 000165435500020, cited 13 times]
533. Diamandis EP.
     Elevated serum prostate-specific antigen levels in a woman with metastatic breast cancer [letter]
     New England Journal of Medicine 2000 Sep 21;343(12):890-1. [PMID 11001696 131 KB, Related Articles] [ISI 000089355600026, cited 6 times]
534. Yousef GM, Chang A, Scorilas A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
     Biochemical and Biophysical Research Communications 2000 Sep 16;276(1):125-33. [PMID 11006094 129 KB, Related Articles] [ISI 000089388100023, cited 92 times]
535. Scorilas A, Bjartell A, Lilja H, Moller C, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
     Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays
     Clinical Chemistry 2000 Sep;46(9):1450-5. [PMID 10973889 521 KB, Related Articles] [ISI 000089182500034, cited 54 times]
536. Magklara A, Scorilas A, Stephan C, Kristiansen GO, Hauptmann S, Jung K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue
     Urology 2000 Sep 1;56(3):527-32. [PMID 10962338 197 KB, Related Articles] [ISI 000089092100038, cited 61 times]
537. Yousef GM, Scorilas A, Magklara A, Soosaipillai A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Ont. M5G 1X5, Toronto, Canada
     The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation
     (GenBank: AF166330)
     Gene 2000 Aug 22;254(1-2):119-28. [PMID 10974542 484 KB, Related Articles] [ISI 000089210100013, cited 43 times]
538. Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy
     Clinical Cancer Research 2000 Aug;6(8):3260-70. [PMID 10955812 155 KB, Related Articles] [ISI 000088753300044, cited 21 times]
539. Foussias G, Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Identification and molecular characterization of a novel member of the siglec family (SIGLEC9)
     (GenBank: AF135027)
     Genomics 2000 Jul 15;67(2):171-8. [PMID 10903842 160 KB, Related Articles] [ISI 000088474300007, cited 26 times]
540. Zand RS, Jenkins DJ, Diamandis EP.
     Department of Nutritional Sciences, University of Toronto, Ontario, Canada
     Steroid hormone activity of flavonoids and related compounds
     Breast Cancer Research and Treatment 2000 Jul;62(1):35-49. [PMID 10989984 168 KB, Related Articles] [ISI 000088220100003, cited 44 times]
541. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
     Clinical Biochemistry 2000 Jul;33(5):369-75. [PMID 11018688 166 KB, Related Articles] [ISI 000089776000006, cited 69 times]
542. Scorilas A, Diamandis EP.
     Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
     Polyvinylamine-streptavidin complexes labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications
     Clinical Biochemistry 2000 Jul;33(5):345-50. [PMID 11018685 278 KB, Related Articles] [ISI 000089776000003, cited 23 times]
543. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate-specific antigen: a cancer fighter and a valuable messenger? [review, 44 refs]
     Clinical Chemistry 2000 Jul;46(7):896-900. [PMID 10894830 187 KB, Related Articles] [ISI 000088256700002, cited 39 times]
544. Rosenberg Zand RS, Jenkins DJ, Diamandis EP.
     Genistein: a potent natural antiandrogen [letter]
     Clinical Chemistry 2000 Jun;46(6 Pt 1):887-8. [PMID 10839794 142 KB, Related Articles] [ISI 000087682500029, cited 9 times]
545. Obiezu CV, Giltay EJ, Magklara A, Scorilas A, Gooren LJ, Yu H, Howarth DJ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals
     Clinical Chemistry 2000 Jun;46(6 Pt 1):859-62. [PMID 10839777 166 KB, Related Articles] [ISI 000087682500012, cited 12 times]
546. Bharaj B, Scorilas A, Diamandis EP, Giai M, Levesque MA, Sutherland DJ, Hoffman BR.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada
     Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter
     Breast Cancer Research and Treatment 2000 May;61(2):111-9. [PMID 10942096 75 KB, Related Articles] [ISI 000087908200002, cited 15 times]
547. Yousef GM, Chang A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
     Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
     (GenBank: AF135024)
     Journal of Biological Chemistry 2000 Apr 21;275(16):11891-8. [PMID 10766816 315 KB, Related Articles] [ISI 000086695500051, cited 60 times]
548. Yousef GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)
     Genomics 2000 Apr 15;65(2):184-94. [PMID 10783266 259 KB, Related Articles] [ISI 000086972800012, cited 51 times]
549. Bharaj B, Scorilas A, Giai M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     TA repeat polymorphism of the 5alpha-reductase gene and breast cancer
     Cancer Epidemiology Biomarkers & Prevention 2000 Apr;9(4):387-93. [PMID 10794483 260 KB, Related Articles] [ISI 000086682500007, cited 17 times]
550. Obiezu CV, Yousef G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Identification of exon 1 of prostase/KLK-L1 gene
     Clinical Biochemistry 2000 Apr;33(3):221-2. [PMID 10913523 148 KB, Related Articles] [ISI 000088342000012, cited 4 times]
551. Jenkins DJ, Kendall CW, Garsetti M, Rosenberg-Zand RS, Jackson CJ, Agarwal S, Rao AV, Diamandis EP, Parker T, Faulkner D, Vuksan V, Vidgen E.
     Clinical Nutrition and Risk Factor Modification Center, St. Michael's Hospital, Toronto, Ontario, Canada
     Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity--a controlled crossover trial
     Metabolism-Clinical and Experimental 2000 Apr;49(4):537-43. [PMID 10778882 1.1 MB, Related Articles] [ISI 000086444800022, cited 50 times]
552. Luo LY, Grass L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474
     Anticancer Research 2000 Mar-Apr;20(2A):981-6. [PMID 10810385 1.5 MB, Related Articles] [ISI 000086764700051, cited 20 times]
553. Rosenberg Zand RS, Grass L, Magklara A, Jenkins DJ, Diamandis EP.
     Department of Nutritional Sciences, University of Toronto, Mount Sinai Hospital, Ontario, Canada
     Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
     Breast Cancer Research and Treatment 2000 Mar;60(1):1-8. [PMID 10845803 74 KB, Related Articles] [ISI 000086619700001, cited 3 times]
554. Vassilikos EJ, Yu H, Trachtenberg J, Nam RK, Narod SA, Bromberg IL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up
     Clinical Biochemistry 2000 Mar;33(2):115-23. [PMID 10751589 158 KB, Related Articles] [ISI 000086461900006, cited 13 times]
555. Nam RK, Diamandis EP, Toi A, Trachtenberg J, Magklara A, Scorilas A, Papnastasiou PA, Jewett MA, Narod SA.
     Division of Urology, Department of Diagnostic Imaging, Princess Margaret Hospital, University Health Network, University of Toronto, Ontario, Canada
     Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen
     Journal of Clinical Oncology 2000 Mar;18(5):1036-42. [PMID 10694554 62 KB, Related Articles] [ISI 000085586000013, cited 49 times]
556. Obiezu CV, Giltay EJ, Magklara A, Scorilas A, Gooren L, Yu H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada
     Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals
     Journal of Urology 2000 Mar;163(3):802-5. [PMID 10687981 196 KB, Related Articles] [ISI 000085250300029, cited 12 times]
557. Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     The new human kallikrein gene family: implications in carcinogenesis [review, 48 refs]
     Trends in Endocrinology and Metabolism 2000 Mar;11(2):54-60. [PMID 10675891 180 KB, Related Articles] [ISI 000085476800003, cited 174 times]
558. Scorilas A, Yu H, Soosaipillai AR, Gregorakis AK, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Canada
     Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy
     Clinica Chimica Acta 2000 Feb 25;292(1-2):127-38. [PMID 10686282 141 KB, Related Articles] [ISI 000085779200011, cited 11 times]
559. Magklara A, Grass L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and University of Toronto, Ontario, Canada
     Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines
     Breast Cancer Research and Treatment 2000 Feb;59(3):263-70. [PMID 10832596 116 KB, Related Articles] [ISI 000086514600007, cited 37 times]
560. Angelopoulou K, Yu H, Bharaj B, Giai M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer
     Clinical Biochemistry 2000 Feb;33(1):53-62. [PMID 10693987 444 KB, Related Articles] [ISI 000085320500008, cited 17 times]
561. Black MH, Giai M, Ponzone R, Sismondi P, Yu H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Serum total and free prostate-specific antigen for breast cancer diagnosis in women
     Clinical Cancer Research 2000 Feb;6(2):467-73. [PMID 10690525 58 KB, Related Articles] [ISI 000085502600021, cited 27 times]
562. Black MH, Magklara A, Obiezu C, Levesque MA, Sutherland DJ, Tindall DJ, Young CY, Sauter ER, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
     British Journal of Cancer 2000 Jan;82(2):361-7. [PMID 10646889 89 KB, Related Articles] [ISI 000084777000017, cited 39 times]
563. Yu H, Bharaj B, Vassilikos EJ, Giai M, Diamandis EP.
     Louisiana State University Medical Centre, Department of Medicine, Shreveport, USA
     Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
     Breast Cancer Research and Treatment 2000 Jan;59(2):153-61. [PMID 10817350 61 KB, Related Articles] [ISI 000085975000006, cited 64 times]
564. Black MH, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast [review, 146 refs]
     Breast Cancer Research and Treatment 2000 Jan;59(1):1-14. [PMID 10752675 110 KB, Related Articles] [ISI 000085546400001, cited 47 times]
565. Yousef GM, Scorilas A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family
     Genomics 2000 Jan 1;63(1):88-96. [PMID 10662548 217 KB, Related Articles] [ISI 000085432100011, cited 48 times]

1999

566. Katsaros D, Levesque MA, Genta F, Durando A, Bellino R, Richiardi G, Fracchioli S, Diamandis EP, Massobrio M.
     Dose-response effect between p53 concentrations, survival and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy [proceedings paper]
     7th Biennial Meeting of the International Gynecologic Cancer Society 1999;225-229 [ISI 000083638300040]

2000

567. Levesque MA, D'Costa M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     p21WAF1 protein expression determined by quantitative immunoassay in relation to non-small-cell lung cancer aggressiveness
     Journal of Cancer Research and Clinical Oncology 2000 Jan;126(1):48-52. [PMID 10641749 148 KB, Related Articles] [ISI 000084269900007]

1999

568. Yousef GM, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto M5G 1X5, Toronto, Ontario M5G 1L5, Canada
     The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation
     (GenBank: AF135028)
     Journal of Biological Chemistry 1999 Dec 31;274(53):37511-6. [PMID 10608802 404 KB, Related Articles] [ISI 000084528000002, cited 71 times]
569. Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF.
     Division of Population Sciences, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
     Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size
     British Journal of Cancer 1999 Dec;81(7):1222-7. [PMID 10584885 79 KB, Related Articles] [ISI 000083774900020, cited 26 times]
570. Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
     Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease
     (GenBank: AF149289, AZ081611, AZ081612)
     Genomics 1999 Dec 1;62(2):251-9. [PMID 10610719 224 KB, Related Articles] [ISI 000084825100016, cited 68 times]
571. Diamandis EP.
     Beta-trace protein as indicator of glomerular filtration rate - Reply [letter]
     Urology 1999 Nov;54(5):941 [ISI 000083536100043 62 KB]
572. Yu H, Diamandis EP, Hoffman B.
     Elevated estradiol and testosterone levels and risk for breast cancer [comment]
     Annals of Internal Medicine 1999 Nov 2;131(9):715. [PMID 10577342 45 KB, Related Articles] [ISI 000083446200020, cited 3 times]
     Comment on -- Ann Intern Med. 1999 Feb 16;130(4 Pt 1):270-7. [PMID 10068384 148 KB, Related Articles]
573. Magklara A, Scorilas A, Catalona WJ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
     The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
     Clinical Chemistry 1999 Nov;45(11):1960-6. [PMID 10545066 206 KB, Related Articles] [ISI 000083440300011, cited 86 times]
574. Yu H, Levesque MA, Clark GM, Diamandis EP.
     Section of Cancer Prevention and Control, Feist-Weiller Cancer Center, Louisiana State University Medical Center, Shreveport 71130, USA
     Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
     British Journal of Cancer 1999 Oct;81(3):490-5. [PMID 10507775 83 KB, Related Articles] [ISI 000082809800017, cited 7 times]
575. Magklara A, Scorilas A, López-Otín C, Vizoso F, Ruibal A, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. Canada M5G 1L5
     Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid
     Clinical Chemistry 1999 Oct;45(10):1774-80. [PMID 10508124 204 KB, Related Articles] [ISI 000083038200011, cited 25 times]
576. Angelopoulou K, Borchert G, Melegos DN, Lianidou E, Lilja H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Characterization of the BRCA1-like immunoreactivity of human seminal plasma
     Urology 1999 Oct;54(4):753-62. [PMID 10510943 344 KB, Related Articles] [ISI 000082792700038, cited once]
577. Yousef GM, Obiezu CV, Luo LY, Black MH, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated
     (GenBank: AF113140, AF113141, AF135023)
     Cancer Research 1999 Sep 1;59(17):4252-6. [PMID 10485467 580 KB, Related Articles] [ISI 000082380200023, cited 96 times]
578. Yousef GM, Luo LY, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4
     Anticancer Research 1999 Jul-Aug;19(4B):2843-52. [PMID 10652563 1.1 MB, Related Articles] [ISI 000084768100004, cited 48 times]
579. Bharaj BS, Vassilikos EJ, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis
     Clinical Biochemistry 1999 Jul;32(5):327-32. [PMID 10480446 386 KB, Related Articles] [ISI 000082175500003, cited 24 times]
580. Scorilas A, Diamandis EP, Levesque MA, Papanastasiou-Diamandi A, Khosravi MJ, Giai M, Ponzone R, Roagna R, Sismondi P, López-Otin C.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients
     Clinical Cancer Research 1999 Jul;5(7):1778-85. [PMID 10430082 96 KB, Related Articles] [ISI 000081514600026, cited 23 times]
581. Wald NJ, Hackshaw AK, Diamandis EP, Melegos DN. <N.J.Wald@mds.qmw.ac.uk>
     Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St. Bartholomews and the Royal London School of Medicine and Dentistry, Charterhouse Square, London, EC1M 6BQ, U.K
     Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. International Prenatal Screening Research Group
     Prenatal Diagnosis 1999 Jul;19(7):674-6. [PMID 10419619 117 KB, Related Articles] [ISI 000081794100015, cited 4 times]
582. Black MH, Magklara A, Obiezu CV, Melegos DN, Diamandis EP.
     Department of Pathology, Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
     Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen
     Clinical Chemistry 1999 Jun;45(6 Pt 1):790-9. [PMID 10351987 253 KB, Related Articles] [ISI 000080671400007, cited 51 times]
     Comment in -- Clin Chem. 1999 Jun;45(6 Pt 1):753-4. [PMID 10351981 112 KB, Related Articles]
583. Lianidous ES, Angelopoulou K, Katsaros D, Durando A, Massobrio M, Diamandis EP.
     Fragment analysis of the p53 gene in ovarian tumors (vol 31, pg 551, 1998) [correction]
     Clinical Biochemistry 1999 Mar;32(2):155 [ISI 000079248300012 33 KB]

1998

584. Griniatsos J, Diamandis E, Gioti J, Karyda I, Vassilopoulos PP, Agnanti N.
     Correlation of prostate specific antigen immunoreactivity (IR-PSA) to other prognostic factors in female breast cancer
     Anticancer Research 1998 Jan-Feb;18(1B):683-688 [ISI 000072955700033 1.2 MB, cited 5 times]

1999

585. Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC.
     Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Ontario, Canada
     Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial
     American Journal of Clinical Nutrition 1999 Mar;69(3):395-402. [PMID 10075322 93 KB, Related Articles] [ISI 000078832700009, cited 69 times]
586. Majumdar S, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines
     British Journal of Cancer 1999 Mar;79(9-10):1594-602. [PMID 10188912 235 KB, Related Articles] [ISI 000079121100042, cited 23 times]
587. Black MH, Grass CL, Leinonen J, Stenman UH, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5
     Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays
     Clinical Chemistry 1999 Mar;45(3):347-54. [PMID 10053035 259 KB, Related Articles] [ISI 000078979100005, cited 19 times]
588. Diamandis EP, Arnett WP, Foussias G, Pappas H, Ghandi S, Melegos DN, Mullen B, Yu H, Srigley J, Jarvi K.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada
     Seminal plasma biochemical markers and their association with semen analysis findings
     Urology 1999 Mar;53(3):596-603. [PMID 10096390 491 KB, Related Articles] [ISI 000079193000028, cited 17 times]
589. Diamandis EP, Helle SI, Yu H, Melegos DN, Lundgren S, Lonning PE.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma
     Cancer 1999 Feb 15;85(4):891-8. [PMID 10091767 114 KB, Related Articles] [ISI 000078552700017, cited 14 times]
590. Foekens JA, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WL, Klijn JG.
     Department of Medical Oncology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
     British Journal of Cancer 1999 Feb;79(5-6):888-94. [PMID 10070886 96 KB, Related Articles] [ISI 000078597600032, cited 21 times]
591. Borchert GH, Melegos DN, Yu H, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification
     Clinical Biochemistry 1999 Feb;32(1):39-44. [PMID 10074890 93 KB, Related Articles] [ISI 000078660600006, cited 4 times]
592. Lianidou ES, Levesque MA, Katsaros D, Angelopoulou K, Yu H, Genta F, Arisio R, Massobrio M, Bharaj B, Diamandis EP.
     Department of Chemistry, University of Athens, Greece
     Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma
     Anticancer Research 1999 Jan-Feb;19(1B):749-56. [PMID 10216487 1.3 MB, Related Articles] [ISI 000079786300021, cited 5 times]
593. Rosenberg Zand RS, Jenkins DJ, Diamandis EP.
     Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
     Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2
     Journal of Clinical Laboratory Analysis 1999;13(5):241-5. [PMID 10494134 73 KB, Related Articles] [ISI 000082855300009, cited twice]
594. Borchert GH, Yu H, Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease
     Journal of Clinical Laboratory Analysis 1999;13(2):75-81. [PMID 10102136 69 KB, Related Articles] [ISI 000078782400006, cited 12 times]
595. Luo LY, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer
     Journal of Clinical Laboratory Analysis 1999;13(2):69-74. [PMID 10102135 274 KB, Related Articles] [ISI 000078782400005cited once]
596. Melegos DN, Grass L, Pierratos A, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure
     Urology 1999 Jan;53(1):32-7. [PMID 9886584 131 KB, Related Articles] [ISI 000077739500006, cited 41 times]
     Comment in -- Urology. 1999 Nov;54(5):940-1. [PMID 10565766 118 KB, Related Articles]

1998

597. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP.
     Section of Cancer Prevention and Control, Feist-Weiller Cancer Center, Louisiana State University Medical Center, Shreveport, USA
     Insulin-like growth factor-binding protein-3 and breast cancer survival
     International Journal of Cancer 1998 Dec 18;79(6):624-8. [PMID 9842972 78 KB, Related Articles] [ISI 000077187500012, cited 34 times]
598. Angelopoulou K, Prody C, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     A candidate new gene on human chromosome 5q12 contains a motif that is found in transcriptional co-activators
     (GenBank: AF038385)
     Clinical Biochemistry 1998 Nov;31(8):687-8. [PMID 9876903 130 KB, Related Articles] [ISI 000077656800013]
599. Levesque MA, D'Costa M, Spratt EH, Yaman MM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value
     International Journal of Cancer 1998 Oct 23;79(5):494-501. [PMID 9761119 114 KB, Related Articles] [ISI 000076118200009, cited 14 times]
600. Lianidou ES, Angelopoulou K, Katsaros D, Durando A, Massobrio M, Diamandis EP, Massdario M.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Fragment analysis of the p53 gene in ovarian tumors
     Clinical Biochemistry 1998 Oct;31(7):551-3. [PMID 9812175 125 KB, Related Articles] [ISI 000076771400006, cited twice]
     Erratum in -- Clin Biochem 1999 Mar;32(2):155. [PMID 9812175 erratum 33 KB] -- Note: Massdario M [corrected to Massobrio M]
601. Rao PN, Wang Z, Cessac JW, Rosenberg RS, Jenkins DJ, Diamandis EP.
     Department of Organic Chemistry, Southwest Foundation for Biomedical Research, San Antonio, Texas 78245-0549, USA
     New 11 beta-aryl-substituted steroids exhibit both progestational and antiprogestational activity
     Steroids 1998 Oct;63(10):523-30. [PMID 9800283 611 KB, Related Articles] [ISI 000076425500005, cited 9 times]
602. Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
     Prostate-specific Antigen: Its Usefulness in Clinical Medicine
     Trends in Endocrinology and Metabolism 1998 Oct 1;9(8):310-6. [PMID 18406295 164 KB, Related Articles] [ISI 000076403500002, cited 88 times]
603. López-Otín C, Diamandis EP.
     Departamento de Bioquímica, Facultad de Medicina, Universidad de Oviedo, Spain
     Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features [review, 410 refs]
     Endocrine Reviews 1998 Aug;19(4):365-96. [PMID 9715372 444 KB, Related Articles] [ISI 000075390300001, cited 123 times]
604. Levesque MA, Yu H, Clark GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort
     Journal of Clinical Oncology 1998 Aug;16(8):2641-50. [PMID 9704714 1.6 MB, Related Articles] [ISI 000075215900010, cited 19 times]
605. Rosenberg RS, Grass L, Jenkins DJ, Kendall CW, Diamandis EP.
     Department of Nutritional Sciences, University of Toronto, Ontario, Canada
     Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines
     Biochemical and Biophysical Research Communications 1998 Jul 30;248(3):935-9. [PMID 9704030 85 KB, Related Articles] [ISI 000075396700087, cited 19 times]
606. Bharaj BS, Angelopoulou K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Rapid sequencing of the p53 gene with a new automated DNA sequencer
     Clinical Chemistry 1998 Jul;44(7):1397-403. [PMID 9665415 656 KB, Related Articles] [ISI 000074574200006, cited 12 times]
607. Diamandis EP.
     Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer [comment]
     Mayo Clinic Proceedings 1998 Jul;73(7):706-7. [PMID 9663206 79 KB, Related Articles] [ISI 000074598400021, cited twice]
     Comment on -- Mayo Clin Proc. 1997 Oct;72(10):932-4. [PMID 9379696 141 KB, Related Articles]
608. Luo L, Herbrick JA, Scherer SW, Beatty B, Squire J, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Structural characterization and mapping of the normal epithelial cell-specific 1 gene
     (GenBank: AF055481)
     Biochemical and Biophysical Research Communications 1998 Jun 29;247(3):580-6. [PMID 9647736 340 KB, Related Articles] [ISI 000074586700009, cited 47 times]
609. Katsaros D, Melegos DN, Diamandis EP.
     Department of Gynecologic Oncology, University of Turin, Italy
     Prostate specific antigen production by breast tumors after induction with oral contraceptives
     Clinical Biochemistry 1998 Jun;31(4):285-8. [PMID 9646955 130 KB, Related Articles] [ISI 000074301500013, cited 5 times]
610. Yu H, Levesque MA, Clark GM, Diamandis EP.
     Diagnostic Systems Laboratories Inc., Webster, Texas 77598-4217, USA
     Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study
     Clinical Cancer Research 1998 Jun;4(6):1489-97. [PMID 9626467 1.5 MB, Related Articles] [ISI 000074219700017, cited 64 times]
611. Diamandis EP.
     The female prostate - Response [letter]
     Journal of the National Cancer Institute 1998 May 6;90(9):713-714 [ISI 000073501400019 27 KB, cited twice]
612. Levesque MA, Katsaros D, Yu H, Giai M, Genta F, Roagna R, Ponzone R, Massobrio M, Sismondi P, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients
     International Journal of Cancer 1998 Apr 17;79(2):147-52. [PMID 9583729 93 KB, Related Articles] [ISI 000073402000009, cited 8 times]
613. Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis E. <SauterE@health.missouri.edu>
     Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 191
     Prostate-specific antigen production in the female breast: association with progesterone
     Cancer Epidemiology Biomarkers & Prevention 1998 Apr;7(4):315-20. [PMID 9568787 1 MB, Related Articles] [ISI 000073015500008, cited 25 times]
614. Kogan I, Ballinger JR, Redshaw R, Diamandis EP, Melegos DN, Kuba RM, Rauth AM.
     Department of Medical Biophysics, University of Toronto, Ontario, Canada
     Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice
     Breast Cancer Research and Treatment 1998 Mar;48(1):73-80. [PMID 9541191 318 KB, Related Articles] [ISI 000072340000008, cited 4 times]
615. Melegos DN, Diamandis EP.
     Is prostate-specific antigen present in female serum? [letter]
     Clinical Chemistry 1998 Mar;44(3):691-2. [PMID 9510891 306 KB, Related Articles] [ISI 000072357500046, cited 7 times]
616. Lambert-Messerlian GM, Canick JA, Melegos DN, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Women and Infants Hospital, Providence, RI 02905, USA
     Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome
     Clinical Chemistry 1998 Feb;44(2):205-8. [PMID 9474012 322 KB, Related Articles] [ISI 000071904100002, cited 6 times]
617. Angelopoulou K, Levesque MA, Katsaros D, Shipman R, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Exon 5 of the p53 gene is a target for deletions in ovarian cancer
     Clinical Chemistry 1998 Jan;44(1):72-7. [PMID 9550561 457 KB, Related Articles] [ISI 000071436000011, cited 8 times]
618. Angelopoulou K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors
     Journal of Clinical Laboratory Analysis 1998;12(4):250-6. [PMID 9671178 94 KB, Related Articles] [ISI 000074441300010, cited 7 times]
619. Randell E, Diamandis EP, Goldberg DM.
     Department of Clinical Biochemistry, University of Toronto, Ontario, Canada
     Changes in serum carbohydrate-deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males
     Journal of Clinical Laboratory Analysis 1998;12(2):92-7. [PMID 9524293 75 KB, Related Articles] [ISI 000072214600004, cited 14 times]
620. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ont., Canada
     Prostate-specific antigen or human kallikrein 3? Recent developments [comment]
     Tumor Biology 1998;19(2):65-7; discussion 67-8. [PMID 9486557 161 KB, Related Articles] [ISI 000072082900001, cited 4 times]
     Comment on -- Tumour Biol. 1997;18(2):123-34. [PMID 9222310, Related Articles]

1997

621. Soleas GJ, Diamandis EP, Karumanchiri A, Goldberg DM.
     A multiresidue derivatization gas chromatographic assay for fifteen phenolic constituents with mass selective detection
     Analytical Chemistry 1997 Nov 1;69(21):4405-4409 [ISI A1997YD67800022 122 KB, cited 47 times]
622. Soleas GJ, Tomlinson G, Diamandis EP, Goldberg DM.
     Relative contributions of polyphenolic constituents to the antioxidant status of wines: Development of a predictive model
     Journal of Agricultural and Food Chemistry 1997 Oct;45(10):3995-4003 [ISI A1997YB39700052 210 KB, cited 49 times]
623. Zarghami N, Grass L, Sauter ER, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate-specific antigen in serum during the menstrual cycle
     Clinical Chemistry 1997 Oct;43(10):1862-7. [PMID 9342005 184 KB, Related Articles] [ISI A1997YA35900010, cited 28 times]
624. Tsuyuki D, Grass L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer
     European Journal of Cancer 1997 Oct;33(11):1851-4. [PMID 9470845 362 KB, Related Articles] [ISI A1997YJ79100034, cited 10 times]
625. Degenhardt TP, Grass L, Reddy S, Thorpe SR, Diamandis EP, Baynes JW.
     Department of Chemistry and Biochemistry, University of South Carolina, Columbia, USA
     Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia
     Kidney International 1997 Oct;52(4):1064-7. [PMID 9328946 862 KB, Related Articles] [ISI A1997XY56400022, cited 77 times]
626. Zarghami N, Levesque M, D'Costa M, Angelopoulou K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Frequency of expression of prostate-specific antigen mRNA in lung tumors
     (GenBank: U90205)
     American Journal of Clinical Pathology 1997 Aug;108(2):184-90. [PMID 9260759 1.6 MB, Related Articles] [ISI A1997XP07000009, cited 20 times]
627. Diamandis EP, Nadkarni S, Bhaumik B, Abdelrahman A, Melegos DN, Borchert G, Black MH, Alonso M, Salas A, de los Toyos JR, Sampedro A, López-Otín C. <EDiamandis@mtsinai.on.ca>
     Department of Pathology, Mount Sinai Hospital
     Immunofluorometric assay of pepsinogen C and preliminary clinical applications
     Clinical Chemistry 1997 Aug;43(8 Pt 1):1365-71. [PMID 9267315 184 KB, Related Articles] [ISI A1997XP42500012, cited 14 times]
628. Diamandis EP.
     Clinical application of ultrasensitive prostate-specific antigen assays [comment]
     Journal of the National Cancer Institute 1997 Jul 16;89(14):1077-8. [PMID 9230891 38 KB, Related Articles] [ISI A1997XL16300019, cited twice]
     Comment on -- J Natl Cancer Inst. 1996 Nov 6;88(21):1594-5. [PMID 8901859, Related Articles]
629. Lianidou ES, Melegos DN, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     BRCA1 tumor suppressor gene product shares immunoreactive epitopes with a protein present in seminal plasma
     Clinical Biochemistry 1997 Jul;30(5):425-32. [PMID 9253520 736 KB, Related Articles] [ISI A1997XN01100007, cited 5 times]
630. Zarghami N, D'Costa M, Tsuyuki D, Asa SL, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, 600 University Avenue, Ontario, M5G 1X5 Canada
     Expression of the prostate specific antigen gene by lung tissue
     Clinical Cancer Research 1997 Jul;3(7):1201-6. [PMID 9815800 1.2 MB, Related Articles] [ISI A1997XH78400021, cited 9 times]
631. Melegos DN, Freedman MS, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders
     Prostaglandins 1997 Jul;54(1):463-74. [PMID 9271784 567 KB, Related Articles] [ISI A1997XR76400003, cited 34 times]
632. Soleas GJ, Goldberg DM, Ng E, Karumanchiri A, Tsang E, Diamandis EP.
     Comparative evaluation of four methods for assay of cis- and trans-resveratrol
     American Journal of Enology and Viticulture 1997;48(2):169-176 [ISI A1997XD35200007 1.4 MB, cited 29 times]
633. Melegos DN, Freedman MS, Diamandis EP.
     Prostate-specific antigen in cerebrospinal fluid [letter]
     Clinical Chemistry 1997 May;43(5):855. [PMID 9166248 195 KB, Related Articles] [ISI A1997WY18400033, cited 8 times]
     Comment in -- Clin Chem. 1998 Jun;44(6 Pt 1):1362-3. [PMID 9625072 247 KB, Related Articles]
634. Goldberg DM, Soleas GJ, Hahn SE, Diamandis EP, Karumanchiri A.
     Identification and assay of trihydroxystilbenes and their biological properties [proceedings paper]
     ACS Symposium Series: Wine - Nutritional and Therapeutic Benefits 1997;661:24-43 [ISI A1997BH57R00004 1.4 MB, cited 5 times]
635. Diamandis EP, Yu H.
     Department of Clinical Biochemistry, University of Toronto Faculty of Medicine, Ontario, Canada
     Nonprostatic sources of prostate-specific antigen
     Urologic Clinics of North America 1997 May;24(2):275-82. [PMID 9126224 1.6 MB, Related Articles] [ISI A1997WT71100006, cited 91 times]
636. Borchert GH, Giai M, Diamandis EP.
     Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts [letter]
     Journal of the National Cancer Institute 1997 Apr 16;89(8):587-8. [PMID 9106652 65 KB, Related Articles] [ISI A1997WU26800020, cited 15 times]
     Comment in -- J Natl Cancer Inst. 1998 May 6;90(9):713-4. [PMID 9586671 27 KB, Related Articles]
637. Levesque MA, Tadross L, Diamandis EP, D'Costa M.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Comparison of immunofluorometry and immunohistochemistry for the detection of p53 protein in lung cancer specimens
     American Journal of Clinical Pathology 1997 Mar;107(3):308-16. [PMID 9052381 2.3 MB, Related Articles] [ISI A1997WK22900008, cited 6 times]
638. Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     New diagnostic applications of prostate-specific antigen [review, 53 refs]
     British Journal of Urology 1997 Mar;79 Suppl 1:87-91. [PMID 9088279 967 KB, Related Articles] [ISI A1997WN60400015, cited 5 times]
639. Soleas GJ, Diamandis EP, Goldberg DM.
     Department of Clinical Biochemistry, University of Toronto, Banting Institute, Ontario, Canada
     Resveratrol: a molecule whose time has come? And gone? [review, 183 refs]
     Clinical Biochemistry 1997 Mar;30(2):91-113. [PMID 9127691 2.5 MB, Related Articles] [ISI A1997WU66800002, cited 339 times]
640. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate-specific antigen in female serum, a potential new marker of androgen excess
     Journal of Clinical Endocrinology and Metabolism 1997 Mar;82(3):777-80. [PMID 9062481 425 KB, Related Articles] [ISI A1997WM24500013, cited 39 times]
641. Yu H, Diamandis EP, Wong PY, Nam R, Trachtenberg J.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L
     Journal of Urology 1997 Mar;157(3):913-8. [PMID 9072598 294 KB, Related Articles] [ISI A1997WG21400046, cited 39 times]
     Comment in -- J Urol. 1997 Mar;157(3):919-20. [PMID 9072599, Related Articles]
642. Diamandis EP.
     Department of Clinical Biochemistry, University of Toronto, Ontario, Canada
     Clinical applications of tumor suppressor genes and oncogenes in cancer [review]
     Clinica Chimica Acta 1997 Jan 17;257(2):157-80. [PMID 9118561 1.3 MB, Related Articles] [ISI A1997WG47700003, cited 4 times]
643. Angelopoulou K, Stratis M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Canada
     Humoral immune response against p53 protein in patients with colorectal carcinoma
     International Journal of Cancer 1997 Jan 6;70(1):46-51. [PMID 8985089 154 KB, Related Articles] [ISI A1997WA88700007, cited 50 times]
644. Borchert GH, Melegos DN, Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases
     British Journal of Cancer 1997;76(8):1087-94. [PMID 9376271 1.1 MB, Related Articles] [ISI A1997YC36200017, cited 25 times]
645. Howarth DJ, Aronson IB, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada
     Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues
     British Journal of Cancer 1997;75(11):1646-51. [PMID 9184181 1.1 MB, Related Articles] [ISI A1997XC74400013, cited 31 times]
646. Zarghami N, Grass L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer
     British Journal of Cancer 1997;75(4):579-88. [PMID 9052414 2.3 MB, Related Articles] [ISI A1997WG37000021, cited 73 times]
647. Angelopoulou K, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancer
     European Journal of Cancer 1997 Jan;33(1):115-21. [PMID 9071910 755 KB, Related Articles] [ISI A1997WH23000039, cited 23 times]
648. Soleas GJ, Diamandis EP, Goldberg DM.
     Department of Clinical Biochemistry, Banting Institute, University of Toronto, Ontario, Canada
     Wine as a biological fluid: history, production, and role in disease prevention [review, 230 refs]
     Journal of Clinical Laboratory Analysis 1997;11(5):287-313. [PMID 9292395 248 KB, Related Articles] [ISI A1997XU12800006, cited 335 times]

1996

649. Goldberg DM, Ng E, Karumanchiri A, Diamandis EP, Soleas GJ.
     Resveratrol glucosides are important components of commercial wines
     American Journal of Enology and Viticulture 1996;47(4):415-420 [ISI A1996VZ36900008 1.4 MB, cited 38 times]
650. Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E.
     Division of Population Science, Fox Chase Cancer Center, Philadelphia Pennsylvania 19111, USA
     Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk
     Cancer Epidemiology Biomarkers & Prevention 1996 Dec;5(12):967-70. [PMID 8959318 808 KB, Related Articles] [ISI A1996VX38400004, cited 96 times]
651. Melegos DN, Yu H, Allen LC, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies
     Clinical Biochemistry 1996 Dec;29(6):555-62. [PMID 8939403 671 KB, Related Articles] [ISI A1996VT99400008, cited 23 times]
652. Melegos DN, Diamandis EP, Oda H, Urade Y, Hayaishi O.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids
     Clinical Chemistry 1996 Dec;42(12):1984-91. [PMID 8969637 1.1 MB, Related Articles] [ISI A1996VX38200015, cited 36 times]
653. Angelopoulou K, Rosen B, Stratis M, Yu H, Solomou M, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival
     Cancer 1996 Nov 15;78(10):2146-52. [PMID 8918407 1 MB, Related Articles] [ISI A1996VQ34300015, cited 52 times]
654. Diamandis EP. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario
     Prostate specific antigen--new applications in breast and other cancers [review]
     Anticancer Research 1996 Nov-Dec;16(6C):3983-4. [PMID 9042323 748 KB, Related Articles] [ISI A1996WB83800013, cited 28 times]
655. Levesque MA, D'Costa M, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Canada
     p53 protein is absent from the serum of patients with lung cancer
     British Journal of Cancer 1996 Nov;74(9):1434-40. [PMID 8912541 1.5 MB, Related Articles] [ISI A1996VP31500018, cited 22 times]
656. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer
     British Journal of Cancer 1996 Oct;74(8):1242-7. [PMID 8883411 1.1 MB, Related Articles] [ISI A1996VM36700014, cited 46 times]
657. James GK, Pudek M, Berean KW, Diamandis EP, Archibald BL.
     Department of Pathology, Vancouver Hospital and Health Sciences Centre, British Columbia, Canada
     Salivary duct carcinoma secreting prostate-specific antigen
     American Journal of Clinical Pathology 1996 Aug;106(2):242-7. [PMID 8712181 1.5 MB, Related Articles] [ISI A1996VC01500016, cited 31 times]
658. Melegos DN, Yu H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Prostaglandin D2 synthase: a component of human amniotic fluid and its association with fetal abnormalities
     Clinical Chemistry 1996 Jul;42(7):1042-50. [PMID 8674187 2.9 MB, Related Articles] [ISI A1996UU42600008, cited 11 times]
659. Diamandis EP.
     ... and secreted tumour suppressors [comment]
     Nature Genetics 1996 Jul;13(3):268; author reply 269-72. [PMID 8673122 97 KB, Related Articles] [ISI A1996UU28300010, cited 11 times]
     Comment on -- Nat Genet. 1996 Mar;12(3):303-8. [PMID 8589722, Related Articles]
660. Diamandis EP.
     Prostaglandin D2 synthase in amniotic fluid and maternal serum: Possible association with fetal abnormalities [proceedings paper]
     Prostaglandins 1996 Apr;51(4):297 [ISI A1996UM14400020 35 KB]
661. Melegos DN, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontarid, Canada
     Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer
     Clinical Biochemistry 1996 Jun;29(3):193-200. [PMID 8740504 1.3 MB, Related Articles] [ISI A1996UJ73000001, cited 22 times]
662. Diamandis EP, Yu H, Melegos DN. <EDiamandis@mtsinai.on.ca>
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario
     Ultrasensitive prostate-specific antigen assays and their clinical application [comment]
     Clinical Chemistry 1996 Jun;42(6 Pt 1):853-7. [PMID 8665675 891 KB, Related Articles] [ISI A1996UQ78300005, cited 36 times]
     Comment on -- Clin Chem. 1996 Jun;42(6 Pt 1):849-52. [PMID 8665674, Related Articles]
     Comment in -- Clin Chem. 1997 Oct;43(10):2010-1. [PMID 9342036, Related Articles]
663. Goldberg DM, Tsang E, Karumanchiri A, Diamandis E, Soleas G, Ng E.
     Department of Clinical Biochemistry, Banting Institute, University of Toronto, Ontario, Canada
     Method to assay the concentrations of phenolic constituents of biological interest in wines
     Analytical Chemistry 1996 May 15;68(10):1688-94. [PMID 8651480 1 MB, Related Articles] [ISI A1996UK58000003, cited 164 times]
664. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
     Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers
     Clinical Chemistry 1996 May;42(5):675-84. [PMID 8653891 1.8 MB, Related Articles] [ISI A1996UJ25300006, cited 124 times]
665. Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Yemoto C, Stamey TA.
     Michigan Prostate Institute and University of Michigan, Ann Arbor, USA
     The periurethral glands do not significantly influence the serum prostate specific antigen concentration
     Journal of Urology 1996 May;155(5):1658-60. [PMID 8627847 81 KB, Related Articles] [ISI A1996UF00800034, cited 15 times]
     Comment in -- J Urol. 1996 May;155(5):1661-2. [PMID 8627848, Related Articles]
     Comment in -- J Urol. 1997 Jan;157(1):269. [PMID 8976275, Related Articles]
666. Hoffman BR, Yu H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Assay of prostate-specific antigen from whole blood spotted on filter paper and application to prostate cancer screening
     Clinical Chemistry 1996 Apr;42(4):536-44. [PMID 8605670 1.7 MB, Related Articles] [ISI A1996UD76500010, cited 15 times]
667. Goldberg DM, Garovic-Kocic V, Diamandis EP, Pace-Asciak CR.
     Department of Clinical Biochemistry, University of Toronto, Ontario, Canada
     Wine: does the colour count?
     Clinica Chimica Acta 1996 Mar 15;246(1-2):183-93. [PMID 8814966 1.2 MB, Related Articles] [ISI A1996UB96400015, cited 31 times]
668. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM.
     Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada
     Wines and grape juices as modulators of platelet aggregation in healthy human subjects
     Clinica Chimica Acta 1996 Mar 15;246(1-2):163-82. [PMID 8814965 2.8 MB, Related Articles] [ISI A1996UB96400014, cited 168 times]
669. Randell EW, Diamandis EP, Ellis G.
     Department of Clinical Biochemistry, University of Toronto, Ontario, Canada
     Serum prostate-specific antigen measured in children from birth to age 18 years
     Clinical Chemistry 1996 Mar;42(3):420-3. [PMID 8598106 637 KB, Related Articles] [ISI A1996TY85500015, cited 12 times]
670. Zarghami N, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Detection of prostate-specific antigen mRNA and protein in breast tumors
     Clinical Chemistry 1996 Mar;42(3):361-6. [PMID 8598096 1.1 MB, Related Articles] [ISI A1996TY85500005, cited 31 times]
671. Zarghami N, Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Sismondi P, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients
     British Journal of Cancer 1996 Feb;73(3):386-90. [PMID 8562347 904 KB, Related Articles] [ISI A1996TR16500020, cited 9 times]
672. Yu H, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M, Croce CM.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
     Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue
     Breast Cancer Research and Treatment 1996;40(2):171-8. [PMID 8879683 1.4 MB, Related Articles] [ISI A1996VG04500006, cited 68 times]
673. Diamandis EP, Yu H, López-Otín C.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate specific antigen--a new constituent of breast cyst fluid
     Breast Cancer Research and Treatment 1996;38(3):259-64. [PMID 8739078 1 MB, Related Articles] [ISI A1996UK78700004, cited 36 times]
674. Diamandis EP.
     Automation of molecular diagnostics [editorial]
     Clinical Chemistry 1996 Jan;42(1):7-8. [PMID 8565236 411 KB, Related Articles] [ISI A1996TR04000003, cited 10 times]
     Comment on -- Clin Chem. 1996 Jan;42(1):9-13. [PMID 8565240, Related Articles]
     Comment in -- Clin Chem. 1996 Oct;42(10):1720. [PMID 8855164, Related Articles]
675. Diamandis EP, Yu H.
     Does prostate cancer start at puberty? [letter]
     Journal of Clinical Laboratory Analysis 1996;10(6):468-9. [PMID 8951622 200 KB, Related Articles] [ISI A1996VV83000027, cited 10 times]
676. Diamandis EP, Yu H.
     Re: The clinical usefulness of prostate specific antigen: update 1994 [comment]
     J Urol 1996 Jan;155(1):294; author reply 295. [PMID 7490867 95 KB, Related Articles]
     Comment on -- J Urol. 1994 Nov;152(5 Pt 1):1358-68. [PMID 7523702, Related Articles]
677. Young DS, Diamandis E, Bohuon C, Siest G, Buttner JS, Laue D, Siekmann L, Anagnostoucacaras E, Spanos E, Salvatore F, Okuda K, Whitehead TP, Apple FS, Ash KO, Bowie LJ, Bruns DE, Demers LM, Doumas BT, Gallwas GE, Garber CC, Hicks JM, Ladenson JH, Mcdonald JM, Rodgerson DO, Schwartz MK, Tietz NW, Valdes R, Weinert H, Werner M.
     The future of clinical chemistry and its role in healthcare: A report of the Athena Society
     Clinical Chemistry 1996 Jan;42(1):96-101 [ISI A1996TR04000019 93 KB, cited 4 times]
678. Partin AW, Oesterling JE, Diamandis EP, Yu H.
     The clinical usefulness of prostate specific antigen: Update 1994 [letter]
     Journal of Urology 1996 Jan;155(1):294 [ISI A1996TJ43400114 95 KB]

1995

679. Levesque MA, D'Costa M, Angelopoulou K, Diamandis EP.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Time-resolved immunofluorometric assay of p53 protein
     Clinical Chemistry 1995 Dec;41(12 Pt 1):1720-9. [PMID 7497612 2.1 MB, Related Articles] [ISI A1995TJ52100008, cited 15 times]
680. Galvan B, Christopoulos TK, Diamandis EP.
     Department of Chemistry and Biochemistry, University of Windsor, Ontario, Canada
     Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry
     Clinical Chemistry 1995 Dec;41(12 Pt 1):1705-9. [PMID 7497609 1.2 MB, Related Articles] [ISI A1995TJ52100005, cited 20 times]
681. Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP.
     Department of Gynecologic Oncology, University of Turin, Italy
     Prostate-specific antigen in serum of women with breast cancer
     British Journal of Cancer 1995 Sep;72(3):728-31. [PMID 7545417 792 KB, Related Articles] [ISI A1995RT00600035, cited 39 times]
682. Levesque MA, Clark GM, Yu H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators
     British Journal of Cancer 1995 Sep;72(3):720-7. [PMID 7545416 1.4 MB, Related Articles] [ISI A1995RT00600034, cited 19 times]
683. Zarghami N, Katsaros D, Yu H, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario
     Prognostic value of creatine kinase BB isoenzyme in epithelial ovarian carcinoma
     Can J Oncol 1995 Sep;5(3):401-7. [PMID 8853514 1 MB, Related Articles]
684. Soleas GJ, Goldberg DM, Diamandis EP, Karumanchiri A, Yan J, Ng E.
     A DERIVATIZED GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC METHOD FOR THE ANALYSIS OF BOTH ISOMERS OF RESVERATROL IN JUICE AND WINE
     American Journal of Enology and Viticulture 1995;46(3):346-352 [ISI A1995RT22100011 1.8 MB, cited 49 times]
685. Goldberg DM, Ng E, Karumanchiri A, Yan J, Diamandis EP, Soleas GJ.
     ASSAY OF RESVERATROL GLUCOSIDES AND ISOMERS IN WINE BY DIRECT-INJECTION HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
     Journal of Chromatography A 1995 Jul 28;708(1):89-98 [ISI A1995RN20000010 1.4 MB, cited 81 times]
686. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Clinical applications of the p53 tumor suppressor gene [review, 42 refs]
     Clinica Chimica Acta 1995 Jun 15;237(1-2):79-90. [PMID 7664481 1.1 MB, Related Articles] [ISI A1995RG59800009, cited 15 times]
687. Zarghami N, Yu H, Diamandis EP, Sutherland DJ.
     Department of Clinical Biochemistry, Toronto Western Division, Toronto Hospital, Ontario, Canada
     Quantification of creatine kinase BB isoenzyme in tumor cytosols and serum with an ultrasensitive time-resolved immunofluorometric technique
     Clinical Biochemistry 1995 Jun;28(3):243-53. [PMID 7554242 1.9 MB, Related Articles] [ISI A1995RE78800004, cited 10 times]
688. Goldberg DM, Yan J, Ng E, Diamandis EP, Karumanchiri A, Soleas G, Waterhouse AL.
     A GLOBAL SURVEY OF TRANS-RESVERATROL CONCENTRATIONS IN COMMERCIAL WINES
     American Journal of Enology and Viticulture 1995;46(2):159-165 [ISI A1995RD29800002 2 MB, cited 132 times]
689. Goldberg DM, Karumanchiri A, Ng E, Yan J, Diamandis EP, Soleas GJ.
     DIRECT GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC METHOD TO ASSAY CIS-RESVERATROL IN WINES - PRELIMINARY SURVEY OF ITS CONCENTRATION IN COMMERCIAL WINES
     Journal of Agricultural and Food Chemistry 1995 May;43(5):1245-1250 [ISI A1995QY97800023 1.2 MB, cited 65 times]
690. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R, Sismondi P.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer
     Cancer Research 1995 May 15;55(10):2104-10. [PMID 7538047 1.8 MB, Related Articles] [ISI A1995QX36700021, cited 142 times]
691. Diamandis EP, Yu H.
     Prostate-specific antigen and lack of specificity for prostate cells [comment]
     Lancet 1995 May 6;345(8958):1186. [PMID 7536878 96 KB, Related Articles] [ISI A1995QW62200061, cited 15 times]
     Comment on -- Lancet. 1994 Nov 12;344(8933):1371-2. [PMID 7526101, Related Articles]
692. Diamandis EP, Yu H.
     New biological functions of prostate-specific antigen? [editorial, 32 refs]
     Journal of Clinical Endocrinology and Metabolism 1995 May;80(5):1515-7. [PMID 7538144 386 KB, Related Articles] [ISI A1995QW61100011, cited 116 times]
693. Dickson EF, Pollak A, Diamandis EP.
     Department of Chemistry and Chemical Engineering, Royal Military College of Canada, Kingston, Ontario
     Ultrasensitive bioanalytical assays using time-resolved fluorescence detection [review, 196 refs]
     Pharmacology & Therapeutics 1995 May;66(2):207-35. [PMID 7667396 2 MB, Related Articles] [ISI A1995RA45600002, cited 70 times]
694. Yu H, Diamandis EP, Levesque M, Asa SL, Monne M, Croce CM.
     Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
     Expression of the prostate-specific antigen gene by a primary ovarian carcinoma
     Cancer Research 1995 Apr 15;55(8):1603-6. [PMID 7536128 1 MB, Related Articles] [ISI A1995QR97300001, cited 54 times]
695. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM.
     Department of Pharmacology, University of Toronto, Canada
     The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease
     Clinica Chimica Acta 1995 Mar 31;235(2):207-19. [PMID 7554275 1.6 MB, Related Articles] [ISI A1995RB68700009, cited 491 times]
696. Yu H, Diamandis EP, Monne M, Croce CM.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Oral contraceptive-induced expression of prostate-specific antigen in the female breast
     Journal of Biological Chemistry 1995 Mar 24;270(12):6615-8. [PMID 7534765 988 KB, Related Articles] [ISI A1995QQ85500031, cited 80 times]
697. Levesque MA, Katsaros D, Yu H, Zola P, Sismondi P, Giardina G, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Toronto Western Division, Ontario, Canada
     Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma
     Cancer 1995 Mar 15;75(6):1327-38. [PMID 7882283 2 MB, Related Articles] [ISI A1995QL72800014, cited 106 times]
698. Yu H, Diamandis EP, Prestigiacomo AF, Stamey TA.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario
     Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy
     Clinical Chemistry 1995 Mar;41(3):430-4. [PMID 7533672 1.2 MB, Related Articles] [ISI A1995QM34800015, cited 44 times]
699. Yu H, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Division, Toronto Hospital, Ontario, Canada
     Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique
     Journal of Urology 1995 Mar;153(3 Pt 2):1004-8. [PMID 7531781 1 MB, Related Articles] [ISI A1995QF63400027, cited 66 times]
700. Yu H, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Prostate-specific antigen immunoreactivity in amniotic fluid
     Clinical Chemistry 1995 Feb;41(2):204-10. [PMID 7533063 1.3 MB, Related Articles] [ISI A1995QG65200008, cited 75 times]
701. Diamandis EP.
     Prostate cancer, prostate-specific antigen, and the polymerase chain reaction [editorial]
     Clinical Chemistry 1995 Feb;41(2):177-9. [PMID 7533061 619 KB, Related Articles] [ISI A1995QG65200001, cited 26 times]
     Comment on -- Clin Chem. 1995 Feb;41(2):182-6. [PMID 7533062, Related Articles]
702. Yu H, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Prostate-specific antigen in milk of lactating women
     Clinical Chemistry 1995 Jan;41(1):54-8. [PMID 7529146 896 KB, Related Articles] [ISI A1995QA21200011, cited 126 times]
     Comment in -- Clin Chem. 1995 Jan;41(1):7-9. [PMID 7529147, Related Articles]
703. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP.
     Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
     Immunoreactive prostate-specific antigen in lung tumors
     Journal of Clinical Laboratory Analysis 1995;9(6):375-9. [PMID 8587005 681 KB, Related Articles] [ISI A1995TF10500006, cited 29 times]
704. Levesque M, Hu H, D'Costa M, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Prostate-specific antigen expression by various tumors
     Journal of Clinical Laboratory Analysis 1995;9(2):123-8. [PMID 7536238 943 KB, Related Articles] [ISI A1995QE89300008, cited 93 times]
705. Diamandis EP, Levesque MA.
     Assessment of p53 overexpression by non-immunohistochemical methods [comment]
     Journal of Pathology 1995 Jan;175(1):93-5. [PMID 7891232 440 KB, Related Articles] [ISI A1995QD71000013, cited 9 times]
     Comment on -- J Pathol. 1992 Apr;166(4):329-30. [PMID 1517889, Related Articles]
     Comment on -- J Pathol. 1994 Jan;172(1):1-4. [PMID 7931821, Related Articles]
706. Dickson EF, Pollak A, Diamandis EP.
     Department of Chemistry and Chemical Engineering, Royal Military College of Canada, Kingston, Ontario
     Time-resolved detection of lanthanide luminescence for ultrasensitive bioanalytical assays [review, 136 refs]
     Journal of Photochemistry and Photobiology B-Biology 1995 Jan;27(1):3-19. [PMID 7699520 1.5 MB, Related Articles] [ISI A1995QF22600001, cited 104 times]
707. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Canada
     New diagnostic applications and physiological functions of prostate specific antigen [review, 38 refs]
     Scandinavian Journal of Clinical & Laboratory Investigation 1995;221:105-12. [PMID 7544479 1 MB, Related Articles] [ISI A1995QW13200018, cited 18 times]

1994

708. Monne M, Croce CM, Yu H, Diamandis EP.
     Department of Microbiology-Immunology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
     Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors
     (GenBank: S75755)
     Cancer Research 1994 Dec 15;54(24):6344-7. [PMID 7527295 1 MB, Related Articles] [ISI A1994PX30600014, cited 97 times]
709. Goldberg DM, Yan J, Ng E, Diamandis EP, Karumanchiri A, Soleas G, Waterhouse AL.
     DIRECT-INJECTION GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC ASSAY FOR TRANS-RESVERATROL
     Analytical Chemistry 1994 Nov 15;66(22):3959-3963 [ISI A1994PQ97700017 839 KB, cited 57 times]
710. Marriott G, Heidecker M, Diamandis EP, Yan-Marriott Y.
     Department of Cell Biology, Max Planck Institute for Biochemistry, München, Germany
     Time-resolved delayed luminescence image microscopy using an europium ion chelate complex
     Biophysical Journal 1994 Sep;67(3):957-65. [PMID 7811952 3 MB, Related Articles] [ISI A1994PE37700003, cited 36 times]
711. Angelopoulou K, Diamandis EP, Sutherland DJ, Kellen JA, Bunting PS.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers
     International Journal of Cancer 1994 Aug 15;58(4):480-7. [PMID 8056443 1.5 MB, Related Articles] [ISI A1994PB58900003, cited 188 times]
712. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP.
     Department of Medicine, Toronto Hospital, Toronto Western Division, Ontario, Canada
     Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD
     Kidney International 1994 Jul;46(1):216-22. [PMID 7933840 930 KB, Related Articles] [ISI A1994NT12800025, cited 119 times]
713. Yu H, Diamandis EP, Sutherland DJ.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age
     Clinical Biochemistry 1994 Apr;27(2):75-9. [PMID 7520846 951 KB, Related Articles] [ISI A1994NF30600001, cited 152 times]
714. Wang T, Diamandis EP, Lane A, Baines AD.
     Department of Clinical Biochemistry, Toronto General Division, Toronto Hospital, Ontario, Canada
     Variable selectivity of the Hitachi chemistry analyzer chloride ion-selective electrode toward interfering ions
     Clinical Biochemistry 1994 Feb;27(1):37-14. [PMID 8200113 1.1 MB, Related Articles] [ISI A1994MX76800007, cited 8 times]
715. Diamandis EP, Yu H, Sutherland DJ.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Detection of prostate-specific antigen immunoreactivity in breast tumors
     Breast Cancer Research and Treatment 1994;32(3):301-10. [PMID 7532468 2 MB, Related Articles] [ISI A1994PQ76400006, cited 127 times]
716. Yu H, Diamandis EP, Zarghami N, Grass L.
     Department of Clinical Biochemistry, Toronto Western Division, Toronto Hospital, Ontario, Canada
     Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines
     Breast Cancer Research and Treatment 1994;32(3):291-300. [PMID 7532467 1.7 MB, Related Articles] [ISI A1994PQ76400005, cited 88 times]
717. Levesque MA, Diamandis EP, Yu H, Sutherland DJ.
     Department of Clinical Biochemistry, Toronto Western Division, Toronto Hospital, Ontario, Canada
     Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer
     Breast Cancer Research and Treatment 1994;30(2):179-95. [PMID 7524772 2.2 MB, Related Articles] [ISI A1994NY58000009, cited 14 times]
718. Yu H, Diamandis EP, Levesque M, Sismondi P, Zola P, Katsaros D.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary
     Journal of Clinical Laboratory Analysis 1994;8(4):251-3. [PMID 7523638 436 KB, Related Articles] [ISI A1994NT65700011, cited 26 times]

1993

719. Angelopoulou K, Diamandis EP.
     AUTOANTIBODIES AGAINST THE P53 TUMOR-SUPPRESSOR GENE-PRODUCT QUANTIFIED IN CANCER-PATIENT SERUM WITH TIME-RESOLVED IMMUNOFLUOROMETRY
     Cancer Journal 1993 Nov-Dec;6(6):315-321 [ISI A1993MQ28600004 1.2 MB, cited 17 times]
720. Goldberg DM, Diamandis EP.
     Department of Clinical Biochemistry, University of Toronto, Banting Institute, Ontario, Canada
     Models of neoplasia and their diagnostic implications: a historical perspective [review]
     Clinical Chemistry 1993 Nov;39(11 Pt 2):2360-74. [PMID 8222248 2.9 MB, Related Articles] [ISI A1993MF58900002, cited 15 times]
721. Yu H, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies
     Clinical Chemistry 1993 Oct;39(10):2108-14. [PMID 7691442 1.3 MB, Related Articles] [ISI A1993MC29500012, cited 115 times]
722. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Time-resolved fluorometry in nucleic acid hybridization and western blotting techniques [review, 33 refs]
     Electrophoresis 1993 Sep;14(9):866-75. [PMID 8223395 1.5 MB, Related Articles] [ISI A1993LZ76000007, cited 10 times]
723. Diamandis EP.
     FLUORESCENCE SPECTROSCOPY [review]
     Analytical Chemistry 1993 Jun 15;65(12):R454-R459 [ISI A1993LG13100041 1.5 MB, cited 4 times]
724. Hassapoglidou S, Diamandis EP, Sutherland DJ.
     Department of Clinical Biochemistry, Toronto Western Division, Toronto Hospital, Ontario
     Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry
     Oncogene 1993 Jun;8(6):1501-9. [PMID 8502476 1.7 MB, Related Articles] [ISI A1993LE06400013, cited 68 times]
725. Chan A, Diamandis EP, Krajden M.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Quantification of polymerase chain reaction products in agarose gels with a fluorescent europium chelate as label and time-resolved fluorescence spectroscopy
     Analytical Chemistry 1993 Jan 15;65(2):158-63. [PMID 7679258 2.2 MB, Related Articles] [ISI A1993KG77800014, cited 25 times]
726. Diamandis EP, Hassapoglidou S, Bean CC.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Evaluation of nonisotopic labeling and detection techniques for nucleic acid hybridization
     Journal of Clinical Laboratory Analysis 1993;7(3):174-9. [PMID 8509946 2.2 MB, Related Articles] [ISI A1993KZ70000007, cited once]

1992

727. Diamandis EP.
     EUROPIUM AND TERBIUM CHELATORS AS CANDIDATE SUBSTRATES FOR ENZYME-LABELED TIME-RESOLVED FLUOROMETRIC IMMUNOASSAYS
     Analyst 1992 Dec;117(12):1879-1884 [ISI A1992KD94100015 1.5 MB, cited 42 times]
728. Hassapoglidou S, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Antibodies to the p53 tumor suppressor gene product quantified in cancer patient serum with a time-resolved immunofluorometric technique
     Clinical Biochemistry 1992 Dec;25(6):445-9. [PMID 1477969 1016 KB, Related Articles] [ISI A1992KC16500006, cited 24 times]
729. Diamandis EP, Grass CL, Uldall R, Mendelssohn D, Maini D.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     An enzymatic method for measuring serum mannitol and its use in hemodialysis patients
     Clinical Biochemistry 1992 Dec;25(6):457-62. [PMID 1335850 974 KB, Related Articles] [ISI A1992KC16500008, cited 5 times]
730. Papanastasiou-Diamandi A, Christopoulos TK, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Ultrasensitive thyrotropin immunoassay based on enzymatically amplified time-resolved fluorescence with a terbium chelate
     Clinical Chemistry 1992 Apr;38(4):545-8. [PMID 1568319 640 KB, Related Articles] [ISI A1992HN92100017, cited 34 times]
731. Diamandis EP, Christopoulos TK, Bean CC.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Quantitative western blot analysis and spot immunodetection using time-resolved fluorometry
     Journal of Immunological Methods 1992 Mar 4;147(2):251-9. [PMID 1372335 1.5 MB, Related Articles] [ISI A1992HH98000014, cited 17 times]
732. Kakabakos SE, Christopoulos TK, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry
     Clinical Chemistry 1992 Mar;38(3):338-42. [PMID 1547548 951 KB, Related Articles] [ISI A1992HJ87000004, cited 50 times]
     Comment in -- Clin Chem. 1992 Mar;38(3):327-8. [PMID 1547545, Related Articles]
733. Christopoulos TK, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates
     Analytical Chemistry 1992 Feb 15;64(4):342-6. [PMID 1377456 850 KB, Related Articles] [ISI A1992HE08100004, cited 150 times]
734. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Hospital, Ontario, Canada
     Oncogenes and tumor suppressor genes: new biochemical tests [review, 79 refs]
     Critical Reviews in Clinical Laboratory Sciences 1992;29(3-4):269-305. [PMID 1489520 7.7 MB, Related Articles] [ISI A1992KF09600004, cited 10 times]

1991

735. Christopoulos TK, Diamandis EP, Wilson G.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Quantification of nucleic acids on nitrocellulose membranes with time-resolved fluorometry
     Nucleic Acids Research 1991 Nov 11;19(21):6015-9. [PMID 1719486 1 MB, Related Articles] [ISI A1991GQ23800029, cited 19 times]
736. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Multiple labeling and time-resolvable fluorophores [review]
     Clinical Chemistry 1991 Sep;37(9):1486-91. [PMID 1716533 1.1 MB, Related Articles] [ISI A1991GF97100004, cited 36 times]
737. Christopoulos TK, Diamandis EP.
     ULTRASENSITIVE DETERMINATION OF EUROPIUM USING MICROSECOND TIME-RESOLVED SPECTROFLUORIMETRY
     Analyst 1991 Jun;116(6):627-630 [ISI A1991FW35800014 588 KB, cited 10 times]
738. Diamandis EP, Christopoulos TK.
     Toronto Western Hospital
     Time-resolved immunofluorometric detection of antigens separated by high-performance liquid chromatography and coated to polystyrene
     Biotechniques 1991 May;10(5):646-8. [PMID 1716927 349 KB, Related Articles] [ISI A1991FL88700018, cited 4 times]
739. Diamandis EP, Christopoulos TK.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     The biotin-(strept)avidin system: principles and applications in biotechnology [review, 106 refs]
     Clinical Chemistry 1991 May;37(5):625-36. [PMID 2032315 2.7 MB, Related Articles] [ISI A1991FL98100003, cited 261 times]

1990

740. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Analytical methodology for immunoassays and DNA hybridization assays--current status and selected systems--critical review [review, 147 refs]
     Clinica Chimica Acta 1990 Dec 17;194(1):19-50. [PMID 2073753 3.8 MB, Related Articles] [ISI A1990EP51900003, cited 29 times]
741. Diamandis EP, Christopoulos TK.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Europium chelate labels in time-resolved fluorescence immunoassays and DNA hybridization assays [review, 34 refs]
     Analytical Chemistry 1990 Nov 15;62(22):1149A-1157A. [PMID 2270861 1.7 MB, Related Articles] [ISI A1990EH23700001, cited 213 times]
742. Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Detection techniques for immunoassay and DNA probing applications [review, 34 refs]
     Clinical Biochemistry 1990 Oct;23(5):437-43. [PMID 2253338 1.1 MB, Related Articles] [ISI A1990EB70800013, cited 10 times]
743. Lianidou ES, Christopoulos TK, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry
     Clinical Chemistry 1990 Sep;36(9):1679-83. [PMID 2208711 967 KB, Related Articles] [ISI A1990EA00300035, cited 5 times]
744. Morton RC, Diamandis EP.
     STREPTAVIDIN-BASED MACROMOLECULAR COMPLEX LABELED WITH A EUROPIUM CHELATOR SUITABLE FOR TIME-RESOLVED FLUORESCENCE IMMUNOASSAY APPLICATIONS
     Analytical Chemistry 1990 Sep 1;62(17):1841-1845 [ISI A1990DW85300023 1.1 MB, cited 63 times]
745. Christopoulos TK, Lianidou ES, Diamandis EP.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Ultrasensitive time-resolved fluorescence method for alpha-fetoprotein
     Clinical Chemistry 1990 Aug;36(8 Pt 1):1497-502. [PMID 1696856 919 KB, Related Articles] [ISI A1990DV47800019, cited 33 times]
746. Diamandis EP, Ogilvie RR.
     Department of Clinical Biochemistry, Toronto Western Hospital, Ontario, Canada
     Ultrasensitive time-resolved immunofluorometry of human albumin in urine using monoclonal antibodies--a new assay for microalbuminuria
     Annals of Clinical Biochemistry 1990 May;27(Pt 3):232-7. [PMID 2200333 1 MB, Related Articles] [ISI A1990DG91400009, cited 4 times]
747. Kahan I, Papanastasiou-Diamandi A, Ellis G, Makela SK, McLaurin J, D'Costa M, Diamandis EP.
     CyberFluor Inc., Toronto, Canada
     Sensitive time-resolved fluorescence immunoassay of somatotropin in serum
     Clinical Chemistry 1990 Mar;36(3):503-8. [PMID 2311221 1.2 MB, Related Articles] [ISI A1990CU68600020, cited 4 times]
748. Shankaran P, Reichstein E, Khosravi MJ, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Detection of immunoglobulins G and M to rubella virus by time-resolved immunofluorometry
     Journal of Clinical Microbiology 1990 Mar;28(3):573-9. [PMID 2182672 1 MB, Related Articles] [ISI A1990CP03500034, cited 4 times]
749. Loucari-Yiannakou E, Yiannakou L, Souvatzoglou A, Diamandis EP.
     Department of Internal Medicine, Alexandra General Hospital, Athens, Greece
     Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances
     Therapeutic Drug Monitoring 1990 Mar;12(2):195-200. [PMID 2315977 1.1 MB, Related Articles] [ISI A1990CQ11200015, cited 9 times]
750. Christopoulos TK, Diamandis EP.
     Laboratory of Analytical Chemistry, University of Athens, Greece
     Binding studies using ion-selective electrodes. Examination of the picrate-albumin interaction as a model system
     Analytical Chemistry 1990 Feb 15;62(4):360-7. [PMID 2310016 1.4 MB, Related Articles] [ISI A1990CN18000010, cited 14 times]

1989

751. Bhayana V, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     A double monoclonal time-resolved immunofluorometric assay of carcinoembryonic antigen in serum
     Clinical Biochemistry 1989 Dec;22(6):433-8. [PMID 2611990 894 KB, Related Articles] [ISI A1989CF17000004, cited 3 times]
752. Diamandis EP, Papanastasiou-Diamandi A, Lustig V, Khosravi MJ, Tan A.
     CyberFluor Inc., Toronto, Ontario, Canada
     Time-resolved immunofluorometric assay of human pancreatic isoamylase in serum, with use of two monoclonal antibodies
     Clinical Chemistry 1989 Sep;35(9):1915-20. [PMID 2476261 1 MB, Related Articles] [ISI A1989AQ82400028, cited 5 times]
753. Papanastasiou-Diamandi A, Conway K, Diamandis EP.
     CyberFluor, Inc., Toronto, Ontario, Canada
     Digoxin immunoassay with monoclonal and polyclonal antibodies using time-resolved fluorometry
     Journal of Pharmaceutical Sciences 1989 Aug;78(8):617-21. [PMID 2674405 973 KB, Related Articles] [ISI A1989AK33100002, cited 6 times]
754. Papanastasiou-Diamandis A, Bhayana V, Diamandis EP.
     CyberFluor Inc, Toronto, Ontario, Canada
     A simple time-resolved fluoroimmunoassay of total thyroxine in serum
     Annals of Clinical Biochemistry 1989 May;26(Pt 3):238-43. [PMID 2764467 864 KB, Related Articles] [ISI A1989AA08700005, cited 4 times]
755. Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Time-resolved fluorescence immunoassay system especially suited for research applications [note]
     Clinical Chemistry 1989 Mar;35(3):491. [PMID 2920419 131 KB, Related Articles] [ISI A1989T595300038, cited 3 times]
756. Reichstein E, Morton RC, Diamandis EP.
     CyberFluor, Inc., Toronto, Ontario, Canada
     Sensitive time-resolved immunofluorometric assay of thyrotropin in serum
     Clinical Biochemistry 1989 Feb;22(1):23-9. [PMID 2650921 1 MB, Related Articles] [ISI A1989T467500005, cited 8 times]
757. Christopoulos TK, Diamandis EP.
     POTENTIOMETRIC MEASUREMENTS IN AIR-SEGMENTED STREAMS WITHOUT DEBUBBLING
     Analytical Chemistry 1989 Mar 1;61(5):504-508 [ISI A1989T389800028 741 KB, cited twice]
758. Diamandis EP, Morton RC, Reichstein E, Khosravi MJ.
     Multiple fluorescence labeling with europium chelators. Application to time-resolved fluoroimmunoassays
     Analytical Chemistry 1989 Jan 1;61(1):48-53. [PMID 2712294 1.2 MB, Related Articles] [ISI A1989R603500013, cited 87 times]
759. Khosravi MJ, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Time-resolved immunofluorometry of follitropin in serum [note]
     Clinical Chemistry 1989 Jan;35(1):181. [PMID 2491976 134 KB, Related Articles] [ISI A1989R751500049, cited 3 times]
760. Tan YK, Khosravi MJ, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Time-resolved immunofluorometric assay for thyroxine-binding globulin in serum
     Journal of Immunoassay 1989;10(4):413-28. [PMID 2514196 1.2 MB, Related Articles] [ISI A1989CE89000008]

1988

761. Diamandis EP, Bhayana V, Conway K, Reichstein E, Papanastasiou-Diamandis A.
     CyberFluor Inc., Toronto, Ontario, Canada
     Time-resolved fluoroimmunoassay of cortisol in serum with a europium chelate as label
     Clinical Biochemistry 1988 Oct;21(5):291-6. [PMID 3233739 970 KB, Related Articles] [ISI A1988Q331600005, cited 20 times]
762. Diamandis EP, Morton RC.
     Cyber Fluor Inc., Toronto, Ontario, Canada
     Time-resolved fluorescence using a europium chelate of 4,7-bis-(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid (BCPDA). Labeling procedures and applications in immunoassays
     Journal of Immunological Methods 1988 Aug 9;112(1):43-52. [PMID 3042870 1.3 MB, Related Articles] [ISI A1988P577300007, cited 48 times]
763. Khosravi MJ, Morton RC, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Sensitive, rapid procedure for time-resolved immunofluorometry of lutropin
     Clinical Chemistry 1988 Aug;34(8):1640-4. [PMID 3042191 880 KB, Related Articles] [ISI A1988P766200028, cited 7 times]
764. Khosravi MJ, Chan MA, Bellem AC, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     A sensitive time-resolved immunofluorometric assay of ferritin in serum with monoclonal antibodies
     Clinica Chimica Acta 1988 Jul 29;175(3):267-75. [PMID 3416487 715 KB, Related Articles] [ISI A1988P593400007, cited 4 times]
765. Christopoulos TK, Diamandis EP.
     USE OF A SINTERED GLASS CRUCIBLE FOR EASY CONSTRUCTION OF LIQUID-MEMBRANE ION-SELECTIVE ELECTRODES
     Journal of Chemical Education 1988 Jul;65(7):648 [ISI A1988P366400043 168 KB]
766. Evangelista RA, Pollak A, Allore B, Templeton EF, Morton RC, Diamandis EP.
     HSC Research Development Corporation, University of Toronto, Ontario, Canada
     A new europium chelate for protein labelling and time-resolved fluorometric applications
     Clinical Biochemistry 1988 Jun;21(3):173-8. [PMID 3390907 1 MB, Related Articles] [ISI A1988N467700006, cited 154 times]
767. Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Immunoassays with time-resolved fluorescence spectroscopy: principles and applications [review, 67 refs]
     Clinical Biochemistry 1988 Jun;21(3):139-50. [PMID 3292080 1.8 MB, Related Articles] [ISI A1988N467700001, cited 194 times]
768. Reichstein E, Shami Y, Ramjeesingh M, Diamandis EP.
     Laser-excited time-resolved solid-phase fluoroimmunoassays with the new europium chelate 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid as label
     Analytical Chemistry 1988 May 15;60(10):1069-74. [PMID 3044187 1.2 MB, Related Articles] [ISI A1988N412600025, cited 32 times]
769. Diamandis EP, D'Costa M.
     Department of Clinical Biochemistry, Mount Sinai Hospital, Toronto, Ontario, Canada
     Selective determination of urinary free cortisol by liquid chromatography after solid-state extraction
     Journal of Chromatography-Biomedical Applications 1988 Apr 8;426(1):25-32. [PMID 3384878 1 MB, Related Articles] [ISI A1988M968800003, cited 16 times]

1987

770. Yannakou L, Diamandis EP, Souvatzoglou A.
     Department of Therapeutics, Faculty of Medicine, University of Athens, Alexandra Hospital, Greece
     Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays
     Therapeutic Drug Monitoring 1987 Dec;9(4):461-3. [PMID 3424414 378 KB, Related Articles] [ISI A1987L169600017, cited 9 times]
771. Khosravi MJ, Diamandis EP.
     CyberFluor Inc., Toronto, Canada
     Immunofluorometry of choriogonadotropin by time-resolved fluorescence spectroscopy, with a new europium chelate as label
     Clinical Chemistry 1987 Nov;33(11):1994-9. [PMID 3119252 1.2 MB, Related Articles] [ISI A1987K997700006, cited 47 times]
772. Chan MA, Bellem AC, Diamandis EP.
     CyberFluor Inc., Toronto, Ontario, Canada
     Time-resolved immunofluorometric assay of alpha-fetoprotein in serum and amniotic fluid, with a novel detection system
     Clinical Chemistry 1987 Nov;33(11):2000-3. [PMID 2445505 717 KB, Related Articles] [ISI A1987K997700007, cited 33 times]
773. Mitsana-Papazoglou A, Christopoulos TK, Diamandis EP, Koupparis MA.
     Laboratory of Analytical Chemistry, University of Athens, Greece
     Dissolution studies of drug formulations using ion-selective electrodes as sensors in an air-segmented continuous flow analyzer
     Journal of Pharmaceutical Sciences 1987 Sep;76(9):724-30. [PMID 11002810 1.1 MB, Related Articles] [ISI A1987K613400010, cited 7 times]
774. Christopoulos TK, Diamandis EP.
     FLOW-THROUGH UNITS FOR SOLID-STATE, LIQUID AND PVC MATRIX MEMBRANE ION-SELECTIVE ELECTRODES TO MINIMIZE STREAMING POTENTIALS
     Analyst 1987 Sep;112(9):1293-1298 [ISI A1987K355600020 974 KB, cited 17 times]
775. Mitsana-Papazoglou A, Diamandis EP, Hadjiioannou TP.
     Ion-selective electrodes for the H2-receptor antagonists cimetidine and ranitidine
     Journal of Pharmaceutical Sciences 1987 Jun;76(6):485-91. [PMID 3625496 1.1 MB, Related Articles] [ISI A1987J239500014, cited 13 times]

1986

776. Christopoulos TK, Diamandis EP.
     A general method for the assay of binders. Application to the potentiometric determination of albumin in human serum, plasma and whole blood
     Clinical Biochemistry 1986 Jun;19(3):151-60. [PMID 3731433 2.1 MB, Related Articles] [ISI A1986C975900002, cited twice]
777. Sarantonis EG, Diamandis EP, Karayannis MI.
     Kinetic study of the reaction between trinitrobenzenesulfonic acid and amino acids with a trinitrobenzenesulfonate ion-selective electrode
     Analytical Biochemistry 1986 May 15;155(1):129-34. [PMID 3717549 617 KB, Related Articles] [ISI A1986C379700023, cited 8 times]
778. Gritzapis PC, Diamandis EP, Hadjiioannou TP.
     DETERMINATION OF THE 2ND IONIZATION-CONSTANT OF 3,5-DINITROSALICYLIC ACID (DNSH2) AND THE INSTABILITY CONSTANT OF [DNSFE]+ AND TITRIMETRIC DETERMINATION OF THIOUREA WITH A 3,5-DINITROSALICYLATE-SELECTIVE ELECTRODE
     Microchemical Journal 1986 Feb;33(1):62-70 [ISI A1986A302400010 676 KB, cited twice]

1985

779. Christopoulos TK, Mitsanapapazoglou A, Diamandis EP.
     ION-SELECTIVE ELECTRODES FOR THE DETERMINATION OF IONIZATION-CONSTANTS OF SPARINGLY SOLUBLE ORGANIC-BASES IN AQUEOUS-SOLUTIONS - APPLICATIONS TO CHLORPROMAZINE AND AMITRIPTYLINE
     Analyst 1985 Dec;110(12):1497-1500 [ISI A1985AXH4000016 605 KB, cited 9 times]
780. Diamandis EP, Papanastasioudiamandi A, Christopoulos TK, Hadjiioannou TP.
     CONTINUOUS-FLOW POTENTIOMETRIC DETERMINATION OF ALPHA-AMYLASE ACTIVITY IN SERUM AND URINE
     Microchemical Journal 1985;32(2):183-190 [ISI A1985ASS3200009 902 KB]
781. Mitsana-Papazoglou A, Christopoulos TK, Diamandis EP, Hadjiioannou TP.
     Construction of ion-selective electrodes for chlorpromazine, amitriptyline, propantheline and meperidine: analytical study and application to pharmaceutical analysis
     Analyst 1985 Sep;110(9):1091-4. [PMID 4061861 956 KB, Related Articles] [ISI A1985ARF4600009, cited 35 times]
782. Koupparis MA, Diamandis EP, Malmstadt HV.
     Automated stopped-flow analyser in clinical chemistry: determination of albumin with bromcresol green and purple
     Clinica Chimica Acta 1985 Jul 15;149(2-3):225-35. [PMID 4028442 1.1 MB, Related Articles] [ISI A1985APD1300013, cited 8 times]
783. Diamandis EP, Papanastasiou-Diamandi A, Soldin SJ.
     Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+, K+-ATPase
     Clinical Biochemistry 1985 Feb;18(1):48-55. [PMID 2985294 1.6 MB, Related Articles] [ISI A1985ABZ6000008, cited 85 times]

1984

784. Ellis G, Diamandis EP, Giesbrecht EE, Daneman D, Allen LC.
     An automated ''high-pressure'' liquid-chromatographic assay for hemoglobin A1c
     Clinical Chemistry 1984 Nov;30(11):1746-52. [PMID 6488517 1.7 MB, Related Articles] [ISI A1984TR42100004, cited 87 times]
785. Papanastasiou-Diamandi A, Diamandis EP, Soldin SJ.
     Enzymic measurement of primary bile acids and the primary bile acid ratio in serum with the IL-Multistat III Fluorescence Light-Scattering Centrifugal Analyzer
     Clinical Biochemistry 1984 Aug;17(4):242-8. [PMID 6090040 1.1 MB, Related Articles] [ISI A1984TB36400005, cited twice]
786. Diamandis EP, Hoffman BR.
     Total Mg2+ measured in serum and urine in the Technicon RA 1000 random access analyzer by use of modified manual calmagite procedure [letter]
     Clinical Chemistry 1984 Jul;30(7):1262. [PMID 6733914 166 KB, Related Articles] [ISI A1984TA70200038, cited 7 times]
787. Mitsanapapazoglou A, Diamandis EP, Hadjiioannou TP.
     CONSTRUCTION AND ANALYTICAL APPLICATIONS OF AN IMPROVED LIQUID-MEMBRANE ELECTRODE FOR SALICYLATE
     Analytica Chimica Acta 1984 May;159:393-396 [ISI A1984SW97800040 530 KB, cited 25 times]
788. Diamandis EP, Ellis G, Daneman D, Allen LC.
     Liquid chromatography of glycated hemobglobins with the Daiichi HA-8110 automated analyzer [letter]
     Clinical Chemistry 1984 Mar;30(3):503-4. [PMID 6697523 241 KB, Related Articles] [ISI A1984SG93900060, cited 11 times]

1983

789. Siskos PA, Diamandis EP, Gillieron E, Colbert JC.
     Laboratory of Analytical Chemistry, University of Athens, 104 Solonos St., Athens 144, Greece
     Potentiometric titration of sulphate, sulphite and dithionate mixtures, with use of a lead ion-selective electrode
     Talanta 1983 Dec;30(12):980-2. [PMID 18963511 285 KB, Related Articles] [ISI A1983RV32100018, cited 15 times]
790. Papanastasiou-Diamandi A, Diamandis EP, Siskos PA.
     Direct enzymic fluorimetric method for the determination of individual bile acids in bile
     Clinica Chimica Acta 1983 Oct 31;134(1-2):17-23. [PMID 6580976 756 KB, Related Articles] [ISI A1983RP00500003, cited 4 times]
791. Diamandis EP, Christopoulos TK.
     POTENTIOMETRIC TITRATION OF PHARMACEUTICAL COMPOUNDS IN FORMULATIONS WITH SODIUM TETRAPHENYLBORATE
     Analytica Chimica Acta 1983 Sep;152:281-284 [ISI A1983RJ14900030 553 KB, cited 22 times]
792. Diamandis EP, Hadjiioannou TP.
     STUDY OF THE STOICHIOMETRY AND THE KINETICS OF THE JAFFE REACTION WITH A PICRATE ION-SELECTIVE ELECTRODE
     Microchemical Journal 1983;28(3):399-408 [ISI A1983RG50100015 1 MB, cited twice]
793. Diamandis EP, Efstathiou CE, Papastathopoulos DS, Hadjiioannou TP.
     CONTINUOUS-FLOW DETERMINATION OF REDUCING SUGARS IN SERUM BY REACTION WITH PERIODATE IONS, WITH USE OF A FLOW-THROUGH PERIODATE-SENSITIVE ELECTRODE
     Microchemical Journal 1983;28(2):227-234 [ISI A1983QQ14300011 798 KB, cited 7 times]
794. Papanastasiou-Diamandi A, Siskos PA, Diamandis EP.
     A direct kinetic fluorimetric method for the enzymic determination of lactate in plasma
     Clinica Chimica Acta 1983 Apr 25;129(3):359-64. [PMID 6851173 605 KB, Related Articles] [ISI A1983QN94000014, cited 3 times]
795. Diamandis EP, Koupparis MA, Hadjiioannou TP.
     KINETIC-STUDIES WITH ION-SELECTIVE ELECTRODES - DETERMINATION OF CREATININE IN URINE WITH A PICRATE ION-SELECTIVE ELECTRODE - A LABORATORY EXPERIMENT
     Journal of Chemical Education 1983;60(1):74-76 [ISI A1983QA17100023 589 KB, cited 3 times]
796. Koupparis MA, Diamandis EP, Malmstadt HV.
     Automated determination of crude protein, phosphorus, calcium, iron, and magnesium in feeds by using stopped-flow analyzer
     Journal of the Association of Official Analytical Chemists 1983 Jan;66(1):188-96. [PMID 6826506 1.4 MB, Related Articles] [ISI A1983QA23300036, cited 3 times]

1982

797. Diamandis EP, Hadjiioannou TP.
     CONTINUOUS-FLOW POTENTIOMETRIC DETERMINATION OF CREATININE IN URINE WITH A PICRATE ION-SELECTIVE ELECTRODE
     Microchemical Journal 1982;27(4):512-518 [ISI A1982PW99000005 576 KB, cited twice]
798. Diamandis EP, Hadjiioannou TP.
     Continuous-flow determination of reducing sugars and sucrose in natural and industrial products with periodate oxidation and a periodate-sensitive flow-through electrode
     Analyst 1982 Dec;107(1281):1471-8. [PMID 6297335 1 MB, Related Articles] [ISI A1982PU20400011, cited 17 times]
799. Christopoulos TK, Diamandis EP, Hadjiioannou TP.
     POTENTIOMETRIC TITRATION OF ORGANIC CATIONS WITH SODIUM TETRAPHENYLBORATE AND A LIQUID-MEMBRANE TETRAPHENYLBORATE ION-SELECTIVE ELECTRODE
     Analytica Chimica Acta 1982;143(1):143-151 [ISI A1982PT27300010 1.2 MB, cited 36 times]
800. Koupparis MA, Diamandis EP, Malmstadt HV.
     Total calcium and magnesium determined in serum with an automated stopped-flow analyzer
     Clinical Chemistry 1982 Oct;28(10):2149-52. [PMID 7127745 707 KB, Related Articles] [ISI A1982PK48500029, cited 4 times]
801. Diamandis EP, Efstathiou CE, Hadjiioannou TP.
     Stability of the composite solution [Mercury (II)-TPTZ-iron(II)] used for the automated determination of serum chloride [letter]
     Clinical Chemistry 1982 Jan;28(1):254. [PMID 7055931 108 KB, Related Articles] [ISI A1982MX79300082, cited twice]

1981

802. Diamandis EP, Athanasioumalaki E, Papastathopoulos DS, Hadjiioannou TP.
     CONSTRUCTION AND ANALYTICAL APPLICATIONS OF LIQUID-MEMBRANE ELECTRODES FOR ATROPINE AND NOVATROPINE
     Analytica Chimica Acta 1981 Jul;128:239-244 [ISI A1981LX40500029 812 KB, cited 26 times]
803. Efstathiou CE, Diamandis EP, Hadjiioannou TP.
     POTENTIOMETRIC DETERMINATION OF NICOTINE IN TOBACCO PRODUCTS WITH A NICOTINE-SENSITIVE LIQUID MEMBRANE-ELECTRODE
     Analytica Chimica Acta 1981 Jun;127:173-180 [ISI A1981LT38000017 977 KB, cited 28 times]
804. Diamandis EP, Hadjiioannou TP.
     Kinetic potentiometric determination of creatinine in serum with a picrate ion-selective membrane electrode
     Clinical Chemistry 1981 Mar;27(3):455-7. [PMID 7471397 564 KB, Related Articles] [ISI A1981LF93000020, cited 14 times]
805. Diamandis EP, Papastathopoulos DS, Hadjiioannou TP.
     Continuous-flow serum albumin determination by reaction with picrate ions, with use of a flow-through picrate ion electrode
     Clinical Chemistry 1981 Mar;27(3):427-30. [PMID 7471392 775 KB, Related Articles] [ISI A1981LF93000013, cited 13 times]
806. Diamandis EP, Hadjiioannou TP.
     CATALYTIC DETERMINATION OF SELENIUM WITH A PICRATE-SELECTIVE ELECTRODE
     Analytica Chimica Acta 1981 Jan;123:143-150 [ISI A1981LA22400017 847 KB, cited 26 times]
807. Diamandis EP, Hadjiioannou TP.
     POTENTIOMETRIC DETERMINATION OF SOME COMMON ALKALOIDS WITH A PICRATE-SELECTIVE ELECTRODE
     Analytica Chimica Acta 1981 Jan;123:341-345 [ISI A1981LA22400042 611 KB, cited 27 times]

1980

808. Diamandis EP, Efstathiou CE, Hadjiioannou TP.
     AUTOMATIC-DETERMINATION OF ETHYLENE-GLYCOL IN ANTI-FREEZE SOLUTIONS WITH A PERIODATE-SENSITIVE FLOW-THROUGH ELECTRODE
     Analyst 1980;105(1257):1203-1207 [ISI A1980LA41700010 586 KB, cited 8 times]
809. Diamandis EP, Hadjiioannou TP.
     TITRIMETRIC DETERMINATION OF IODIDE, HEXACYANOFERRATE(II), THIOUREA, CATIONIC SURFACTANTS, AND OF PICRATE WITH A PICRATE ION-SELECTIVE ELECTRODE
     Mikrochimica Acta 1980;2(1 to 2):27-38 [ISI A1980KW66100004 1 MB, cited 10 times]
810. Diamandis EP, Hadjiioannou TP.
     ANALYTICAL STUDY OF NEW CREATININIUM AND TETRAMETHYLAMMONIUM CATION SELECTIVE MEMBRANE ELECTRODES
     Analytical Letters Part B-Clinical and Biochemical Analysis 1980;13(15):1317-1332 [ISI A1980KU23800002 929 KB, cited 12 times]
811. Papastathopoulos DS, Diamandis EP, Hadjiioannou TP.
     FLOW-THROUGH ELECTRODE UNIT FOR LIQUID MEMBRANE ELECTRODES [review]
     Analytical Chemistry 1980;52(13):2100-2104 [ISI A1980KN38600032 810 KB, cited 19 times]

1978

812. Diamandis EP.
     CORRECTION [correction]
     Microchemical Journal 1978;23(3):415 [ISI A1978FT79100020 32 KB]

1977

813. Diamandis EP, Koupparis MA, Hadjiioannou TP.
     KINETIC POTENTIOMETRIC DETERMINATION OF CREATININE IN URINE WITH A PICRATE-ION-SELECTIVE ELECTRODE
     Microchemical Journal 1977;22(4):498-504 [ISI A1977EG09200013 651 KB, cited 24 times]
814. Hadjiioannou TP, Diamandis EP.
     ANALYTICAL STUDY OF A NEW PICRATE-SELECTIVE MEMBRANE ELECTRODE
     Analytica Chimica Acta 1977;94(2):443-447 [ISI A1977ED27300026 1 MB, cited 38 times]
815. Diamandis EP, Hadjiioannou TP.
     TITRIMETRIC DETERMINATION OF THIOUREA AND SILVER WITH A PICRATE ION-SELECTIVE ELECTRODE
     Mikrochimica Acta 1977;2(3 to 4):255-260 [ISI A1977EA50100018 483 KB, cited 8 times]